Record Q1 profit at Royal Bank of Canada (TSX: RY, NYSE: RY stock)
Royal Bank of Canada reported record Q1 2026 net income of
Record pre-provision, pre-tax earnings of
Credit costs increased modestly, with total provisions for credit losses of
Positive
- Record profitability and double-digit growth: Q1 2026 net income reached a record
$5.8 billion , up13% year over year, with diluted EPS up14% to$4.03 and record pre-provision, pre-tax earnings of$8.5 billion up14% . - Strong returns and capital strength: Return on common equity was
17.6% (adjusted17.8% ), while the CET1 ratio stood at a robust13.7% , supporting$3.3 billion of capital returned to shareholders through dividends and share buybacks. - Broad-based segment growth: Net income grew across core businesses, including Personal Banking up
17% to$1.96 billion , Commercial Banking up11% to$863 million , Wealth Management up32% to$1.30 billion , and Capital Markets up3% to$1.48 billion .
Negative
- None.
Insights
RBC delivered record Q1 earnings with strong capital and broad-based segment growth.
Royal Bank of Canada posted record Q1 2026 net income of
Revenue grew
Credit quality remains manageable: total provisions for credit losses were
| 200 Bay Street | 1 Place Ville Marie | |
| Royal Bank Plaza | Montreal, Quebec | |
| Toronto, Ontario | Canada H3B 3A9 | |
| Canada M5J 2J5 | Attention: Senior Vice-President, | |
| Attention: Senior Vice-President, | Deputy General Counsel | |
| Deputy General Counsel | & Corporate Secretary | |
| & Corporate Secretary |
ROYAL BANK OF CANADA | ||||||
Date: February 26, 2026 |
By: |
/s/ Katherine Gibson | ||||
Name: |
Katherine Gibson | |||||
Title: |
Chief Financial Officer | |||||
Exhibit |
Description of Exhibit | |
99.1 |
First Quarter 2026 Earnings Release | |
99.2 |
First Quarter 2026 Report to Shareholders (which includes management’s discussion and analysis and unaudited interim condensed consolidated financial statements) | |
99.3 |
Return on Equity and Assets Ratios | |
Rule 13a-14(a)/15d-14(a) | ||
31.1 |
- Certification of the Registrant’s Chief Executive Officer | |
31.2 |
- Certification of the Registrant’s Interim Chief Financial Officer | |
101 |
Interactive Data File (formatted as Inline XBRL) | |
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |
| Exhibit 99.1 | ||
|
|
FIRST QUARTER 2026 EARNINGS RELEASE | |
| ROYAL BANK OF CANADA REPORTS FIRST QUARTER 2026 RESULTS |
All amounts are in Canadian dollars and are based on financial statements presented in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Our Q1 2026 Report to Shareholders and Supplementary Financial Information are available at rbc.com/investorrelations and on sedarplus.com.
| Net income
$5.8 Billion
Up 13% YoY
|
Diluted EPS1
$4.03
Up 14% YoY
|
Total PCL1
$1.1 Billion
PCL on loans ratio1 up 2 bps1 QoQ
|
ROE1
17.6%
Up 80 bps YoY |
CET1 ratio1
13.7%
Above regulatory requirements
|
| Adjusted net income2
$5.9 Billion
Up 12% YoY |
Adjusted diluted EPS2
$4.08
Up 13% YoY
|
Total ACL1
$7.8 Billion
ACL on loans ratio1 up 2 bps QoQ
|
Adjusted ROE2
17.8%
Up 60 bps YoY |
LCR1
124%
Down from 127% last quarter
|
TORONTO, February 26, 2026 — Royal Bank of Canada3 (RY on TSX and NYSE) today reported record net income of $5.8 billion for the quarter ended January 31, 2026, up $654 million or 13% from the prior year. Diluted EPS was $4.03, up 14% over the same period, reflecting higher results in Wealth Management, Personal Banking, Commercial Banking and Capital Markets, partially offset by lower results in Insurance. Adjusted net income2 and adjusted diluted EPS2 of $5.9 billion and $4.08 were up 12% and 13%, respectively, from the prior year.
|
“RBC entered the 2026 fiscal year in a position of strength across our diversified business model and the core global markets where we operate. We carried this momentum into our first quarter, reporting record results underpinned by strong earnings growth, our robust balance sheet and capital position, and a premium ROE that continues to deliver value for our shareholders.
Our record performance is a direct reflection of our world-class client franchises and Team RBC’s commitment to delivering exceptional service, advice and insights at scale. In an increasingly complex world, we are focused on bringing the full power of RBC’s global capabilities to support our clients and meet their evolving needs.”
– Dave McKay, President and Chief Executive Officer of Royal Bank of Canada |
Record pre-provision, pre-tax earnings2 of $8.5 billion were up $1.0 billion or 14% from last year, mainly due to higher net interest income reflecting average volume growth in Personal Banking and Commercial Banking and higher spreads in Personal Banking. Higher fee-based revenue in Wealth Management reflecting market appreciation and net sales and higher revenue in Capital Markets driven by strength in Global Markets also contributed to the increase. These factors were partially offset by higher variable compensation commensurate with increased results and higher staff costs.
Our consolidated results reflect an increase in total PCL of $40 million from a year ago, mainly reflecting higher provisions in Capital Markets and Personal Banking, partly offset by lower provisions in Wealth Management and Commercial Banking. The PCL on loans ratio of 41 bps decreased 1 bp from the prior year. The PCL on impaired loans ratio1 was 40 bps up 1 bp, while the PCL on performing loans ratio1 was 1 bp, down 2 bps. Record income before income taxes of $7.4 billion was up $1.0 billion or 15% from last year.
Compared to last quarter, net income was up 6% reflecting growth across each of our business segments. Adjusted net income2 was up 6% over the same period. Pre-provision, pre-tax earnings2 were up $0.7 billion or 8% as higher revenues more than offset expense growth. The PCL on loans ratio of 41 bps increased 2 bps from the prior quarter. The PCL on impaired loans ratio was 40 bps, up 2 bps from the prior quarter, primarily due to higher provisions in Capital Markets and Personal Banking, partially offset by lower provisions in Commercial Banking, while the PCL on performing loans ratio was 1 bp, remaining flat from the prior quarter.
Our capital position remains robust, with a CET1 ratio1 of 13.7%, supporting solid volume growth and $3.3 billion of capital returned to our shareholders, including $1.0 billion of share buybacks and $2.3 billion of common share dividends.
| 1 | See the Glossary section of our interim Management’s Discussion and Analysis dated February 25, 2026, available at sedarplus.com, for an explanation of the composition of these measures. Such explanation is incorporated by reference hereto. |
| 2 | These are non-GAAP measures or ratios. For further information, including a reconciliation, refer to the Key performance and non-GAAP measures section on pages 4 to 5 of this Earnings Release. |
| 3 | When we say “we”, “us”, “our”, “the bank” or “RBC”, we mean Royal Bank of Canada and its subsidiaries, as applicable. |
- 1 -
| Reported: | Adjusted4: | |||||||
| Q1 2026 |
Net income of $5,785 million |
h 13% |
Net income of $5,861 million |
h 12% | ||||
| Compared to |
Diluted EPS of $4.03 |
h 14% |
Diluted EPS of $4.08 |
h 13% | ||||
| Q1 2025 |
ROE of 17.6% |
h 80 bps |
ROE of 17.8% |
h 60 bps | ||||
CET1 ratio5 of 13.7% |
h 50 bps |
|||||||
|
| ||||||||
| Q1 2026 |
Net income of $5,785 million |
h 6% |
Net income of $5,861 million |
h 6% | ||||
| Compared to |
Diluted EPS of $4.03 |
h 7% |
Diluted EPS of $4.08 |
h 6% | ||||
| Q4 2025 |
ROE of 17.6% |
h 80 bps |
ROE of 17.8% |
h 60 bps | ||||
CET1 ratio5 of 13.7% |
h 20 bps |
|||||||
|
| ||||||||
| Personal Banking
|
Net income of $1,962 million increased $284 million or 17% from a year ago, largely driven by higher net interest income reflecting higher spreads and average volume growth of 2%, including 4% in loans, in Personal Banking – Canada. Higher non-interest income driven by higher fee-based client assets reflecting market appreciation and net sales also contributed to the increase. Net interest margin (NIM) was up 14 bps, mainly due to favourable changes in product mix.
Compared to last quarter, net income increased $75 million or 4%, primarily driven by higher net interest income reflecting average volume growth of 1% in loans and higher spreads in Personal Banking – Canada, as well as lower non-interest expenses. NIM was up 2 bps, mainly due to a favourable shift in deposit mix.
| Commercial Banking
|
Net income of $863 million increased $86 million or 11% from a year ago, primarily driven by higher net interest income, reflecting average volume growth of 5% in deposits and 4% in loans, and lower PCL, mainly due to lower provisions on impaired loans in a few sectors.
Compared to last quarter, net income increased $53 million or 7%, primarily due to lower PCL.
| Wealth Management
|
Net income of $1,295 million increased $315 million or 32% from a year ago, primarily due to higher fee-based client assets reflecting market appreciation and net sales.
Compared to last quarter, net income increased $11 million or 1%, mainly reflecting revenue growth driven by higher fee-based client assets, net interest income and performance fees. This was largely offset by higher expenses, primarily reflecting higher staff costs, including seasonally higher compensation, and the impact of favourable tax adjustments in the prior quarter.
| Insurance
|
Net income of $213 million decreased $59 million or 22% from a year ago, primarily due to lower insurance service result driven by the impact of reinsurance contract recaptures in the prior year.
Compared to last quarter, net income increased $115 million or 117%, primarily due to higher insurance service result, as the prior quarter included the impact of unfavourable annual actuarial assumption updates and an adjustment related to reinsurance contract recaptures.
| Capital Markets
|
Net income of $1,478 million increased $46 million or 3% from a year ago, mainly due to higher revenue in Global Markets, partially offset by higher PCL.
Compared to last quarter, net income increased $47 million or 3%, largely due to higher revenue in Global Markets driven by higher equity trading revenue across most regions and higher fixed income trading revenue across all regions. This was partially offset by higher compensation on increased results and higher PCL.
| 4 | These are non-GAAP measures or ratios. For further information, including a reconciliation, refer to the Key performance and non-GAAP measures section on pages 4 to 5 of this Earnings Release. |
| 5 | See the Glossary section of our interim Management’s Discussion and Analysis dated February 25, 2026, available at sedarplus.com, for an explanation of the composition of these measures. Such explanation is incorporated by reference hereto. |
- 2 -
| Corporate Support
|
Net loss was $26 million for the current quarter, primarily due to residual unallocated costs, partially offset by asset/liability management activities.
Net loss was $76 million in the prior quarter, primarily due to residual unallocated costs, partially offset by asset/liability management activities.
Net loss was $8 million in the same quarter last year.
| Capital, Liquidity and Credit Quality
|
Capital – As at January 31, 2026, our CET1 ratio6 of 13.7% was up 20 bps from last quarter, reflecting net internal capital generation, regulatory and model updates, as well as a favourable impact from fair value OCI adjustments, partially offset by business-driven RWA growth and share repurchases.
Liquidity – For the quarter ended January 31, 2026, the average LCR6 was 124%, which translates into a surplus of approximately $91 billion, compared to 127% and a surplus of approximately $97 billion in the prior quarter. Average LCR6 decreased from the prior quarter, primarily due to growth in securities and loans, partially offset by an increase in deposits and funding.
NSFR6 as at January 31, 2026 was 111%, which translates into a surplus of approximately $113 billion, compared to 112% and a surplus of approximately $127 billion in the prior quarter. NSFR6 decreased compared to the previous quarter, primarily due to loan growth.
Credit Quality
Q1 2026 vs. Q1 2025
Total PCL of $1,090 million increased $40 million or 4% from a year ago, primarily due to higher provisions in Capital Markets and Personal Banking, partially offset by lower provisions in Wealth Management and Commercial Banking. The PCL on loans ratio of 41 bps decreased 1 bp. The PCL on impaired loans ratio of 40 bps increased 1 bp.
PCL on performing loans of $28 million decreased $40 million or 59%, largely due to lower unfavourable changes in credit quality and favourable changes to our macroeconomic forecast. This was partially offset by migration to impaired in Capital Markets in the same quarter last year.
PCL on impaired loans of $1,068 million increased $83 million or 8%, primarily due to higher provisions in Personal Banking and Capital Markets, partially offset by lower provisions in Commercial Banking.
Q1 2026 vs. Q4 2025
Total PCL increased $83 million or 8% from last quarter, primarily reflecting higher provisions in Capital Markets, partially offset by lower provisions in Commercial Banking. The PCL on loans ratio increased 2 bps. The PCL on impaired loans ratio increased 2 bps.
PCL on performing loans increased $14 million, primarily due to lower favourable changes to our macroeconomic forecast, partially offset by lower unfavourable changes in credit quality.
PCL on impaired loans increased $84 million or 9%, primarily due to higher provisions in Capital Markets and Personal Banking, partially offset by lower provisions in Commercial Banking.
| 6 | See the Glossary section of our interim Management’s Discussion and Analysis dated February 25, 2026, available at sedarplus.com, for an explanation of the composition of these measures. Such explanation is incorporated by reference hereto. |
- 3 -
| Key Performance and Non-GAAP Measures
|
Performance measures
We measure and evaluate the performance of our consolidated operations and each business segment using a number of financial metrics, such as net income and ROE. Certain financial metrics, including ROE, do not have a standardized meaning under generally accepted accounting principles (GAAP) and may not be comparable to similar measures disclosed by other financial institutions.
Non-GAAP measures
Non-GAAP measures and ratios do not have a standardized meaning under GAAP and may not be comparable to similar measures disclosed by other financial institutions.
The following discussion describes the non-GAAP measures and ratios we use in evaluating our operating results.
Pre-provision, pre-tax earnings
We use pre-provision, pre-tax earnings (PPPT) to assess our ability to generate sustained earnings growth outside of credit losses, which are impacted by the cyclical nature of the credit cycle. PPPT may enhance comparability of our financial performance and enable readers to better assess trends in the underlying businesses. The following table provides a reconciliation of our reported results to PPPT and illustrates the calculation of PPPT presented:
| For the three months ended | ||||||||||||
| (Millions of Canadian dollars) | January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
| Net income |
$ | 5,785 | $ | 5,434 | $ | 5,131 | ||||||
| Add: Income taxes |
1,622 | 1,394 | 1,302 | |||||||||
| Add: PCL |
1,090 | 1,007 | 1,050 | |||||||||
| Pre-provision, pre-tax earnings |
$ | 8,497 | $ | 7,835 | $ | 7,483 | ||||||
Adjusted results and ratios
We believe that adjusted results are more reflective of our ongoing operating results and provide readers with a better understanding of management’s perspective on performance. Specified items discussed below can lead to variability that could obscure trends in underlying business performance and the amortization of acquisition-related intangibles can differ widely between organizations. Excluding the impact of specified items and amortization of acquisition-related intangibles may enhance comparability of our financial performance and enable readers to better assess trends in the underlying businesses.
Our results for the three months ended January 31, 2025 were adjusted for the following specified item:
| | HSBC Bank Canada (HSBC Canada) transaction and integration costs. |
Adjusted ratios, including adjusted EPS (basic and diluted), adjusted ROE and adjusted efficiency ratio, which are derived from adjusted results, are useful to readers because they may enhance comparability in assessing profitability on a per-share basis, how efficiently profits are generated from average common equity and how efficiently costs are managed relative to revenues. Adjusted results and ratios can also help inform and support strategic choices and capital allocation decisions.
- 4 -
The following table provides a reconciliation of our reported results to our adjusted results and illustrates the calculation of adjusted measures presented. The adjusted results and ratios presented below are non-GAAP measures or ratios.
| Consolidated results, reported and adjusted | ||||||||||||
| As at or for the three months ended | ||||||||||||
| (Millions of Canadian dollars, except per share, number of and percentage amounts) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
| Total revenue |
$ | 17,960 | $ | 17,209 | $ | 16,739 | ||||||
| PCL |
1,090 | 1,007 | 1,050 | |||||||||
| Non-interest expense |
9,463 | 9,374 | 9,256 | |||||||||
| Income before income taxes |
7,407 | 6,828 | 6,433 | |||||||||
| Income taxes |
1,622 | 1,394 | 1,302 | |||||||||
| Net income |
$ | 5,785 | $ | 5,434 | $ | 5,131 | ||||||
| Net income available to common shareholders |
$ | 5,643 | $ | 5,293 | $ | 5,011 | ||||||
| Average number of common shares (thousands) |
1,398,580 | 1,403,782 | 1,413,937 | |||||||||
| Basic earnings per share (in dollars) |
$ | 4.03 | $ | 3.77 | $ | 3.54 | ||||||
| Average number of diluted common shares (thousands) |
1,401,884 | 1,406,696 | 1,416,502 | |||||||||
| Diluted earnings per share (in dollars) |
$ | 4.03 | $ | 3.76 | $ | 3.54 | ||||||
| ROE |
17.6% | 16.8% | 16.8% | |||||||||
| Effective income tax rate |
21.9% | 20.4% | 20.2% | |||||||||
| Total adjusting items impacting net income (before-tax) |
$ | 102 | $ | 153 | $ | 165 | ||||||
| Specified item: HSBC Canada transaction and integration costs (1) |
- | - | 12 | |||||||||
| Amortization of acquisition-related intangibles (2) |
102 | 153 | 153 | |||||||||
| Total income taxes for adjusting items impacting net income |
$ | 26 | $ | 33 | $ | 42 | ||||||
| Specified item: HSBC Canada transaction and integration costs (1) |
- | - | 6 | |||||||||
| Amortization of acquisition-related intangibles (2) |
26 | 33 | 36 | |||||||||
| Adjusted results (3) |
||||||||||||
| Income before income taxes - adjusted |
$ | 7,509 | $ | 6,981 | $ | 6,598 | ||||||
| Income taxes - adjusted |
1,648 | 1,427 | 1,344 | |||||||||
| Net income - adjusted |
5,861 | 5,554 | 5,254 | |||||||||
| Net income available to common shareholders - adjusted |
5,719 | 5,413 | 5,134 | |||||||||
| Average number of common shares (thousands) |
1,398,580 | 1,403,782 | 1,413,937 | |||||||||
| Basic earnings per share (in dollars) - adjusted (3) |
$ | 4.09 | $ | 3.86 | $ | 3.63 | ||||||
| Average number of diluted common shares (thousands) |
1,401,884 | 1,406,696 | 1,416,502 | |||||||||
| Diluted earnings per share (in dollars) - adjusted (3) |
$ | 4.08 | $ | 3.85 | $ | 3.62 | ||||||
| ROE - adjusted (3) |
17.8% | 17.2% | 17.2% | |||||||||
| Effective income tax rate - adjusted (3) |
21.9% | 20.4% | 20.4% | |||||||||
| (1) | These amounts have been recognized in Corporate Support. |
| (2) | Represents the impact of amortization of acquisition-related intangibles (excluding amortization of software), and any goodwill impairment. |
| (3) | See the Glossary section of our interim Management’s Discussion and Analysis dated February 25, 2026, available at sedarplus.com, for an explanation of the composition of these measures. Such explanation is incorporated by reference hereto. |
Additional information about ROE and other key performance and non-GAAP measures and ratios can be found under the Key performance and non-GAAP measures section of our Q1 2026 Report to Shareholders.
- 5 -
| Caution Regarding Forward-Looking Statements
|
From time to time, we make written or oral forward-looking statements within the meaning of certain securities laws, including the “safe harbour” provisions of the United States’ Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities legislation. We may make forward-looking statements in this document, in other filings with Canadian regulators or the United States Securities and Exchange Commission, in reports to shareholders and in other communications. In addition, our representatives may communicate forward-looking statements orally to analysts, investors, the media and others. Forward-looking statements in this document include, but are not limited to, statements by our President and Chief Executive Officer. The forward-looking statements contained in this document represent the views of management and are presented for the purpose of assisting the holders of our securities and financial analysts in understanding our financial position and results of operations as at and for the periods ended on the dates presented, as well as our financial performance objectives, vision, strategic goals and priorities and anticipated financial performance, and may not be appropriate for other purposes. Forward-looking statements are typically identified by words such as “believe”, “expect”, “suggest”, “seek”, “foresee”, “forecast”, “schedule”, “anticipate”, “intend”, “estimate”, “goal”, “commit”, “target”, “objective”, “plan”, “outlook”, “timeline” and “project” and similar expressions of future or conditional verbs such as “will”, “may”, “might”, “should”, “could”, “can”, “would” or negative or grammatical variations thereof.
By their very nature, forward-looking statements require us to make assumptions and are subject to inherent risks and uncertainties, both general and specific in nature, which give rise to the possibility that our predictions, forecasts, projections, expectations or conclusions will not prove to be accurate, that our assumptions may not be correct, that our financial performance, environmental & social or other objectives, vision and strategic goals will not be achieved, and that our actual results may differ materially from such predictions, forecasts, projections, expectations or conclusions.
We caution readers not to place undue reliance on our forward-looking statements as a number of risk factors could cause our actual results to differ materially from the expectations expressed in such forward-looking statements. These factors – many of which are beyond our control and the effects of which can be difficult to predict – include, but are not limited to: business and economic conditions in the geographic regions in which we operate, Canadian housing and household indebtedness, information technology, cyber and third-party risks, geopolitical uncertainty, environmental and social (E&S) risk, digital disruption and innovation, privacy and data related risks, regulatory changes, culture and conduct risks, credit, market, liquidity and funding, insurance, operational, compliance, reputation and strategic risks, other risks discussed in the risk sections of our 2025 Annual Report, including legal and regulatory environment risk, the effects of changes in government fiscal, monetary and other policies and tax risk and transparency, risks associated with escalating trade tensions, including protectionist trade policies such as the imposition of tariffs, risks associated with the adoption of emerging technologies, such as cloud computing, artificial intelligence (AI), including generative AI (GenAI), and robotics, fraud risk and our ability to anticipate and successfully manage risks arising from all of the foregoing factors. Additional factors that could cause actual results to differ materially from the expectations in such forward-looking statements can be found in the risk sections of our 2025 Annual Report and the Risk management section of our Q1 2026 Report to Shareholders, as may be updated by subsequent quarterly reports.
We caution that the foregoing list of risk factors is not exhaustive and other factors could also adversely affect our results. When relying on our forward-looking statements to make decisions with respect to us, investors and others should carefully consider the foregoing factors and other uncertainties and potential events, as well as the inherent uncertainty of forward-looking statements. Material economic assumptions underlying the forward-looking statements contained in this document are set out in the Economic, market and regulatory review and outlook section and for each business segment under the Strategic priorities and Outlook headings in our 2025 Annual Report, as updated by the Economic, market and regulatory review and outlook section of our Q1 2026 Report to Shareholders. Such sections may be updated by subsequent quarterly reports. Any forward-looking statements contained in this document represent the views of management only as of the date hereof, and except as required by law, we do not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by us or on our behalf.
ACCESS TO QUARTERLY RESULTS MATERIALS
Interested investors, the media and others may review this quarterly Earnings Release, quarterly results slides, supplementary financial information and our Q1 2026 Report to Shareholders at rbc.com/investorrelations.
Quarterly conference call and webcast presentation
Our quarterly conference call is scheduled for February 26, 2026 at 8:30 a.m. (EST) and will feature a presentation about our first quarter results by RBC executives. It will be followed by a question and answer period with analysts. Interested parties can access the call live on a listen-only basis at rbc.com/investorrelations/quarterly-financial-statements.html or by telephone (647-557-5257 or 866-440-2170, passcode 2559316#). Please call between 8:20 a.m. and 8:25 a.m. (EST).
Management’s comments on results will be posted on our website shortly following the call. A recording will be available by 5:00 p.m. (EST) from February 26, 2026 until May 27, 2026 at rbc.com/investorrelations/quarterly-financial-statements.html or by telephone (647-362-9199 or 800-770-2030, passcode 2559316#).
Media Relations Contacts
Gillian McArdle, Vice President, Corporate Communications, gillian.mcardle@rbccm.com, 416-842-4231
Tracy Tong, Director, Financial Communications, tracy.tong@rbc.com, 437-655-1915
Investor Relations Contact
Asim Imran, Senior Vice President, Head of Investor Relations, asim.imran@rbc.com, 416-955-7804
ABOUT RBC
Royal Bank of Canada is a global financial institution with a purpose-driven, principles-led approach to delivering leading performance. Our success comes from the 101,000+ employees who leverage their imaginations and insights to bring our vision, values and strategy to life so we can help our clients thrive and communities prosper. As Canada’s biggest bank and one of the largest in the world, based on market capitalization, we have a diversified business model with a focus on innovation and providing exceptional experiences to our more than 19 million clients in Canada, the U.S. and 27 other countries. Learn more at rbc.com.
We are proud to support a broad range of community initiatives through donations, community investments and employee volunteer activities. See how at rbc.com/peopleandplanet.
Information contained in or otherwise accessible through the websites mentioned herein does not form part of this document. All references in this document to websites are inactive textual references and are for your information only.
® Registered Trademarks of Royal Bank of Canada.
|
|
- 6 -

Royal Bank of Canada first quarter 2026 results |
Net income $5.8 Billion Up 13% YoY |
Diluted EPS 1 $4.03 Up 14% YoY |
Total PCL 1 $1.1 Billion PCL on loans ratio 1 up 2 bps 1 QoQ |
ROE 1, 2 17.6% Up 80 bps YoY |
CET1 ratio 1 13.7% Above regulatory requirements | ||||||||||||
Adjusted net income 3 $5.9 Billion Up 12% YoY |
Adjusted diluted EPS 3 $4.08 Up 13% YoY |
Total ACL 1 $7.8 Billion ACL on loans ratio 1 up 2 bps QoQ |
Adjusted ROE 3 17.8% Up 60 bps YoY |
LCR 1 124% Down from 127% last quarter |
“RBC entered the 2026 fiscal year in a position of strength across our diversified business model and the core global markets where we operate. We carried this momentum into our first quarter, reporting record results underpinned by strong earnings growth, our robust balance sheet and capital position, and a premium ROE that continues to deliver value for our shareholders. Our record performance is a direct reflection of our world-class client franchises and Team RBC’s commitment to delivering exceptional service, advice and insights at scale. In an increasingly complex world, we are focused on bringing the full power of RBC’s global capabilities to support our clients and meet their evolving needs.” – Dave McKay, President and Chief Executive Officer of Royal Bank of Canada | ||
| Q1 2026 Compared to Q1 2025 |
Reported: • Net income of $5,785 million• Diluted EPS of $4.03• ROE of 17.6%• CET1 ratio of 13.7% |
h h h h |
Adjusted 3 :• Net income of $5,861 million• Diluted EPS of $4.08• ROE of 17.8% |
h h h | ||||||
| Q1 2026 Compared to Q4 2025 |
• Net income of $5,785 million• Diluted EPS• ROE of 17.6%• CET1 ratio of 13.7% |
h h h h |
• Net income of $5,861 million• Diluted EPS• ROE of 17.8% |
h h h | ||||||
| (1) | See the Glossary section of this Q1 2026 Report to Shareholders for composition of these measures. |
| (2) | Return on equity (ROE). This measure does not have a standardized meaning under generally accepted accounting principles (GAAP). For further information, refer to the Key performance and non-GAAP measures section of this Q1 2026 Report to Shareholders. |
| (3) | These are non-GAAP measures or ratios. For further information, including a reconciliation, refer to the Key performance and non-GAAP measures section of this Q1 2026 Report to Shareholders. |
| (4) | When we say “we”, “us”, “our”, “the bank” or “RBC”, we mean Royal Bank of Canada and its subsidiaries, as applicable. |
| (5) | Pre-provision, pre-tax (PPPT) earnings is calculated as income (January 31, 2026: $5,785 million; October 31, 2025: $5,434 million; January 31, 2025: $5,131 million) before income taxes (January 31, 2026: $1,622 million; October 31, 2025: $1,394 million; January 31, 2025: $1,302 million) and PCL (January 31, 2026: $1,090 million; October 31, 2025: $1,007 million; January 31, 2025: $1,050 million). This is a non-GAAP measure. PPPT earnings do not have a standardized meaning under GAAP and may not be comparable to similar measures disclosed by other financial institutions. We use PPPT earnings to assess our ability to generate sustained earnings growth outside of credit losses, which are impacted by the cyclical nature of a credit cycle. We believe that certain non-GAAP measures are more reflective of our ongoing operating results and provide readers with a better understanding of management’s perspective on our performance. |
1 |
First quarter highlights | |||
2 |
Management’s Discussion and Analysis | |||
3 |
Caution regarding forward- looking statements | |||
3 |
Overview and outlook | |||
| 3 | About Royal Bank of Canada | |||
| 4 | Selected financial and other highlights | |||
| 5 | Economic, market and regulatory review and outlook | |||
7 |
Financial performance | |||
| 7 | Overview | |||
| 7 | Impact of foreign currency translation | |||
| 8 | Total revenue | |||
| 9 | Provision for credit losses | |||
| 10 | Non-interest expense | |||
| 10 | Income taxes | |||
11 |
Business segment results | |||
| 11 | How we measure and report our business segments | |||
| 11 | Key performance and non-GAAP measures | |||
| 13 | Personal Banking | |||
| 14 | Commercial Banking | |||
| 15 | Wealth Management | |||
| 16 | Insurance | |||
| 17 | Capital Markets | |||
| 18 | Corporate Support | |||
19 |
Quarterly results and trend analysis | |||
20 |
Financial condition | |||
| 20 | Condensed balance sheets | |||
| 21 | Off-balance sheet arrangements | |||
21 |
Risk management | |||
| 21 | Credit risk | |||
| 25 | Market risk | |||
| 29 | Liquidity and funding risk | |||
37 |
Capital management | |||
43 |
Accounting and control matters | |||
| 43 | Summary of accounting policies and estimates | |||
| 43 | Controls and procedures | |||
43 |
Related party transactions | |||
44 |
Glossary | |||
47 |
Enhanced Disclosure Task Force recommendations index | |||
48 |
Interim Condensed Consolidated Financial Statements | |||
53 |
Notes to the Interim Condensed Consolidated Financial Statements | |||
70 |
Shareholder Information | |||
Management’s Discussion and Analysis |
Caution regarding forward-looking statements |
Overview and outlook |
About Royal Bank of Canada |
Selected financial and other highlights |
| As at or for the three months ended | For the three months ended | |||||||||||||||||||||
(Millions of Canadian dollars, except per share, number of and percentage amounts) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
Q1 2026 vs. Q4 2025 |
Q1 2026 vs. Q1 2025 |
|||||||||||||||||
Total revenue |
$ |
17,960 |
$ | 17,209 | $ | 16,739 | $ |
751 |
$ |
1,221 |
||||||||||||
Provision for credit losses (PCL) |
1,090 |
1,007 | 1,050 | 83 |
40 |
|||||||||||||||||
Non-interest expense |
9,463 |
9,374 | 9,256 | 89 |
207 |
|||||||||||||||||
Income before income taxes |
7,407 |
6,828 | 6,433 | 579 |
974 |
|||||||||||||||||
Net income |
$ |
5,785 |
$ | 5,434 | $ | 5,131 | $ |
351 |
$ |
654 |
||||||||||||
Net income – adjusted (1), (2) |
$ |
5,861 |
$ | 5,554 | $ | 5,254 | $ |
307 |
$ |
607 |
||||||||||||
Segments – net income |
||||||||||||||||||||||
Personal Banking |
$ |
1,962 |
$ | 1,887 | $ | 1,678 | $ |
75 |
$ |
284 |
||||||||||||
Commercial Banking |
863 |
810 | 777 | 53 |
86 |
|||||||||||||||||
Wealth Management |
1,295 |
1,284 | 980 | 11 |
315 |
|||||||||||||||||
Insurance |
213 |
98 | 272 | 115 |
(59 |
) | ||||||||||||||||
Capital Markets |
1,478 |
1,431 | 1,432 | 47 |
46 |
|||||||||||||||||
Corporate Support |
(26 |
) |
(76 | ) | (8 | ) | 50 |
(18 |
) | |||||||||||||
Net income |
$ |
5,785 |
$ | 5,434 | $ | 5,131 | $ |
351 |
$ |
654 |
||||||||||||
Selected information |
||||||||||||||||||||||
Earnings per share (EPS) – basic |
$ |
4.03 |
$ | 3.77 | $ | 3.54 | $ |
0.26 |
$ |
0.49 |
||||||||||||
– diluted |
4.03 |
3.76 | 3.54 | 0.27 |
0.49 |
|||||||||||||||||
– basic adjusted (1), (2) |
4.09 |
3.86 | 3.63 | 0.23 |
0.46 |
|||||||||||||||||
– diluted adjusted (1), (2) |
4.08 |
3.85 | 3.62 | 0.23 |
0.46 |
|||||||||||||||||
Return on common equity (ROE) (2) |
17.6% |
16.8% | 16.8% | 80 bps |
80 bps |
|||||||||||||||||
ROE – adjusted (1), (2) |
17.8% |
17.2% | 17.2% | 60 bps |
60 bps |
|||||||||||||||||
Average common equity (3) |
$ |
127,350 |
$ | 124,900 | $ | 118,550 | $ |
2,450 |
$ |
8,800 |
||||||||||||
Net interest margin (NIM) – on average earning assets, net (2) |
1.55% |
1.62% | 1.60% | (7) bps |
(5) bps |
|||||||||||||||||
PCL on loans as a % of average net loans and acceptances |
0.41% |
0.39% | 0.42% | 2 bps |
(1) bps |
|||||||||||||||||
PCL on performing loans as a % of average net loans and acceptances |
0.01% |
0.01% | 0.03% | – bps |
(2) bps |
|||||||||||||||||
PCL on impaired loans as a % of average net loans and acceptances |
0.40% |
0.38% | 0.39% | 2 bps |
1 bps |
|||||||||||||||||
Gross impaired loans (GIL) as a % of loans and acceptances |
0.86% |
0.83% | 0.78% | 3 bps |
8 bps |
|||||||||||||||||
Liquidity coverage ratio (LCR) (2), (4) |
124% |
127% | 128% | (300) bps |
(400) bps |
|||||||||||||||||
Net stable funding ratio (NSFR) (2), (4) |
111% |
112% | 115% | (100) bps |
(400) bps |
|||||||||||||||||
Capital, Leverage and Total loss absorbing capacity (TLAC) ratios (2), (5) |
||||||||||||||||||||||
Common Equity Tier 1 (CET1) ratio |
13.7% |
13.5% | 13.2% | 20 bps |
50 bps |
|||||||||||||||||
Tier 1 capital ratio |
15.2% |
15.1% | 14.6% | 10 bps |
60 bps |
|||||||||||||||||
Total capital ratio |
16.8% |
16.8% | 16.4% | – bps |
40 bps |
|||||||||||||||||
Leverage ratio |
4.4% |
4.4% | 4.4% | – bps |
– bps |
|||||||||||||||||
TLAC ratio |
30.9% |
31.5% | 29.8% | (60) bps |
110 bps |
|||||||||||||||||
TLAC leverage ratio |
9.0% |
9.2% | 8.9% | (20) bps |
10 bps |
|||||||||||||||||
Selected balance sheet and other information (6) |
||||||||||||||||||||||
Total assets |
$ |
2,342,393 |
$ | 2,325,006 | $ | 2,191,026 | $ |
17,387 |
$ |
151,367 |
||||||||||||
Securities, net of applicable allowance |
588,966 |
561,788 | 488,025 | 27,178 |
100,941 |
|||||||||||||||||
Loans, net of allowance for loan losses |
1,054,881 |
1,042,422 | 1,006,050 | 12,459 |
48,831 |
|||||||||||||||||
Derivative assets |
170,830 |
177,206 | 153,686 | (6,376 |
) |
17,144 |
||||||||||||||||
Deposits |
1,542,216 |
1,515,616 | 1,441,940 | 26,600 |
100,276 |
|||||||||||||||||
Common equity |
128,670 |
127,417 | 122,763 | 1,253 |
5,907 |
|||||||||||||||||
Total risk-weighted assets (RWA) (2), (5) |
734,693 |
730,225 | 708,941 | 4,468 |
25,752 |
|||||||||||||||||
Assets under management (AUM) (2) |
1,588,700 |
1,573,800 | 1,428,700 | 14,900 |
160,000 |
|||||||||||||||||
Assets under administration (AUA) (2), (7) |
5,632,300 |
5,599,000 | 5,148,300 | 33,300 |
484,000 |
|||||||||||||||||
Common share information |
||||||||||||||||||||||
Shares outstanding (000s) – average basic |
1,398,580 |
1,403,782 | 1,413,937 | (5,202 |
) |
(15,357 |
) | |||||||||||||||
– average diluted |
1,401,884 |
1,406,696 | 1,416,502 | (4,812 |
) |
(14,618 |
) | |||||||||||||||
– end of period |
1,396,775 |
1,400,114 | 1,412,878 | (3,339 |
) |
(16,103 |
) | |||||||||||||||
Dividends declared per common share |
$ |
1.64 |
$ | 1.54 | $ | 1.48 | $ |
0.10 |
$ |
0.16 |
||||||||||||
Dividend yield (2) |
3.0% |
3.1% | 3.4% | (10) bps |
(40) bps |
|||||||||||||||||
Dividend payout ratio (2) |
41% |
41% | 42% | – bps |
(100) bps |
|||||||||||||||||
Common share price (RY on TSX) (8) |
$ |
226.72 |
$ | 205.47 | $ | 177.18 | $ |
21.25 |
$ |
49.54 |
||||||||||||
Market capitalization (TSX) (8) |
316,677 |
287,681 | 250,334 | 28,996 |
66,343 |
|||||||||||||||||
Business information (number of) |
||||||||||||||||||||||
Employees (full-time equivalent) (FTE) |
97,469 |
96,628 | 94,624 | 841 |
2,845 |
|||||||||||||||||
Bank branches |
1,258 |
1,263 | 1,286 | (5 |
) |
(28 |
) | |||||||||||||||
Automated teller machines (ATMs) |
4,163 |
4,183 | 4,358 | (20 |
) |
(195 |
) | |||||||||||||||
Period average US$ equivalent of C$1.00 (9) |
0.726 |
0.720 | 0.699 | 0.006 |
0.027 |
|||||||||||||||||
Period-end US$ equivalent of C$1.00 |
0.734 |
0.713 | 0.687 | 0.021 |
0.047 |
|||||||||||||||||
| (1) | These are non-GAAP measures or ratios. For further details, including a reconciliation, refer to the Key performance and non-GAAP measures section. |
| (2) | See Glossary for composition of these measures. |
| (3) | Average amounts are calculated using methods intended to approximate the average of the daily balances for the period. |
| (4) | The LCR and NSFR are calculated in accordance with the Office of the Superintendent of Financial Institutions’ (OSFI) Liquidity Adequacy Requirements (LAR) guideline. LCR is the average for the three months ended for each respective period. For further details, refer to the Liquidity and funding risk section. |
| (5) | Capital ratios and RWA are calculated using OSFI’s Capital Adequacy Requirements (CAR) guideline, the Leverage ratio is calculated using OSFI’s Leverage Requirements (LR) guideline and both the TLAC and TLAC leverage ratios are calculated using OSFI’s TLAC guideline. Both the CAR guideline and LR guideline are based on the Basel III framework. For further details, refer to the Capital management section. |
| (6) | Represents period-end spot balances. |
| (7) | AUA includes $14 billion and $5 billion (October 31, 2025 – $15 billion and $5 billion; January 31, 2025 – $15 billion and $6 billion) of securitized residential mortgages and credit card loans, respectively. |
| (8) | Based on TSX closing market price at period-end. |
| (9) | Average amounts are calculated using month-end spot rates for the period. |
Economic, market and regulatory review and outlook – data as at February 25, 2026 |
| 1 | Annualized rate |
| • | Failure to reach trade agreements, leading to prolonged uncertainty, a shift away from global economic integration and negative impacts on productivity and growth prospects, especially for emerging markets and developing economies; |
| • | Shifting global policy priorities, including ongoing uncertainty around U.S. trade, foreign relations, defense and immigration policies, which could disrupt global alliances and heighten economic, market and other risks, and intensifying political pressures on policy institutions and policymaking, which could weaken policy credibility, reduce investor confidence and heighten macroeconomic vulnerabilities; |
| • | Substantial projected fiscal deficits and high public debt across major economies, which could lead to upward pressure on long-term interest rates, financial market instability and/or deceleration in growth, along with their associated impact on consumer and business confidence; |
| • | Reevaluation of the productivity growth expectations of technology, specifically AI-linked sectors, which could lead to a decline in investment and drive abrupt financial market corrections of these sectors as well as other segments and erode household wealth; |
| • | An aging demographic in advanced economies, as well as changing immigration policies, which could have an associated long-term impact on labour supply, economic productivity and government fiscal capacity; |
| • | Ongoing conflicts including those between Russia and Ukraine, in the Middle East and Asia, and rising tensions between China and Taiwan, together with increased polarization and social unrest; and |
| • | Extreme weather-related events. |
Financial performance |
Overview |
Impact of foreign currency translation |
| For the three months ended | ||||||||
(Millions of Canadian dollars, except per share amounts) |
Q1 2026 vs. Q1 2025 |
Q1 2026 vs. Q4 2025 |
||||||
Increase (decrease): |
||||||||
Total revenue |
$ |
(224 |
) |
$ |
(61 |
) | ||
PCL |
(10 |
) |
(3 |
) | ||||
Non-interest expense |
(114 |
) |
(34 |
) | ||||
Income taxes |
(9 |
) |
(2 |
) | ||||
Net income |
(91 |
) |
(22 |
) | ||||
Impact on EPS |
||||||||
Basic |
$ |
(0.06 |
) |
$ |
(0.02 |
) | ||
Diluted |
(0.06 |
) |
(0.02 |
) | ||||
| $ | $ | $ | $ | $ | ||||||||||||||||
| (Average foreign currency equivalent of C$1.00) (1) | For the three months ended | |||||||||||||||||||
January 31 2026 |
October 31 2025 |
January 31 2025 |
||||||||||||||||||
U.S. dollar |
0.726 |
0.720 | 0.699 | |||||||||||||||||
British pound |
0.539 |
0.539 | 0.556 | |||||||||||||||||
Euro |
0.619 |
0.618 | 0.669 | |||||||||||||||||
| (1) | Average amounts are calculated using month-end spot rates for the period. |
Total revenue |
| (Millions of Canadian dollars, except percentage amounts) | For the three months ended | |||||||||||
January 31 2026 |
October 31 2025 |
January 31 2025 |
||||||||||
Interest and dividend income |
$ |
26,104 |
$ | 26,290 | $ | 26,455 | ||||||
Interest expense |
17,519 |
17,645 | 18,507 | |||||||||
Net interest income |
$ |
8,585 |
$ | 8,645 | $ | 7,948 | ||||||
NIM |
1.55% |
1.62% | 1.60% | |||||||||
Insurance service result |
$ |
240 |
$ | 78 | $ | 286 | ||||||
Insurance investment result |
59 |
76 | 82 | |||||||||
Trading revenue |
1,180 |
604 | 1,195 | |||||||||
Investment management and custodial fees |
2,924 |
2,794 | 2,667 | |||||||||
Mutual fund revenue |
1,414 |
1,364 | 1,236 | |||||||||
Securities brokerage commissions |
508 |
504 | 471 | |||||||||
Service charges |
593 |
608 | 612 | |||||||||
Underwriting and other advisory fees |
742 |
760 | 674 | |||||||||
Foreign exchange revenue, other than trading |
380 |
334 | 318 | |||||||||
Card service revenue |
335 |
349 | 317 | |||||||||
Credit fees |
423 |
470 | 435 | |||||||||
Net gains on investment securities |
76 |
2 | 55 | |||||||||
Income (loss) from joint ventures and associates |
37 |
13 | 19 | |||||||||
Other |
464 |
608 | 424 | |||||||||
Non-interest income |
9,375 |
8,564 | 8,791 | |||||||||
Total revenue |
$ |
17,960 |
$ | 17,209 | $ | 16,739 | ||||||
Additional trading information |
||||||||||||
Net interest income (1) |
$ |
473 |
$ | 698 | $ | 364 | ||||||
Non-interest income |
1,180 |
604 | 1,195 | |||||||||
Total trading revenue |
$ |
1,653 |
$ | 1,302 | $ | 1,559 | ||||||
| (1) | Reflects net interest income arising from trading-related positions, including assets and liabilities that are classified or designated at fair value through profit or loss (FVTPL). |
Provision for credit losses (1) |
| For the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Personal Banking |
$ |
16 |
$ | 33 | $ | 63 | ||||||
Commercial Banking |
13 |
27 | 30 | |||||||||
Wealth Management |
(16 |
) |
(39 | ) | 36 | |||||||
Capital Markets |
15 |
(8 | ) | (61 | ) | |||||||
Corporate Support and other (2) |
– |
1 | – | |||||||||
PCL on performing loans |
28 |
14 | 68 | |||||||||
Personal Banking |
$ |
516 |
$ | 489 | $ | 427 | ||||||
Commercial Banking |
273 |
346 | 308 | |||||||||
Wealth Management |
34 |
35 | 45 | |||||||||
Capital Markets |
245 |
115 | 205 | |||||||||
Corporate Support and other (2) |
– |
(1 | ) | – | ||||||||
PCL on impaired loans |
1,068 |
984 | 985 | |||||||||
PCL – Loans |
1,096 |
998 | 1,053 | |||||||||
PCL – Other (3) |
(6 |
) |
9 | (3 | ) | |||||||
Total PCL |
$ |
1,090 |
$ | 1,007 | $ | 1,050 | ||||||
| PCL on loans is comprised of: | ||||||||||||
Retail |
$ |
15 |
$ | 25 | $ | 104 | ||||||
Wholesale |
13 |
(11 | ) | (36 | ) | |||||||
PCL on performing loans |
28 |
14 | 68 | |||||||||
Retail |
564 |
548 | 485 | |||||||||
Wholesale |
504 |
436 | 500 | |||||||||
PCL on impaired loans |
1,068 |
984 | 985 | |||||||||
PCL – Loans |
$ |
1,096 |
$ | 998 | $ | 1,053 | ||||||
PCL on loans as a % of average net loans and acceptances |
0.41% |
0.39% | 0.42% | |||||||||
PCL on impaired loans as a % of average net loans and acceptances |
0.40% |
0.38% | 0.39% | |||||||||
| (1) | Information on loans represents loans, acceptances and commitments. |
| (2) | Includes PCL recorded in Corporate Support and Insurance. |
| (3) | PCL – Other includes amounts related to debt securities measured at fair value through other comprehensive income (FVOCI) and amortized cost, accounts receivable, and financial and purchased guarantees. |
Non-interest expense |
| For the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Salaries |
$ |
2,392 |
$ | 2,350 | $ | 2,354 | ||||||
Variable compensation |
2,753 |
2,561 | 2,569 | |||||||||
Benefits and retention compensation |
801 |
636 | 686 | |||||||||
Share-based compensation |
343 |
241 | 378 | |||||||||
Human resources |
6,289 |
5,788 | 5,987 | |||||||||
Equipment |
728 |
721 | 681 | |||||||||
Occupancy |
420 |
412 | 429 | |||||||||
Communications |
355 |
435 | 327 | |||||||||
Professional fees |
471 |
609 | 502 | |||||||||
Amortization of other intangibles |
386 |
431 | 435 | |||||||||
Other |
814 |
978 | 895 | |||||||||
Non-interest expense |
$ |
9,463 |
$ | 9,374 | $ | 9,256 | ||||||
Efficiency ratio (1) |
52.7% |
54.5% | 55.3% | |||||||||
Efficiency ratio – adjusted (1), (2) |
52.1% |
53.6% | 54.3% | |||||||||
| (1) | See Glossary for composition of these measures. |
| (2) | This is a non-GAAP ratio. For further details, including a reconciliation, refer to the Key performance and non-GAAP measures section. |
Income taxes |
| For the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Income taxes |
$ |
1,622 |
$ | 1,394 | $ | 1,302 | ||||||
Income before income taxes |
7,407 |
6,828 | 6,433 | |||||||||
Effective income tax rate |
21.9% |
20.4% | 20.2% | |||||||||
Adjusted results (1), (2) |
||||||||||||
Income taxes – adjusted |
$ |
1,648 |
$ | 1,427 | $ | 1,344 | ||||||
Income before income taxes – adjusted |
7,509 |
6,981 | 6,598 | |||||||||
Effective income tax rate – adjusted |
21.9% |
20.4% | 20.4% | |||||||||
| (1) | These are non-GAAP measures or ratios. For further details, including a reconciliation, refer to the Key performance and non-GAAP measures section. |
| (2) | See Glossary for composition of these measures. |
Business segment results |
How we measure and report our business segments |
Key performance and non-GAAP measures |
| For the three months ended | ||||||||||||||||||||||||||||||||||||||||
January 31 2026 |
October 31 2025 |
January 31 2025 |
||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars, except percentage amounts) |
Personal Banking |
Commercial Banking |
Wealth Management |
Insurance |
Capital Markets |
Corporate Support |
Total |
Total | Total | |||||||||||||||||||||||||||||||
Net income available to common shareholders |
$ |
1,929 |
$ |
841 |
$ |
1,267 |
$ |
209 |
$ |
1,433 |
$ |
(36 |
) |
$ |
5,643 |
$ | 5,293 | $ | 5,011 | |||||||||||||||||||||
Total average common equity (2), (3) |
29,100 |
19,700 |
25,600 |
3,350 |
39,450 |
10,150 |
127,350 |
124,900 | 118,550 | |||||||||||||||||||||||||||||||
ROE |
26.3% |
16.9% |
19.6% |
24.9% |
14.4% |
n.m. |
17.6% |
16.8% | 16.8% | |||||||||||||||||||||||||||||||
| (1) | Effective the first quarter of 2026, we updated our methodology for allocating capital to Insurance to more closely align with legal entity capital requirements. For further details, refer to the How we measure and report our business segments section. |
| (2) | Total average common equity represents rounded figures. |
| (3) | The amounts for the segments are referred to as attributed capital. |
| n.m. | not meaningful |
| • | HSBC Bank Canada (HSBC Canada) transaction and integration costs. |
| As at or for the three months ended | ||||||||||||
(Millions of Canadian dollars, except per share, number of and percentage amounts) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Total revenue |
$ |
17,960 |
$ | 17,209 | $ | 16,739 | ||||||
PCL |
1,090 |
1,007 | 1,050 | |||||||||
Non-interest expense |
9,463 |
9,374 | 9,256 | |||||||||
Income before income taxes |
7,407 |
6,828 | 6,433 | |||||||||
Income taxes |
1,622 |
1,394 | 1,302 | |||||||||
Net income |
$ |
5,785 |
$ | 5,434 | $ | 5,131 | ||||||
Net income available to common shareholders |
$ |
5,643 |
$ | 5,293 | $ | 5,011 | ||||||
Average number of common shares (thousands) |
1,398,580 |
1,403,782 | 1,413,937 | |||||||||
Basic earnings per share (in dollars) |
$ |
4.03 |
$ | 3.77 | $ | 3.54 | ||||||
Average number of diluted common shares (thousands) |
1,401,884 |
1,406,696 | 1,416,502 | |||||||||
Diluted earnings per share (in dollars) |
$ |
4.03 |
$ | 3.76 | $ | 3.54 | ||||||
ROE |
17.6% |
16.8% | 16.8% | |||||||||
Effective income tax rate |
21.9% |
20.4% | 20.2% | |||||||||
Total adjusting items impacting net income (before-tax) |
$ |
102 |
$ | 153 | $ | 165 | ||||||
Specified item: HSBC Canada transaction and integration costs (1) |
– |
– | 12 | |||||||||
Amortization of acquisition-related intangibles (2) |
102 |
153 | 153 | |||||||||
Total income taxes for adjusting items impacting net income |
$ |
26 |
$ | 33 | $ | 42 | ||||||
Specified item: HSBC Canada transaction and integration costs (1) |
– |
– | 6 | |||||||||
Amortization of acquisition-related intangibles (2) |
26 |
33 | 36 | |||||||||
Adjusted results |
||||||||||||
Income before income taxes – adjusted |
$ |
7,509 |
$ | 6,981 | $ | 6,598 | ||||||
Income taxes – adjusted |
1,648 |
1,427 | 1,344 | |||||||||
Net income – adjusted |
5,861 |
5,554 | 5,254 | |||||||||
Net income available to common shareholders – adjusted (3) |
5,719 |
5,413 | 5,134 | |||||||||
Average number of common shares (thousands) |
1,398,580 |
1,403,782 | 1,413,937 | |||||||||
Basic earnings per share (in dollars) – adjusted |
$ |
4.09 |
$ | 3.86 | $ | 3.63 | ||||||
Average number of diluted common shares (thousands) |
1,401,884 |
1,406,696 | 1,416,502 | |||||||||
Diluted earnings per share (in dollars) – adjusted |
$ |
4.08 |
$ | 3.85 | $ | 3.62 | ||||||
ROE – adjusted |
17.8% |
17.2% | 17.2% | |||||||||
Effective income tax rate – adjusted |
21.9% |
20.4% | 20.4% | |||||||||
Adjusted efficiency ratio |
||||||||||||
Total revenue |
$ |
17,960 |
$ | 17,209 | $ | 16,739 | ||||||
Non-interest expense |
9,463 |
9,374 | 9,256 | |||||||||
Less specified item: HSBC Canada transaction and integration costs (before-tax) (1) |
– |
– | 12 | |||||||||
Less: Amortization of acquisition-related intangibles (before-tax) (2) |
102 |
153 | 153 | |||||||||
Non-interest expense – adjusted (3) |
$ |
9,361 |
$ | 9,221 | $ | 9,091 | ||||||
Efficiency ratio |
52.7% |
54.5% | 55.3% | |||||||||
Efficiency ratio – adjusted |
52.1% |
53.6% | 54.3% | |||||||||
| (1) | These amounts have been recognized in Corporate Support. |
| (2) | Represents the impact of amortization of acquisition-related intangibles (excluding amortization of software), and any goodwill impairment. |
| (3) | See Glossary for composition of these measures. |
Personal Banking |
| As at or for the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts and as otherwise noted) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Net interest income |
$ |
3,831 |
$ | 3,774 | $ | 3,505 | ||||||
Non-interest income |
1,407 |
1,404 | 1,306 | |||||||||
Total revenue |
5,238 |
5,178 | 4,811 | |||||||||
PCL on performing assets |
16 |
32 | 63 | |||||||||
PCL on impaired assets |
515 |
487 | 425 | |||||||||
PCL |
531 |
519 | 488 | |||||||||
Non-interest expense |
2,020 |
2,076 | 2,015 | |||||||||
Income before income taxes |
2,687 |
2,583 | 2,308 | |||||||||
Net income |
$ |
1,962 |
$ | 1,887 | $ | 1,678 | ||||||
Revenue by business |
||||||||||||
Personal Banking – Canada |
$ |
4,923 |
$ | 4,860 | $ | 4,499 | ||||||
Caribbean & U.S. Banking |
315 |
318 | 312 | |||||||||
Selected balance sheet and other information |
||||||||||||
ROE |
26.3% |
25.6% | 23.7% | |||||||||
NIM |
2.72% |
2.70% | 2.58% | |||||||||
Efficiency ratio |
38.6% |
40.1% | 41.9% | |||||||||
Operating leverage (1) |
8.7% |
9.1% | 2.5% | |||||||||
Average total earning assets, net |
$ |
559,500 |
$ | 554,300 | $ | 539,900 | ||||||
Average loans and acceptances, net |
548,500 |
543,500 | 530,100 | |||||||||
Average deposits |
436,800 |
436,400 | 437,200 | |||||||||
AUA (2) |
293,100 |
288,500 | 266,400 | |||||||||
Average AUA |
290,100 |
280,400 | 261,600 | |||||||||
PCL on impaired loans as a % of average net loans and acceptances |
0.37% |
0.36% | 0.32% | |||||||||
Other selected information – Personal Banking – Canada |
||||||||||||
Net income |
$ |
1,868 |
$ | 1,788 | $ | 1,583 | ||||||
NIM |
2.66% |
2.63% | 2.50% | |||||||||
Efficiency ratio |
37.1% |
38.4% | 40.5% | |||||||||
Operating leverage |
9.1% |
9.0% | 2.3% | |||||||||
| (1) | See Glossary for composition of this measure. |
| (2) | AUA represents period-end spot balances and includes securitized residential mortgages and credit card loans as at January 31, 2026 of $14 billion and $5 billion, respectively (October 31, 2025 – $15 billion and $5 billion; January 31, 2025 – $15 billion and $6 billion). |
Commercial Banking |
| As at or for the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts and as otherwise noted) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Net interest income |
$ |
1,895 |
$ | 1,910 | $ | 1,796 | ||||||
Non-interest income |
312 |
311 | 331 | |||||||||
Total revenue |
2,207 |
2,221 | 2,127 | |||||||||
PCL on performing assets |
13 |
27 | 31 | |||||||||
PCL on impaired assets |
273 |
346 | 308 | |||||||||
PCL |
286 |
373 | 339 | |||||||||
Non-interest expense |
725 |
728 | 710 | |||||||||
Income before income taxes |
1,196 |
1,120 | 1,078 | |||||||||
Net income |
$ |
863 |
$ | 810 | $ | 777 | ||||||
Selected balance sheet and other information |
||||||||||||
ROE |
16.9% |
15.8% | 15.5% | |||||||||
NIM |
3.93% |
3.99% | 3.89% | |||||||||
Efficiency ratio |
32.9% |
32.8% | 33.4% | |||||||||
Operating leverage |
1.7% |
4.8% | 0.9% | |||||||||
Average total earning assets, net |
$ |
191,300 |
$ | 190,000 | $ | 183,300 | ||||||
Average loans and acceptances, net |
191,300 |
190,000 | 183,200 | |||||||||
Average deposits |
318,800 |
311,300 | 304,900 | |||||||||
PCL on impaired loans as a % of average net loans and acceptances |
0.57% |
0.72% | 0.67% | |||||||||
Wealth Management |
| As at or for the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts and as otherwise noted) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Net interest income |
$ |
1,454 |
$ | 1,443 | $ | 1,394 | ||||||
Non-interest income |
4,630 |
4,457 | 4,174 | |||||||||
Total revenue |
6,084 |
5,900 | 5,568 | |||||||||
PCL on performing assets |
(16 |
) |
(39 | ) | 36 | |||||||
PCL on impaired assets |
34 |
35 | 45 | |||||||||
PCL |
18 |
(4 | ) | 81 | ||||||||
Non-interest expense |
4,384 |
4,313 | 4,204 | |||||||||
Income before income taxes |
1,682 |
1,591 | 1,283 | |||||||||
Net income |
$ |
1,295 |
$ | 1,284 | $ | 980 | ||||||
Revenue by business |
||||||||||||
Canadian Wealth Management |
$ |
1,916 |
$ | 1,847 | $ | 1,693 | ||||||
U.S. Wealth Management (including City National Bank (City National)) |
2,656 |
2,573 | 2,466 | |||||||||
U.S. Wealth Management (including City National) (US$ millions) |
1,929 |
1,852 | 1,722 | |||||||||
Global Asset Management |
964 |
908 | 867 | |||||||||
International Wealth Management |
358 |
377 | 344 | |||||||||
Investor Services |
190 |
195 | 198 | |||||||||
Selected balance sheet and other information |
||||||||||||
ROE |
19.6% |
19.7% | 15.2% | |||||||||
NIM |
3.38% |
3.45% | 3.34% | |||||||||
Pre-tax margin (1) |
27.6% |
27.0% | 23.0% | |||||||||
Number of advisors (2) |
6,301 |
6,229 | 6,180 | |||||||||
Average total earning assets, net |
$ |
170,700 |
$ | 166,100 | $ | 165,700 | ||||||
Average loans and acceptances, net |
129,800 |
125,800 | 122,100 | |||||||||
Average deposits |
177,100 |
173,200 | 183,700 | |||||||||
AUA (3) |
5,314,400 |
5,284,800 | 4,856,800 | |||||||||
AUM (3) |
1,578,900 |
1,563,900 | 1,419,200 | |||||||||
Average AUA |
5,335,600 |
5,191,400 | 4,778,100 | |||||||||
Average AUM |
1,569,700 |
1,529,100 | 1,361,700 | |||||||||
PCL on impaired loans as a % of average net loans and acceptances |
0.10% |
0.11% | 0.15% | |||||||||
Estimated impact of U.S. dollar, British pound and Euro translation on key income statement items (Millions of Canadian dollars, except percentage amounts) |
For the three months ended |
|||||||
Q1 2026 vs. Q1 2025 |
Q1 2026 vs. Q4 2025 |
|||||||
Increase (decrease): |
||||||||
Total revenue |
$ |
(99 |
) |
$ |
(27 |
) | ||
PCL |
(1 |
) |
(1 |
) | ||||
Non-interest expense |
(72 |
) |
(20 |
) | ||||
Net income |
(21 |
) |
(5 |
) | ||||
Percentage change in average U.S. dollar equivalent of C$1.00 |
4% |
1% |
||||||
Percentage change in average British pound equivalent of C$1.00 |
(3)% |
–% |
||||||
Percentage change in average Euro equivalent of C$1.00 |
(7)% |
–% |
||||||
| (1) | Pre-tax margin is defined as income before income taxes divided by total revenue. |
| (2) | Represents client-facing advisors across all of our Wealth Management businesses. |
| (3) | Represents period-end spot balances. |
Insurance |
| As at or for the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts and as otherwise noted) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Non-interest income |
||||||||||||
Insurance service result |
$ |
240 |
$ | 78 | $ | 286 | ||||||
Insurance investment result |
59 |
76 | 82 | |||||||||
Other income |
39 |
55 | 38 | |||||||||
Total revenue |
338 |
209 | 406 | |||||||||
Non-interest expense |
78 |
74 | 87 | |||||||||
Income before income taxes |
260 |
135 | 319 | |||||||||
Net income |
$ |
213 |
$ | 98 | $ | 272 | ||||||
Selected balances and other information |
||||||||||||
ROE (1) |
24.9% |
20.6% | 49.9% | |||||||||
Premiums and deposits (2), (3) |
$ |
1,683 |
$ | 1,778 | $ | 2,422 | ||||||
Contractual service margin (CSM) (4) |
1,773 |
1,802 | 2,008 | |||||||||
| (1) | Effective the first quarter of 2026, we revised our methodology for allocating capital to Insurance to more closely align with legal entity capital requirements. For further details, refer to the How we measure and report our business segments section. |
| (2) | Premiums and deposits include premiums on risk-based individual and group insurance and annuity products as well as segregated fund deposits, consistent with insurance industry practices. |
| (3) | Comparative amounts have been revised from those previously presented. |
| (4) | Represents the CSM of insurance contract assets and liabilities net of reinsurance contract held assets and liabilities. For insurance contracts, the CSM represents the unearned profit (net inflows) for providing insurance coverage. For reinsurance contracts held, the CSM represents the net cost or net gain of purchasing reinsurance. The CSM is not applicable to contracts measured using the premium allocation approach. |
Capital Markets |
| As at or for the three months ended | ||||||||||||
(Millions of Canadian dollars, except percentage amounts and as otherwise noted) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Net interest income (1) |
$ |
1,218 |
$ | 1,309 | $ | 918 | ||||||
Non-interest income(1) |
2,800 |
2,302 | 2,838 | |||||||||
Total revenue (1) |
4,018 |
3,611 | 3,756 | |||||||||
PCL on performing assets |
16 |
1 | (63 | ) | ||||||||
PCL on impaired assets |
240 |
118 | 205 | |||||||||
PCL |
256 |
119 | 142 | |||||||||
Non-interest expense |
2,119 |
1,981 | 2,041 | |||||||||
Income before income taxes |
1,643 |
1,511 | 1,573 | |||||||||
Net income |
$ |
1,478 |
$ | 1,431 | $ | 1,432 | ||||||
Revenue by business |
||||||||||||
Corporate & Investment Banking |
$ |
1,722 |
$ | 1,812 | $ | 1,715 | ||||||
Global Markets |
2,224 |
1,749 | 2,079 | |||||||||
Other |
72 |
50 | (38 | ) | ||||||||
Selected balance sheet and other information |
||||||||||||
ROE |
14.4% |
14.1% | 14.9% | |||||||||
Average total assets |
$ |
1,462,000 |
$ | 1,353,700 | $ | 1,326,700 | ||||||
Average trading securities |
253,500 |
219,300 | 211,600 | |||||||||
Average loans and acceptances, net |
175,500 |
169,600 | 159,700 | |||||||||
Average deposits |
454,400 |
421,200 | 360,300 | |||||||||
PCL on impaired loans as a % of average net loans and acceptances |
0.56% |
0.27% | 0.51% | |||||||||
Estimated impact of U.S. dollar, British pound and Euro translation on key income statement items (Millions of Canadian dollars, except percentage amounts) |
For the three months ended |
|||||||
Q1 2026 vs. Q1 2025 |
Q1 2026 vs. Q4 2025 |
|||||||
Increase (decrease): |
||||||||
Total revenue |
$ |
(95 |
) |
$ |
(27 |
) | ||
PCL |
(9 |
) |
(3 |
) | ||||
Non-interest expense |
(32 |
) |
(11 |
) | ||||
Net income |
(48 |
) |
(12 |
) | ||||
Percentage change in average U.S. dollar equivalent of C$1.00 |
4% |
1% |
||||||
Percentage change in average British pound equivalent of C$1.00 |
(3)% |
–% |
||||||
Percentage change in average Euro equivalent of C$1.00 |
(7)% |
–% |
||||||
| (1) | The taxable equivalent basis (teb) adjustment for the three months ended January 31, 2026 was $25 million (October 31, 2025 – $47 million; January 31, 2025 – $26 million). For further discussion, refer to the How we measure and report our business segments section of our 2025 Annual Report. |
Corporate Support |
| For the three months ended | ||||||||||||
(Millions of Canadian dollars) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Net interest income (loss) (1) |
$ |
187 |
$ | 209 | $ | 335 | ||||||
Non-interest income (loss)(1), (2) |
(112 |
) |
(119 | ) | (264 | ) | ||||||
Total revenue (1), (2) |
75 |
90 | 71 | |||||||||
PCL |
(1 |
) |
– | – | ||||||||
Non-interest expense (2) |
137 |
202 | 199 | |||||||||
Income (loss) before income taxes (1) |
(61 |
) |
(112 | ) | (128 | ) | ||||||
Income taxes (recoveries) (1) |
(35 |
) |
(36 | ) | (120 | ) | ||||||
Net income (loss) |
$ |
(26 |
) |
$ | (76 | ) | $ | (8 | ) | |||
| (1) | Teb adjusted. |
| (2) | Revenue for the three months ended January 31, 2026 included gains of $90 million (October 31, 2025 and January 31, 2025 – gains of $173 million and gains of $112 million, respectively) on economic hedges of our U.S. Wealth Management (including City National) share-based compensation plans, and non-interest expense included $86 million (October 31, 2025 and January 31, 2025 – $161 million and $108 million, respectively) of share-based compensation expense driven by changes in the fair value of liabilities relating to our U.S. Wealth Management (including City National) share-based compensation plans. |
Quarterly results and trend analysis |
2026 |
2025 | 2024 | ||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars, except per share and percentage amounts) |
Q1 |
Q4 | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | ||||||||||||||||||||||||||||||||
Personal Banking |
$ |
5,238 |
$ | 5,178 | $ | 5,060 | $ | 4,805 | $ | 4,811 | $ | 4,658 | $ | 4,490 | $ | 4,163 | ||||||||||||||||||||||||
Commercial Banking |
2,207 |
2,221 | 2,152 | 2,062 | 2,127 | 2,077 | 2,036 | 1,656 | ||||||||||||||||||||||||||||||||
Wealth Management |
6,084 |
5,900 | 5,513 | 5,397 | 5,568 | 5,186 | 4,964 | 4,789 | ||||||||||||||||||||||||||||||||
Insurance |
338 |
209 | 368 | 338 | 406 | 278 | 285 | 298 | ||||||||||||||||||||||||||||||||
Capital Markets (2) |
4,018 |
3,611 | 3,758 | 3,301 | 3,756 | 2,903 | 3,004 | 3,154 | ||||||||||||||||||||||||||||||||
Corporate Support (2) |
75 |
90 | 134 | (231 | ) | 71 | (28 | ) | (148 | ) | 94 | |||||||||||||||||||||||||||||
Total revenue |
17,960 |
17,209 | 16,985 | 15,672 | 16,739 | 15,074 | 14,631 | 14,154 | ||||||||||||||||||||||||||||||||
PCL |
1,090 |
1,007 | 881 | 1,424 | 1,050 | 840 | 659 | 920 | ||||||||||||||||||||||||||||||||
Non-interest expense |
9,463 |
9,374 | 9,232 | 8,730 | 9,256 | 9,019 | 8,599 | 8,308 | ||||||||||||||||||||||||||||||||
Income before income taxes |
7,407 |
6,828 | 6,872 | 5,518 | 6,433 | 5,215 | 5,373 | 4,926 | ||||||||||||||||||||||||||||||||
Income taxes |
1,622 |
1,394 | 1,458 | 1,128 | 1,302 | 993 | 887 | 976 | ||||||||||||||||||||||||||||||||
Net income |
$ |
5,785 |
$ | 5,434 | $ | 5,414 | $ | 4,390 | $ | 5,131 | $ | 4,222 | $ | 4,486 | $ | 3,950 | ||||||||||||||||||||||||
EPS – basic |
$ |
4.03 |
$ | 3.77 | $ | 3.76 | $ | 3.03 | $ | 3.54 | $ | 2.92 | $ | 3.09 | $ | 2.75 | ||||||||||||||||||||||||
– diluted |
4.03 |
3.76 | 3.75 | 3.02 | 3.54 | 2.91 | 3.09 | 2.74 | ||||||||||||||||||||||||||||||||
Effective income tax rate |
21.9% |
20.4% | 21.2% | 20.4% | 20.2% | 19.0% | 16.5% | 19.8% | ||||||||||||||||||||||||||||||||
Period average US$ equivalent of C$1.00 |
$ |
0.726 |
$ | 0.720 | $ | 0.728 | $ | 0.704 | $ | 0.699 | $ | 0.733 | $ | 0.730 | $ | 0.734 | ||||||||||||||||||||||||
| (1) | Fluctuations in the Canadian dollar relative to other foreign currencies have affected our consolidated results over the period. |
| (2) | Teb adjusted. For further discussion, refer to the How we measure and report our business segments section of our 2025 Annual Report. |
Financial condition |
Condensed balance sheets |
| As at | ||||||||
(Millions of Canadian dollars) |
January 31 2026 |
October 31 2025 |
||||||
Assets |
||||||||
Cash and deposits with banks (1) |
$ |
99,299 |
$ | 87,388 | ||||
Securities, net of applicable allowance (2) |
588,966 |
561,788 | ||||||
Assets purchased under reverse repurchase agreements and securities borrowed |
279,800 |
309,683 | ||||||
Loans |
||||||||
Retail |
655,434 |
652,344 | ||||||
Wholesale |
406,848 |
397,171 | ||||||
Allowance for loan losses |
(7,401 |
) |
(7,093 | ) | ||||
Other – Derivatives |
170,830 |
177,206 | ||||||
– Other |
148,617 |
146,519 | ||||||
Total assets |
$ |
2,342,393 |
$ | 2,325,006 | ||||
Liabilities |
||||||||
Deposits |
$ |
1,542,216 |
$ | 1,515,616 | ||||
Other – Obligations related to assets sold under repurchase agreements and securities loaned |
288,016 |
289,516 | ||||||
– Derivatives |
170,731 |
183,953 | ||||||
– Other |
189,697 |
182,809 | ||||||
Subordinated debentures |
11,875 |
13,961 | ||||||
Total liabilities |
2,202,535 |
2,185,855 | ||||||
Equity attributable to shareholders |
139,801 |
139,092 | ||||||
Non-controlling interests |
57 |
59 | ||||||
Total equity |
139,858 |
139,151 | ||||||
Total liabilities and equity |
$ |
2,342,393 |
$ | 2,325,006 | ||||
| (1) | Cash and deposits with banks comprise Cash and due from banks and Interest-bearing deposits with banks. |
| (2) | Securities comprise trading and investment securities. |
Off-balance sheet arrangements |
Risk management |
Credit risk |
As at January 31, 2026 |
||||||||||||||||||||||||||||||
(Millions of Canadian dollars, except percentage amounts) |
Residential mortgages |
Home equity lines of credit |
||||||||||||||||||||||||||||
Insured |
Uninsured |
Total |
Total |
|||||||||||||||||||||||||||
Region (4) |
||||||||||||||||||||||||||||||
Canada |
||||||||||||||||||||||||||||||
Atlantic provinces |
$ |
9,188 |
41 |
% |
$ |
13,130 |
59 |
% |
$ |
22,318 |
$ |
1,747 |
||||||||||||||||||
Quebec |
11,326 |
24 |
36,319 |
76 |
47,645 |
3,515 |
||||||||||||||||||||||||
Ontario |
30,784 |
13 |
200,965 |
87 |
231,749 |
18,369 |
||||||||||||||||||||||||
Alberta |
17,677 |
40 |
26,852 |
60 |
44,529 |
4,588 |
||||||||||||||||||||||||
Saskatchewan and Manitoba |
8,181 |
39 |
12,866 |
61 |
21,047 |
1,706 |
||||||||||||||||||||||||
B.C. and territories |
12,041 |
13 |
78,267 |
87 |
90,308 |
8,314 |
||||||||||||||||||||||||
Total Canada (5) |
89,197 |
19 |
368,399 |
81 |
457,596 |
38,239 |
||||||||||||||||||||||||
U.S. |
– |
– |
35,615 |
100 |
35,615 |
2,154 |
||||||||||||||||||||||||
Other International |
– |
– |
3,318 |
100 |
3,318 |
1,374 |
||||||||||||||||||||||||
Total International |
– |
– |
38,933 |
100 |
38,933 |
3,528 |
||||||||||||||||||||||||
Total |
$ |
89,197 |
18 |
% |
$ |
407,332 |
82 |
% |
$ |
496,529 |
$ |
41,767 |
||||||||||||||||||
| As at October 31, 2025 | ||||||||||||||||||||||||||||||
(Millions of Canadian dollars, except percentage amounts) |
Residential mortgages | Home equity lines of credit (2) |
||||||||||||||||||||||||||||
| Insured (3) | Uninsured | Total | Total | |||||||||||||||||||||||||||
Region (4) |
||||||||||||||||||||||||||||||
Canada |
||||||||||||||||||||||||||||||
Atlantic provinces |
$ | 9,143 | 42 | % | $ | 12,883 | 58 | % | $ | 22,026 | $ | 1,745 | ||||||||||||||||||
Quebec |
11,504 | 24 | 35,859 | 76 | 47,363 | 3,537 | ||||||||||||||||||||||||
Ontario |
30,857 | 13 | 198,588 | 87 | 229,445 | 18,623 | ||||||||||||||||||||||||
Alberta |
17,888 | 40 | 26,517 | 60 | 44,405 | 4,646 | ||||||||||||||||||||||||
Saskatchewan and Manitoba |
8,299 | 39 | 12,813 | 61 | 21,112 | 1,728 | ||||||||||||||||||||||||
B.C. and territories |
12,041 | 13 | 77,954 | 87 | 89,995 | 8,384 | ||||||||||||||||||||||||
Total Canada (5) |
89,732 | 20 | 364,614 | 80 | 454,346 | 38,663 | ||||||||||||||||||||||||
U.S. |
– | – | 35,673 | 100 | 35,673 | 2,227 | ||||||||||||||||||||||||
Other International |
– | – | 3,394 | 100 | 3,394 | 1,387 | ||||||||||||||||||||||||
Total International |
– | – | 39,067 | 100 | 39,067 | 3,614 | ||||||||||||||||||||||||
Total |
$ | 89,732 | 18 | % | $ | 403,681 | 82 | % | $ | 493,413 | $ | 42,277 | ||||||||||||||||||
| (1) | Disclosure is provided in accordance with the requirements of OSFI’s Guideline B-20 (Residential Mortgage Underwriting Practices and Procedures). |
| (2) | Includes $41,751 million and $16 million of uninsured and insured home equity lines of credit, respectively (October 31, 2025 – $42,260 million and $17 million, respectively), reported within the personal loan category. The amounts in U.S. and Other International include term loans collateralized by residential properties. |
| (3) | Insured residential mortgages are mortgages whereby our exposure to default is mitigated by insurance through the Canadian Mortgage and Housing Corporation or other private mortgage default insurers. |
| (4) | Region is based upon the address of the property mortgaged. The Atlantic provinces comprise Newfoundland and Labrador, Prince Edward Island, Nova Scotia and New Brunswick; B.C. and territories comprise British Columbia, Nunavut, Northwest Territories and Yukon. |
| (5) | Total consolidated residential mortgages in Canada of $458 billion (October 31, 2025 – $454 billion) includes $12 billion (October 31, 2025 – $12 billion) of mortgages with commercial clients in Commercial Banking, of which $9 billion (October 31, 2025 – $9 billion) are insured, and $18 billion (October 31, 2025 – $17 billion) of residential mortgages in Capital Markets, of which $18 billion (October 31, 2025 – $17 billion) are held for securitization purposes. All of the residential mortgages held for securitization purposes are insured (October 31, 2025 – all insured). |
| As at | ||||||||||||||||||||||||||
January 31 2026 |
October 31 2025 | |||||||||||||||||||||||||
Canada |
U.S. and other International |
Total |
Canada (2) | U.S. and other International |
Total | |||||||||||||||||||||
Amortization period |
||||||||||||||||||||||||||
≤ 25 years |
75 |
% |
40 |
% |
72 |
% |
76 | % | 38 | % | 73 | % | ||||||||||||||
> 25 years ≤ 30 years |
25 |
60 |
28 |
24 | 62 | 27 | ||||||||||||||||||||
Total |
100 |
% |
100 |
% |
100 |
% |
100 | % | 100 | % | 100 | % | ||||||||||||||
| (1) | Disclosure is provided in accordance with the requirements of OSFI’s Guideline B-20 (Residential Mortgage Underwriting Practices and Procedures). |
| (2) | Our policy is to originate mortgages with amortization periods of 30 years or less. We do not originate mortgage products with a structure that would result in negative amortization, as payments on variable rate mortgages automatically increase to ensure accrued interest is covered. |
| For the three months ended | ||||||||||||||||||
January 31 2026 |
October 31 2025 |
|||||||||||||||||
Uninsured |
Uninsured | |||||||||||||||||
Residential mortgages |
RBC Homeline Plan products |
Residential mortgages (2) |
RBC Homeline Plan products (3) |
|||||||||||||||
Average of newly originated and acquired for the period, by region (4) |
||||||||||||||||||
Atlantic provinces |
70 |
% |
70 |
% |
70 | % | 70 | % | ||||||||||
Quebec |
69 |
70 |
70 | 70 | ||||||||||||||
Ontario |
71 |
67 |
70 | 66 | ||||||||||||||
Alberta |
70 |
70 |
71 | 71 | ||||||||||||||
Saskatchewan and Manitoba |
72 |
73 |
73 | 73 | ||||||||||||||
B.C. and territories |
67 |
64 |
68 | 64 | ||||||||||||||
U.S. |
70 |
n.m. |
73 | n.m. | ||||||||||||||
Other International |
72 |
n.m. |
69 | n.m. | ||||||||||||||
Average of newly originated and acquired for the period (5), (6) |
70 |
% |
67 |
% |
70 | % | 67 | % | ||||||||||
Total Personal Banking – Canada residential mortgages portfolio (7) |
61 |
% |
51 |
% |
60 | % | 49 | % | ||||||||||
| (1) | Disclosure is provided in accordance with the requirements of OSFI’s Guideline B-20 (Residential Mortgage Underwriting Practices and Procedures). |
| (2) | Residential mortgages exclude residential mortgages within the RBC Homeline Plan products. |
| (3) | RBC Homeline Plan products comprise both residential mortgages and home equity lines of credit. |
| (4) | Region is based upon the address of the property mortgaged. The Atlantic provinces comprise Newfoundland and Labrador, Prince Edward Island, Nova Scotia and New Brunswick; B.C. and territories comprise of British Columbia, Nunavut, Northwest Territories and Yukon. |
| (5) | The average LTV ratios for newly originated and acquired uninsured residential mortgages and RBC Homeline Plan products are calculated on a weighted basis by mortgage amounts at origination. |
| (6) | For newly originated mortgages and RBC Homeline Plan products, LTV is calculated based on the total facility amount for the residential mortgage and RBC Homeline Plan product divided by the value of the related residential property. |
| (7) | Weighted by mortgage balances and adjusted for property values based on the Teranet-National Bank House Price Index ‡ |
| n.m. | not meaningful |
| As at | ||||||||||||||||||||||||||||||||||||||||||
January 31 2026 |
October 31 2025 |
|||||||||||||||||||||||||||||||||||||||||
Asset type |
Client type |
|||||||||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Loans Outstanding |
Securities |
Repo-style transactions |
Derivatives |
Financials |
Sovereign |
Corporate |
Total |
Total | |||||||||||||||||||||||||||||||||
Europe (excluding U.K.) |
$ |
20,010 |
$ |
24,657 |
$ |
7,929 |
$ |
3,841 |
$ |
31,571 |
$ |
7,587 |
$ |
17,279 |
$ |
56,437 |
$ | 56,215 | ||||||||||||||||||||||||
U.K. |
15,198 |
38,005 |
11,101 |
1,891 |
21,639 |
31,226 |
13,330 |
66,195 |
45,368 | |||||||||||||||||||||||||||||||||
Caribbean |
7,084 |
10,213 |
2,935 |
1,768 |
8,845 |
5,238 |
7,917 |
22,000 |
22,789 | |||||||||||||||||||||||||||||||||
Asia-Pacific |
9,377 |
39,831 |
4,875 |
1,507 |
20,947 |
28,992 |
5,651 |
55,590 |
46,151 | |||||||||||||||||||||||||||||||||
Other (4) |
2,868 |
1,718 |
3,673 |
294 |
2,752 |
2,681 |
3,120 |
8,553 |
8,114 | |||||||||||||||||||||||||||||||||
Net International exposure (5) |
$ |
54,537 |
$ |
114,424 |
$ |
30,513 |
$ |
9,301 |
$ |
85,754 |
$ |
75,724 |
$ |
47,297 |
$ |
208,775 |
$ | 178,637 | ||||||||||||||||||||||||
| (1) | Geographic profile is based on country of risk, which reflects our assessment of the geographic risk associated with a given exposure. Typically, this is the residence of the borrower. |
| (2) | Exposures are calculated on a fair value basis and net of collateral, which includes $470 billion against repo-style transactions (October 31, 2025 – $467 billion) and $24 billion against derivatives (October 31, 2025 – $20 billion). |
| (3) | Securities include $28 billion of trading securities (October 31, 2025 – $26 billion), $38 billion of deposits (October 31, 2025 – $24 billion), and $48 billion of investment securities (October 31, 2025 – $43 billion). |
| (4) | Includes exposures in the Middle East, Africa and Latin America. |
| (5) | Excludes $6,883 million (October 31, 2025 – $7,643 million) of exposures to supranational agencies. |
| As at and for the three months ended | ||||||||
(Millions of Canadian dollars, except percentage amounts) |
January 31 2026 |
October 31 2025 |
||||||
Personal Banking |
$ |
2,385 |
$ | 2,091 | ||||
Commercial Banking |
3,450 |
3,362 | ||||||
Wealth Management |
699 |
609 | ||||||
Capital Markets |
2,633 |
2,620 | ||||||
Total GIL |
$ |
9,167 |
$ | 8,682 | ||||
Impaired loans, beginning balance |
$ |
8,682 |
$ | 8,751 | ||||
Classified as impaired during the period (new impaired) (1) |
2,348 |
1,962 | ||||||
Net repayments (1) |
(578 |
) |
(249 | ) | ||||
Amounts written off |
(753 |
) |
(1,216 | ) | ||||
Other (2) |
(532 |
) |
(566 | ) | ||||
Impaired loans, balance at end of period |
$ |
9,167 |
$ | 8,682 | ||||
GIL as a % of related loans and acceptances |
||||||||
Total GIL as a % of related loans and acceptances |
0.86% |
0.83% | ||||||
Personal Banking |
0.43% |
0.38% | ||||||
Personal Banking – Canada |
0.40% |
0.34% | ||||||
Commercial Banking |
1.78% |
1.74% | ||||||
Wealth Management |
0.54% |
0.47% | ||||||
Capital Markets |
1.46% |
1.52% | ||||||
| (1) | Certain GIL movements for Personal Banking – Canada and Commercial Banking are generally allocated to new impaired, as Net repayments and certain Other movements are not reasonably determinable. |
| (2) | Includes return to performing status during the period, recoveries of loans and advances previously written off, sold, amounts related to foreclosed properties held as investment properties and interests in joint ventures for certain co-lending arrangements, foreign exchange translation and other movements. |
| As at | ||||||||
(Millions of Canadian dollars) |
January 31 2026 |
October 31 2025 |
||||||
Personal Banking |
$ |
3,794 |
$ | 3,739 | ||||
Commercial Banking |
2,436 |
2,300 | ||||||
Wealth Management |
482 |
496 | ||||||
Capital Markets |
1,039 |
923 | ||||||
Corporate Support and other |
1 |
1 | ||||||
ACL on loans |
7,752 |
7,459 | ||||||
ACL on other financial assets (1) |
15 |
11 | ||||||
Total ACL |
$ |
7,767 |
$ | 7,470 | ||||
ACL on loans is comprised of: |
||||||||
Retail |
$ |
3,466 |
$ | 3,454 | ||||
Wholesale |
2,005 |
2,019 | ||||||
ACL on performing loans |
$ |
5,471 |
$ | 5,473 | ||||
ACL on impaired loans |
2,281 |
1,986 | ||||||
| (1) | ACL on other financial assets mainly represents allowances on debt securities measured at FVOCI and amortized cost, accounts receivable and financial guarantees. |
Market risk |
January 31, 2026 |
October 31, 2025 | January 31, 2025 | ||||||||||||||||||||||||||||||||||
For the three months ended |
For the three months ended |
For the three months ended |
||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | As at |
Average |
High |
Low |
As at | Average | As at | Average | ||||||||||||||||||||||||||||
Equity |
$ |
12 |
$ |
16 |
$ |
25 |
$ |
11 |
$ | 17 | $ | 16 | $ | 13 | $ | 15 | ||||||||||||||||||||
Foreign exchange |
7 |
5 |
9 |
2 |
5 | 6 | 6 | 4 | ||||||||||||||||||||||||||||
Commodities |
10 |
11 |
15 |
7 |
8 | 7 | 7 | 7 | ||||||||||||||||||||||||||||
Interest rate (1) |
25 |
27 |
32 |
21 |
33 | 24 | 22 | 23 | ||||||||||||||||||||||||||||
Credit specific (2) |
5 |
6 |
6 |
5 |
5 | 6 | 8 | 8 | ||||||||||||||||||||||||||||
Diversification (3) |
(39 |
) |
(37 |
) |
n.m. |
n.m. |
(38 | ) | (36 | ) | (33 | ) | (32 | ) | ||||||||||||||||||||||
Trading VaR |
$ |
20 |
$ |
28 |
$ |
34 |
$ |
20 |
$ | 30 | $ | 23 | $ | 23 | $ | 25 | ||||||||||||||||||||
Total VaR |
$ |
26 |
$ |
42 |
$ |
56 |
$ |
26 |
$ | 40 | $ | 36 | $ | 26 | $ | 32 | ||||||||||||||||||||
| (1) | General credit spread risk and funding spread risk associated with uncollateralized derivatives are included under interest rate VaR. |
| (2) | Credit specific risk captures issuer-specific credit spread volatility. |
| (3) | Trading VaR is less than the sum of the individual risk factor VaR results due to risk factor diversification. |
| n.m. | not meaningful |

| (1) | Trading revenue (teb) in the chart above excludes the impact of loan underwriting commitments. |
January 31 2026 |
October 31 2025 |
January 31 2025 |
||||||||||||||||||||||||||||||||||||||||||||
EVE risk |
NII risk (1) |
|||||||||||||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Canadian dollar impact |
U.S. dollar and other impact |
Total |
Canadian dollar impact |
U.S. dollar and other impact |
Total |
EVE risk | NII risk (1) | EVE risk | NII risk (1) | ||||||||||||||||||||||||||||||||||||
Before-tax impact of: |
||||||||||||||||||||||||||||||||||||||||||||||
100 bps increase in rates |
$ |
(2,134 |
) |
$ |
(507 |
) |
$ |
(2,641 |
) |
$ |
153 |
$ |
62 |
$ |
215 |
$ | (2,648 | ) | $ | 197 | $ | (2,107 | ) | $ | 503 | |||||||||||||||||||||
100 bps decrease in rates |
1,984 |
(2 |
) |
1,982 |
(244 |
) |
(153 |
) |
(397 |
) |
1,932 | (373 | ) | 1,644 | (589 | ) | ||||||||||||||||||||||||||||||
| (1) | Represents the 12-month NII exposure to an instantaneous and sustained shift in interest rates. |
| (2) | Effective the third quarter of 2025, EVE and NII risk for currencies other than the Canadian and U.S. dollar are presented within the U.S. dollar and other impact category. Previously, the impact of other currencies was presented in the Canadian dollar impact category. |
As at January 31, 2026 | ||||||||||||||
Market risk measure |
||||||||||||||
| (Millions of Canadian dollars) | Balance sheet amount |
Traded risk |
Non-traded risk ) |
Non-traded riskprimary risk sensitivity | ||||||||||
Assets subject to market risk |
||||||||||||||
Cash and due from banks |
$ |
46,226 |
$ |
– |
$ |
46,226 |
Interest rate | |||||||
Interest-bearing deposits with banks |
53,073 |
– |
53,073 |
Interest rate | ||||||||||
Securities |
||||||||||||||
Trading |
229,840 |
198,098 |
31,742 |
Interest rate, credit spread | ||||||||||
Investment, net of applicable allowance |
359,126 |
– |
359,126 |
Interest rate, credit spread, equity | ||||||||||
Assets purchased under reverse repurchase agreements and securities borrowed |
279,800 |
229,322 |
50,478 |
Interest rate | ||||||||||
Loans |
||||||||||||||
Retail |
655,434 |
14 |
655,420 |
Interest rate | ||||||||||
Wholesale |
406,848 |
5,220 |
401,628 |
Interest rate | ||||||||||
Allowance for loan losses |
(7,401 |
) |
– |
(7,401 |
) |
Interest rate | ||||||||
Other |
||||||||||||||
Derivatives |
170,830 |
165,880 |
4,950 |
Interest rate, foreign exchange | ||||||||||
Other assets |
140,478 |
67,133 |
73,345 |
Interest rate | ||||||||||
Assets not subject to market risk (3) |
8,139 |
|||||||||||||
Total assets |
$ |
2,342,393 |
$ |
665,667 |
$ |
1,668,587 |
||||||||
Liabilities subject to market risk |
||||||||||||||
Deposits |
$ |
1,542,216 |
$ |
74,176 |
$ |
1,468,040 |
Interest rate | |||||||
Other |
||||||||||||||
Obligations related to securities sold short |
47,809 |
47,134 |
675 |
Interest rate, equity | ||||||||||
Obligations related to assets sold under repurchase agreements and securities loaned |
288,016 |
253,515 |
34,501 |
Interest rate | ||||||||||
Derivatives |
170,731 |
168,184 |
2,547 |
Interest rate, foreign exchange | ||||||||||
Other liabilities |
117,460 |
56,804 |
60,656 |
Interest rate | ||||||||||
Subordinated debentures |
11,875 |
– |
11,875 |
Interest rate | ||||||||||
Liabilities not subject to market risk (4) |
24,428 |
|||||||||||||
Total liabilities |
$ |
2,202,535 |
$ |
599,813 |
$ |
1,578,294 |
||||||||
Total equity |
139,858 |
|||||||||||||
Total liabilities and equity |
$ |
2,342,393 |
||||||||||||
| (1) | Traded risk includes positions that are classified or designated as FVTPL and positions whose revaluation gains and losses are reported in revenue within our trading portfolios. Market risk measures of VaR and stress tests are used as risk controls for traded risk. |
| (2) | Non-traded risk includes positions used in the management of IRRBB and other non-trading portfolios. Other non-trading portfolios include positions from RBC Insurance and investment securities, net of applicable allowance, not included in IRRBB. |
| (3) | Assets not subject to market risk primarily include insurance-related assets. |
| (4) | Liabilities not subject to market risk primarily include insurance contract liabilities. |
| As at October 31, 2025 | ||||||||||||||
| Market risk measure | ||||||||||||||
| (Millions of Canadian dollars) | Balance sheet amount |
Traded risk (1) | Non-traded risk (2) |
Non-traded riskprimary risk sensitivity | ||||||||||
Assets subject to market risk |
||||||||||||||
Cash and due from banks |
$ | 37,024 | $ | – | $ | 37,024 | Interest rate | |||||||
Interest-bearing deposits with banks |
50,364 | 6 | 50,358 | Interest rate | ||||||||||
Securities |
||||||||||||||
Trading |
219,067 | 188,249 | 30,818 | Interest rate, credit spread | ||||||||||
Investment, net of applicable allowance |
342,721 | – | 342,721 | Interest rate, credit spread, equity | ||||||||||
Assets purchased under reverse repurchase agreements and securities borrowed |
309,683 | 251,147 | 58,536 | Interest rate | ||||||||||
Loans |
||||||||||||||
Retail |
652,344 | 2 | 652,342 | Interest rate | ||||||||||
Wholesale |
397,171 | 3,271 | 393,900 | Interest rate | ||||||||||
Allowance for loan losses |
(7,093 | ) | – | (7,093 | ) | Interest rate | ||||||||
Other |
||||||||||||||
Derivatives |
177,206 | 171,721 | 5,485 | Interest rate, foreign exchange | ||||||||||
Other assets |
138,647 | 62,521 | 76,126 | Interest rate | ||||||||||
Assets not subject to market risk (3) |
7,872 | |||||||||||||
Total assets |
$ | 2,325,006 | $ | 676,917 | $ | 1,640,217 | ||||||||
Liabilities subject to market risk |
||||||||||||||
Deposits |
$ | 1,515,616 | $ | 74,278 | $ | 1,441,338 | Interest rate | |||||||
Other |
||||||||||||||
Obligations related to securities sold short |
49,891 | 49,428 | 463 | Interest rate, equity | ||||||||||
Obligations related to assets sold under repurchase agreements and securities loaned |
289,516 | 252,956 | 36,560 | Interest rate | ||||||||||
Derivatives |
183,953 | 180,047 | 3,906 | Interest rate, foreign exchange | ||||||||||
Other liabilities |
108,398 | 49,489 | 58,909 | Interest rate | ||||||||||
Subordinated debentures |
13,961 | – | 13,961 | Interest rate | ||||||||||
Liabilities not subject to market risk (4) |
24,520 | |||||||||||||
Total liabilities |
$ | 2,185,855 | $ | 606,198 | $ | 1,555,137 | ||||||||
Total equity |
139,151 | |||||||||||||
Total liabilities and equity |
$ | 2,325,006 | ||||||||||||
| (1) | Traded risk includes positions that are classified or designated as FVTPL and positions whose revaluation gains and losses are reported in revenue within our trading portfolios. Market risk measures of VaR and stress tests are used as risk controls for traded risk. |
| (2) | Non-traded risk includes positions used in the management of IRRBB and other non-trading portfolios. Other non-trading portfolios include positions from RBC Insurance and investment securities, net of applicable allowance, not included in IRRBB. |
| (3) | Assets not subject to market risk primarily include insurance-related assets. |
| (4) | Liabilities not subject to market risk primarily include insurance contract liabilities. |
Liquidity and funding risk |
As at January 31, 2026 |
||||||||||||||||||||||||
| (Millions of Canadian dollars) | Bank-owned liquid assets |
Securities received as collateral from securities financing and derivative transactions |
Total liquid assets |
Encumbered liquid assets |
Unencumbered liquid assets |
|||||||||||||||||||
Cash and deposits with banks |
$ |
99,299 |
$ |
– |
$ |
99,299 |
$ |
2,995 |
$ |
96,304 |
||||||||||||||
Securities issued or guaranteed by sovereigns, central banks or multilateral development banks (1) |
437,696 |
346,687 |
784,383 |
448,779 |
335,604 |
|||||||||||||||||||
Other securities |
178,370 |
183,087 |
361,457 |
209,706 |
151,751 |
|||||||||||||||||||
Other liquid assets (2) |
55,813 |
– |
55,813 |
44,989 |
10,824 |
|||||||||||||||||||
Total liquid assets |
$ |
771,178 |
$ |
529,774 |
$ |
1,300,952 |
$ |
706,469 |
$ |
594,483 |
||||||||||||||
As at October 31, 2025 |
||||||||||||||||||||||||
| (Millions of Canadian dollars) | Bank-owned liquid assets |
Securities received as collateral from securities financing and derivative transactions |
Total liquid assets |
Encumbered liquid assets |
Unencumbered liquid assets |
|||||||||||||||||||
Cash and deposits with banks |
$ | 87,388 | $ | – | $ | 87,388 | $ | 3,195 | $ | 84,193 | ||||||||||||||
Securities issued or guaranteed by sovereigns, central banks or multilateral development banks (1) |
436,725 | 352,312 | 789,037 | 434,060 | 354,977 | |||||||||||||||||||
Other securities |
179,279 | 156,840 | 336,119 | 207,703 | 128,416 | |||||||||||||||||||
Other liquid assets (2) |
50,082 | – | 50,082 | 40,974 | 9,108 | |||||||||||||||||||
Total liquid assets |
$ | 753,474 | $ | 509,152 | $ | 1,262,626 | $ | 685,932 | $ | 576,694 | ||||||||||||||
| As at | ||||||||||||||||||||||||
(Millions of Canadian dollars) |
January 31 2026 |
October 31 2025 |
||||||||||||||||||||||
Royal Bank of Canada |
$ |
285,939 |
$ | 279,012 | ||||||||||||||||||||
Foreign branches |
80,597 |
77,977 | ||||||||||||||||||||||
Subsidiaries |
227,947 |
219,705 | ||||||||||||||||||||||
Total unencumbered liquid assets |
$ |
594,483 |
$ | 576,694 | ||||||||||||||||||||
| (1) | Includes marketable securities issued by provincial governments and U.S. government-sponsored entities working under U.S. Federal government’s conservatorship (e.g., Federal National Mortgage Association and Federal Home Loan Mortgage Corporation). |
| (2) | Encumbered liquid assets amount includes cash collateral and margin deposit amounts pledged related to over-the-counter |
As at January 31, 2026 |
||||||||||||||||||||||||||||||||||||
Total assets |
Encumbered |
Unencumbered |
||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Bank-owned assets |
Securities received as collateral from securities financing and derivative transactions |
Total |
Pledged as collateral |
Other |
Available as collateral |
Other |
|||||||||||||||||||||||||||||
Cash and deposits with banks |
$ |
99,299 |
$ |
– |
$ |
99,299 |
$ |
– |
$ |
2,995 |
$ |
96,304 |
$ |
– |
||||||||||||||||||||||
Securities (4) |
601,113 |
599,881 |
1,200,994 |
703,854 |
33,543 |
459,348 |
4,249 |
|||||||||||||||||||||||||||||
Loans, net of allowance for loan losses |
||||||||||||||||||||||||||||||||||||
Mortgage securities |
53,008 |
– |
53,008 |
25,638 |
– |
27,370 |
– |
|||||||||||||||||||||||||||||
Mortgage loans |
442,676 |
– |
442,676 |
70,484 |
– |
37,260 |
334,932 |
|||||||||||||||||||||||||||||
Other loans |
559,197 |
– |
559,197 |
5,089 |
– |
26,443 |
527,665 |
|||||||||||||||||||||||||||||
Derivatives |
170,830 |
– |
170,830 |
– |
– |
– |
170,830 |
|||||||||||||||||||||||||||||
Others (5) |
148,617 |
– |
148,617 |
44,989 |
– |
10,824 |
92,804 |
|||||||||||||||||||||||||||||
Total |
$ |
2,074,740 |
$ |
599,881 |
$ |
2,674,621 |
$ |
850,054 |
$ |
36,538 |
$ |
657,549 |
$ |
1,130,480 |
||||||||||||||||||||||
| As at October 31, 2025 | ||||||||||||||||||||||||||||||||||||
| Total assets | Encumbered | Unencumbered | ||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Bank-owned assets |
Securities received as collateral from securities financing and derivative transactions |
Total | Pledged as collateral |
Other (1) | Available as collateral (2) |
Other (3) | |||||||||||||||||||||||||||||
Cash and deposits with banks |
$ | 87,388 | $ | – | $ | 87,388 | $ | – | $ | 3,195 | $ | 84,193 | $ | – | ||||||||||||||||||||||
Securities (4) |
575,466 | 573,672 | 1,149,138 | 670,404 | 33,437 | 441,458 | 3,839 | |||||||||||||||||||||||||||||
Loans, net of allowance for loan losses |
||||||||||||||||||||||||||||||||||||
Mortgage securities |
54,607 | – | 54,607 | 26,714 | – | 27,893 | – | |||||||||||||||||||||||||||||
Mortgage loans |
438,012 | – | 438,012 | 64,928 | – | 41,010 | 332,074 | |||||||||||||||||||||||||||||
Other loans |
549,803 | – | 549,803 | 5,244 | – | 26,496 | 518,063 | |||||||||||||||||||||||||||||
Derivatives |
177,206 | – | 177,206 | – | – | – | 177,206 | |||||||||||||||||||||||||||||
Others (5) |
146,519 | – | 146,519 | 40,974 | – | 9,108 | 96,437 | |||||||||||||||||||||||||||||
Total |
$ | 2,029,001 | $ | 573,672 | $ | 2,602,673 | $ | 808,264 | $ | 36,632 | $ | 630,158 | $ | 1,127,619 | ||||||||||||||||||||||
| (1) | Includes assets restricted from use to generate secured funding due to legal or other constraints. |
| (2) | Represents assets that are immediately available for use as collateral, including National Housing Act Mortgage-Backed Securities (NHA MBS), our unencumbered mortgage loans that qualify as eligible collateral at Federal Home Loan Banks (FHLB), as well as loans that qualify as eligible collateral for discount window facility available to us and lodged at the Federal Reserve Bank of New York (FRBNY). |
| (3) | Other unencumbered assets are not subject to any restrictions on their use to secure funding or as collateral but would not be considered immediately available. |
| (4) | Includes bank-owned liquid assets and securities received as collateral from off-balance sheet securities financing, derivative transactions and margin lending. Includes $34 billion (October 31, 2025 – $33 billion) of collateral received through reverse repurchase transactions that cannot be rehypothecated in its current legal form. |
| (5) | The Pledged as collateral amount includes cash collateral and margin deposit amounts pledged related to OTC and exchange-traded derivative transactions. |
Programs by geography |
Canada |
U.S. |
Europe | ||
• Canadian Shelf Program – $25 billion |
• U.S. Shelf Program – US$75 billion |
• European Debt Issuance Program – US$75 billion | ||
• Global Covered Bond Program – € 75 billion | ||||
![]() |
![]() | |
(1) Includes unsecured and secured long-term funding and subordinated debentures with an original term to maturity greater than 1 year |
(1) Includes unsecured and secured long-term funding and subordinated debentures with an original term to maturity greater than 1 year | |
(2) Mortgage-backed securities and Canada Mortgage Bonds |
As at January 31, 2026 |
||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Less than 1 month |
1 to 3 months |
3 to 6 months |
6 to 12 months |
Less than 1 year sub-total |
1 year to 2 years |
2 years and greater |
Total |
||||||||||||||||||||||||
Deposits from banks (2) |
$ |
4,314 |
$ |
177 |
$ |
396 |
$ |
1,043 |
$ |
5,930 |
$ |
– |
$ |
– |
$ |
5,930 |
||||||||||||||||
Certificates of deposit and commercial paper (3) |
11,911 |
27,356 |
33,477 |
53,519 |
126,263 |
– |
– |
126,263 |
||||||||||||||||||||||||
Asset-backed commercial paper (4) |
4,500 |
6,645 |
6,173 |
1,704 |
19,022 |
– |
– |
19,022 |
||||||||||||||||||||||||
Senior unsecured medium-term notes (5) |
1,493 |
6,738 |
17,139 |
22,443 |
47,813 |
29,973 |
57,407 |
135,193 |
||||||||||||||||||||||||
Senior unsecured structured notes (6) |
3,269 |
4,351 |
1,842 |
4,928 |
14,390 |
1,982 |
13,329 |
29,701 |
||||||||||||||||||||||||
Mortgage securitization |
– |
200 |
542 |
1,374 |
2,116 |
2,125 |
12,120 |
16,361 |
||||||||||||||||||||||||
Covered bonds/asset-backed securities (7) |
– |
3,227 |
5,150 |
15,773 |
24,150 |
13,679 |
18,519 |
56,348 |
||||||||||||||||||||||||
Subordinated liabilities |
– |
– |
– |
– |
– |
– |
11,871 |
11,871 |
||||||||||||||||||||||||
Other (8) |
102 |
3,104 |
4,259 |
116 |
7,581 |
240 |
23,112 |
30,933 |
||||||||||||||||||||||||
Total |
$ |
25,589 |
$ |
51,798 |
$ |
68,978 |
$ |
100,900 |
$ |
247,265 |
$ |
47,999 |
$ |
136,358 |
$ |
431,622 |
||||||||||||||||
Of which: |
||||||||||||||||||||||||||||||||
– Secured |
$ |
4,572 |
$ |
13,136 |
$ |
16,086 |
$ |
18,851 |
$ |
52,645 |
$ |
15,804 |
$ |
35,751 |
$ |
104,200 |
||||||||||||||||
– Unsecured |
21,017 |
38,662 |
52,892 |
82,049 |
194,620 |
32,195 |
100,607 |
327,422 |
||||||||||||||||||||||||
| (Millions of Canadian dollars) | As at October 31, 2025 | |||||||||||||||||||||||||||||||
| Less than 1 month |
1 to 3 months |
3 to 6 months |
6 to 12 months |
Less than 1 year sub-total |
1 year to 2 years |
2 years and greater |
Total | |||||||||||||||||||||||||
Deposits from banks (2) |
$ | 3,255 | $ | 311 | $ | 243 | $ | 1,014 | $ | 4,823 | $ | – | $ | – | $ | 4,823 | ||||||||||||||||
Certificates of deposit and commercial paper (3) |
15,877 | 20,614 | 38,985 | 38,595 | 114,071 | – | – | 114,071 | ||||||||||||||||||||||||
Asset-backed commercial paper (4) |
4,989 | 5,324 | 8,027 | 1,680 | 20,020 | – | – | 20,020 | ||||||||||||||||||||||||
Senior unsecured medium-term notes (5) |
2,412 | 4,858 | 8,257 | 22,164 | 37,691 | 29,161 | 63,988 | 130,840 | ||||||||||||||||||||||||
Senior unsecured structured notes (6) |
5,050 | 1,841 | 2,581 | 2,986 | 12,458 | 3,243 | 13,430 | 29,131 | ||||||||||||||||||||||||
Mortgage securitization |
– | 509 | 200 | 1,202 | 1,911 | 2,479 | 12,249 | 16,639 | ||||||||||||||||||||||||
Covered bonds/asset-backed securities (7) |
– | 3,257 | 3,233 | 13,136 | 19,626 | 20,277 | 20,010 | 59,913 | ||||||||||||||||||||||||
Subordinated liabilities |
– | 2,103 | – | – | 2,103 | – | 11,838 | 13,941 | ||||||||||||||||||||||||
Other (8) |
11 | 60 | 2,876 | 90 | 3,037 | 256 | 23,181 | 26,474 | ||||||||||||||||||||||||
Total |
$ | 31,594 | $ | 38,877 | $ | 64,402 | $ | 80,867 | $ | 215,740 | $ | 55,416 | $ | 144,696 | $ | 415,852 | ||||||||||||||||
Of which: |
||||||||||||||||||||||||||||||||
– Secured |
$ | 4,989 | $ | 9,106 | $ | 14,264 | $ | 16,018 | $ | 44,377 | $ | 22,756 | $ | 36,883 | $ | 104,016 | ||||||||||||||||
– Unsecured |
26,605 | 29,771 | 50,138 | 64,849 | 171,363 | 32,660 | 107,813 | 311,836 | ||||||||||||||||||||||||
| (1) | Excludes repos. |
| (2) | Excludes deposits associated with services we provide to banks (e.g., custody, cash management). |
| (3) | Includes bearer deposit notes (unsecured). |
| (4) | Only includes consolidated liabilities, including our collateralized commercial paper program. |
| (5) | Includes deposit notes and floating rate notes (unsecured). |
| (6) | Includes notes where the payout is tied to movements in foreign exchange, commodities and equities. |
| (7) | Includes covered bonds collateralized with residential mortgages and securities backed by credit card receivables. |
| (8) | Includes tender option bonds (secured) of $5,112 million (October 31, 2025 – $4,581 million), other long-term structured deposits (unsecured) of $18,259 million (October 31, 2025 – $18,851 million), FHLB advances (secured) of $7,357 million (October 31, 2025 – $2,804 million) and wholesale guaranteed interest certificates of $205 million (October 31, 2025 – $238 million). |
As at February 25, 2026 |
||||||||||||||||
Short-term debt |
Legacy senior long-term debt |
Senior long-term debt |
Outlook |
|||||||||||||
Moody’s ‡ (4) |
P-1 |
Aa1 |
A1 |
stable |
||||||||||||
Standard & Poor’s ‡ (5) |
A-1+ |
AA- |
A |
stable |
||||||||||||
Fitch Ratings ‡ (6) |
F1+ |
AA |
AA- |
stable |
||||||||||||
DBRS ‡ (7) |
R-1 (high) |
AA (high) |
AA |
stable |
||||||||||||
| (1) | Credit ratings are not recommendations to purchase, sell or hold a financial obligation in as much as they do not comment on market price or suitability for a particular investor. Ratings are determined by the rating agencies based on criteria established from time to time by them and are subject to revision or withdrawal at any time by the rating organization. |
| (2) | Includes senior long-term debt issued prior to September 23, 2018 and senior long-term debt issued on or after September 23, 2018 which is excluded from the Bail-in regime. |
| (3) | Includes senior long-term debt issued on or after September 23, 2018 which is subject to conversion under the Bail-in regime. |
| (4) | On October 9, 2025, Moody’s announced completion of a periodic review of our ratings. There were no changes to our ratings. |
| (5) | On December 10, 2025, Standard & Poor’s performed an annual review of our ratings. There were no changes to our ratings. |
| (6) | On June 3, 2025, Fitch Ratings affirmed our ratings with a stable outlook. |
| (7) | On May 9, 2025, DBRS affirmed our ratings with a stable outlook. |
| As at | ||||||||||||||||||||||||||
January 31 2026 |
October 31 2025 |
|||||||||||||||||||||||||
| (Millions of Canadian dollars) | One-notch downgrade |
Two-notch downgrade |
Three-notch downgrade |
One-notch downgrade |
Two-notch downgrade |
Three-notch downgrade |
||||||||||||||||||||
Contractual derivatives funding or margin requirements |
$ |
294 |
$ |
109 |
$ |
209 |
$ | 275 | $ | 137 | $ | 209 | ||||||||||||||
Other contractual funding or margin requirements (1) |
45 |
19 |
508 |
41 | 55 | 188 | ||||||||||||||||||||
| (1) | Includes Guaranteed Investment Certificates (GICs) issued by our municipal markets business out of New York. |
| For the three months ended | ||||||||
January 31 2026 |
||||||||
| (Millions of Canadian dollars, except percentage amounts) | Total unweighted value (average) |
Total weighted value (average) |
||||||
High-quality liquid assets |
||||||||
Total high-quality liquid assets (HQLA) |
$ |
468,324 |
||||||
Cash outflows |
||||||||
Retail deposits and deposits from small business customers, of which: |
$ |
417,179 |
$ |
41,057 |
||||
Stable deposits (3) |
136,532 |
4,096 |
||||||
Less stable deposits |
280,647 |
36,961 |
||||||
Unsecured wholesale funding, of which: |
545,036 |
259,217 |
||||||
Operational deposits (all counterparties) and deposits in networks of cooperative banks (4) |
191,339 |
45,181 |
||||||
Non-operational deposits |
331,915 |
192,254 |
||||||
Unsecured debt |
21,782 |
21,782 |
||||||
Secured wholesale funding |
63,037 |
|||||||
Additional requirements, of which: |
461,680 |
99,910 |
||||||
Outflows related to derivative exposures and other collateral requirements |
96,595 |
28,691 |
||||||
Outflows related to loss of funding on debt products |
11,395 |
11,395 |
||||||
Credit and liquidity facilities |
353,690 |
59,824 |
||||||
Other contractual funding obligations (5) |
25,696 |
25,696 |
||||||
Other contingent funding obligations (6) |
979,820 |
17,335 |
||||||
Total cash outflows |
$ |
506,252 |
||||||
Cash inflows |
||||||||
Secured lending (e.g., reverse repos) |
$ |
426,068 |
$ |
81,191 |
||||
Inflows from fully performing exposures |
24,128 |
10,517 |
||||||
Other cash inflows |
36,967 |
36,967 |
||||||
Total cash inflows |
$ |
128,675 |
||||||
Total adjusted value |
||||||||
Total HQLA |
$ |
468,324 |
||||||
Total net cash outflows |
377,577 |
|||||||
Liquidity coverage ratio |
124% |
|||||||
October 31 2025 |
||||||||
| (Millions of Canadian dollars, except percentage amounts) | Total adjusted value |
|||||||
Total HQLA |
$ | 458,576 | ||||||
Total net cash outflows |
361,519 | |||||||
Liquidity coverage ratio |
127% | |||||||
| (1) | The LCR is calculated in accordance with OSFI’s LAR guideline, which, in turn, reflects liquidity-related requirements issued by the BCBS. The LCR for the quarter ended January 31, 2026 is calculated as an average of 61 daily positions. |
| (2) | With the exception of other contingent funding obligations, unweighted inflow and outflow amounts are items maturing or callable in 30 days or less. Other contingent funding obligations also include debt securities with remaining maturity greater than 30 days. |
| (3) | As defined by the BCBS, stable deposits from retail and small business customers are deposits that are insured and are either held in transactional accounts or the bank has an established relationship with the client making the withdrawal unlikely. |
| (4) | Operational deposits from customers other than retail and small and medium-sized enterprises, are deposits which clients need to keep with the bank in order to facilitate their access and ability to use payment and settlement systems primarily for clearing, custody and cash management activities. |
| (5) | Other contractual funding obligations primarily include outflows from unsettled securities trades and outflows from obligations related to securities sold short. |
| (6) | Other contingent funding obligations include outflows related to other off-balance sheet facilities that carry low LCR runoff factors (0% – 5%). |
As at January 31, 2026 |
||||||||||||||||||||
Unweighted value by residual maturity |
Weighted value |
|||||||||||||||||||
| (Millions of Canadian dollars, except percentage amounts) | No maturity |
< 6 months |
6 months to < 1 year |
≥ 1 year |
||||||||||||||||
Available Stable Funding (ASF) Item |
||||||||||||||||||||
Capital: |
$ |
141,048 |
$ |
– |
$ |
– |
$ |
12,183 |
$ |
153,231 |
||||||||||
Regulatory Capital |
141,048 |
– |
– |
12,183 |
153,231 |
|||||||||||||||
Other Capital Instruments |
– |
– |
– |
– |
– |
|||||||||||||||
Retail deposits and deposits from small business customers: |
351,089 |
122,678 |
56,068 |
67,789 |
546,157 |
|||||||||||||||
Stable deposits (3) |
107,149 |
53,273 |
27,123 |
30,189 |
208,357 |
|||||||||||||||
Less stable deposits |
243,940 |
69,405 |
28,945 |
37,600 |
337,800 |
|||||||||||||||
Wholesale funding: |
383,784 |
496,607 |
125,887 |
156,017 |
436,695 |
|||||||||||||||
Operational deposits (4) |
198,792 |
– |
– |
– |
99,396 |
|||||||||||||||
Other wholesale funding |
184,992 |
496,607 |
125,887 |
156,017 |
337,299 |
|||||||||||||||
Liabilities with matching interdependent assets (5) |
– |
1,318 |
2,380 |
21,210 |
– |
|||||||||||||||
Other liabilities: |
56,559 |
324,580 |
22,392 |
|||||||||||||||||
NSFR derivative liabilities |
53,662 |
|||||||||||||||||||
All other liabilities and equity not included in the above categories |
56,559 |
248,259 |
532 |
22,127 |
22,392 |
|||||||||||||||
Total ASF |
$ |
1,158,475 |
||||||||||||||||||
Required Stable Funding (RSF) Item |
||||||||||||||||||||
Total NSFR high-quality liquid assets (HQLA) |
$ |
48,553 |
||||||||||||||||||
Deposits held at other financial institutions for operational purposes |
– |
2,410 |
– |
– |
1,205 |
|||||||||||||||
Performing loans and securities: |
317,061 |
297,083 |
137,300 |
559,508 |
837,928 |
|||||||||||||||
Performing loans to financial institutions secured by Level 1 HQLA |
157 |
82,263 |
13,777 |
38 |
12,100 |
|||||||||||||||
Performing loans to financial institutions secured by non-Level 1 HQLA and unsecured performing loans to financial institutions |
10,987 |
94,251 |
31,146 |
33,889 |
72,587 |
|||||||||||||||
Performing loans to non-financial corporate clients, loans to retail and small business customers, and loans to sovereigns, central banks and PSEs, of which: |
208,418 |
57,829 |
38,528 |
181,234 |
376,345 |
|||||||||||||||
With a risk weight of less than or equal to 35% under the Basel II standardized approach for credit risk |
– |
– |
– |
17,372 |
11,292 |
|||||||||||||||
Performing residential mortgages, of which: |
40,934 |
58,611 |
52,237 |
318,243 |
303,966 |
|||||||||||||||
With a risk weight of less than or equal to 35% under the Basel II standardized approach for credit risk |
36,091 |
58,557 |
52,193 |
303,633 |
287,382 |
|||||||||||||||
Securities that are not in default and do not qualify as HQLA, including exchange-traded equities |
56,565 |
4,129 |
1,612 |
26,104 |
72,930 |
|||||||||||||||
Assets with matching interdependent liabilities (5) |
– |
1,318 |
2,380 |
21,210 |
– |
|||||||||||||||
Other assets: |
10,824 |
459,013 |
119,204 |
|||||||||||||||||
Physical traded commodities, including gold |
10,824 |
9,200 |
||||||||||||||||||
Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs to default funds of CCPs |
29,969 |
25,473 |
||||||||||||||||||
NSFR derivative assets |
54,066 |
404 |
||||||||||||||||||
NSFR derivative liabilities before deduction of variation margin posted |
99,692 |
4,985 |
||||||||||||||||||
All other assets not included in the above categories |
– |
198,035 |
45 |
77,206 |
79,142 |
|||||||||||||||
Off-balance sheet items |
1,017,759 |
38,936 |
||||||||||||||||||
Total RSF |
$ |
1,045,826 |
||||||||||||||||||
Net Stable Funding Ratio (%) |
111% |
|||||||||||||||||||
| As at October 31, 2025 | ||||||||||||||||||||
| (Millions of Canadian dollars, except percentage amounts) | Weighted value |
|||||||||||||||||||
Total ASF |
$ | 1,162,701 | ||||||||||||||||||
Total RSF |
1,035,994 | |||||||||||||||||||
Net Stable Funding Ratio (%) |
112% | |||||||||||||||||||
| (1) | The NSFR is calculated in accordance with OSFI’s LAR guideline, which, in turn, reflects liquidity-related requirements issued by the BCBS. |
| (2) | Totals for the following rows encompass the residual maturity categories of less than 6 months, 6 months to less than 1 year, and greater than or equal to 1 year in accordance with the requirements of the common disclosure template prescribed by OSFI: Other liabilities, NSFR derivative liabilities, Other assets, Assets posted as initial margin for derivative contracts and contributions to default funds of central counterparties (CCPs), NSFR derivative assets, NSFR derivative liabilities before deduction of variation margin posted and Off-balance sheet items. |
| (3) | As defined by the BCBS, stable deposits from retail and small business customers are deposits that are insured and are either held in transactional accounts or the bank has an established relationship with the client making the withdrawal unlikely. |
| (4) | Operational deposits from customers other than retail and small- and medium-sized enterprises, are deposits which clients need to keep with the bank in order to facilitate their access and ability to use payment and settlement systems primarily for clearing, custody and cash management activities. |
| (5) | Interdependent assets and liabilities represent NHA MBS liabilities, including liabilities arising from transactions involving the Canada Mortgage Bond program and their corresponding encumbered mortgages. |
As at January 31, 2026 |
||||||||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Less than 1 month |
1 to 3 months |
3 to 6 months |
6 to 9 months |
9 to 12 months |
1 year to 2 years |
2 years to 5 years |
5 years and greater |
With no specific maturity |
Total |
||||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||||||
Cash and deposits with banks |
$ |
96,558 |
$ |
21 |
$ |
– |
$ |
– |
$ |
6 |
$ |
– |
$ |
– |
$ |
– |
$ |
2,714 |
$ |
99,299 |
||||||||||||||||||||
Securities |
||||||||||||||||||||||||||||||||||||||||
Trading (1) |
99,547 |
2,274 |
2,176 |
824 |
179 |
156 |
543 |
14,244 |
109,897 |
229,840 |
||||||||||||||||||||||||||||||
Investment, net of applicable allowance |
8,899 |
10,837 |
9,940 |
17,590 |
15,409 |
95,263 |
86,640 |
112,926 |
1,622 |
359,126 |
||||||||||||||||||||||||||||||
Assets purchased under reverse repurchase agreements and securities borrowed (2) |
116,584 |
65,919 |
38,030 |
21,421 |
19,828 |
39 |
29 |
– |
17,950 |
279,800 |
||||||||||||||||||||||||||||||
Loans, net of applicable allowance |
25,520 |
33,942 |
60,705 |
53,835 |
51,832 |
288,391 |
321,519 |
86,933 |
132,204 |
1,054,881 |
||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||||||
Derivatives |
16,097 |
26,170 |
14,243 |
9,280 |
12,775 |
18,151 |
34,356 |
39,758 |
– |
170,830 |
||||||||||||||||||||||||||||||
Other financial assets |
61,657 |
5,778 |
2,576 |
1,213 |
515 |
450 |
215 |
4,689 |
5,231 |
82,324 |
||||||||||||||||||||||||||||||
Total financial assets |
424,862 |
144,941 |
127,670 |
104,163 |
100,544 |
402,450 |
443,302 |
258,550 |
269,618 |
2,276,100 |
||||||||||||||||||||||||||||||
Other non-financial assets |
746 |
604 |
3,011 |
629 |
569 |
2,466 |
4,423 |
6,264 |
47,581 |
66,293 |
||||||||||||||||||||||||||||||
Total assets |
$ |
425,608 |
$ |
145,545 |
$ |
130,681 |
$ |
104,792 |
$ |
101,113 |
$ |
404,916 |
$ |
447,725 |
$ |
264,814 |
$ |
317,199 |
$ |
2,342,393 |
||||||||||||||||||||
Liabilities and equity |
||||||||||||||||||||||||||||||||||||||||
Deposits (3) |
||||||||||||||||||||||||||||||||||||||||
Unsecured borrowing |
$ |
140,049 |
$ |
89,355 |
$ |
99,460 |
$ |
78,214 |
$ |
93,217 |
$ |
60,610 |
$ |
87,557 |
$ |
57,276 |
$ |
732,068 |
$ |
1,437,806 |
||||||||||||||||||||
Secured borrowing |
4,777 |
7,784 |
8,294 |
4,575 |
2,120 |
4,018 |
11,871 |
10,867 |
– |
54,306 |
||||||||||||||||||||||||||||||
Covered bonds |
– |
3,222 |
5,145 |
6,374 |
7,130 |
13,493 |
12,296 |
2,444 |
– |
50,104 |
||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||||||
Obligations related to securities sold short |
40,869 |
648 |
2,576 |
1,552 |
1,794 |
370 |
– |
– |
– |
47,809 |
||||||||||||||||||||||||||||||
Obligations related to assets sold under repurchase agreements and securities loaned (2) |
125,697 |
72,421 |
49,478 |
14,198 |
3,540 |
2,326 |
– |
– |
20,356 |
288,016 |
||||||||||||||||||||||||||||||
Derivatives |
18,120 |
25,921 |
13,371 |
10,447 |
12,537 |
19,798 |
32,218 |
38,319 |
– |
170,731 |
||||||||||||||||||||||||||||||
Other financial liabilities |
54,222 |
5,755 |
6,605 |
1,495 |
1,426 |
806 |
1,727 |
21,192 |
2,788 |
96,016 |
||||||||||||||||||||||||||||||
Subordinated debentures |
– |
– |
– |
– |
– |
– |
– |
11,875 |
– |
11,875 |
||||||||||||||||||||||||||||||
Total financial liabilities |
383,734 |
205,106 |
184,929 |
116,855 |
121,764 |
101,421 |
145,669 |
141,973 |
755,212 |
2,156,663 |
||||||||||||||||||||||||||||||
Other non-financial liabilities |
1,627 |
1,200 |
281 |
205 |
3,107 |
1,825 |
1,789 |
23,676 |
12,162 |
45,872 |
||||||||||||||||||||||||||||||
Equity |
– |
– |
– |
– |
– |
– |
– |
– |
139,858 |
139,858 |
||||||||||||||||||||||||||||||
Total liabilities and equity |
$ |
385,361 |
$ |
206,306 |
$ |
185,210 |
$ |
117,060 |
$ |
124,871 |
$ |
103,246 |
$ |
147,458 |
$ |
165,649 |
$ |
907,232 |
$ |
2,342,393 |
||||||||||||||||||||
Off-balance sheet items |
||||||||||||||||||||||||||||||||||||||||
Financial guarantees |
$ |
1,172 |
$ |
3,179 |
$ |
4,307 |
$ |
4,224 |
$ |
6,010 |
$ |
1,933 |
$ |
5,897 |
$ |
2,848 |
$ |
55 |
$ |
29,625 |
||||||||||||||||||||
Commitments to extend credit |
3,856 |
12,200 |
17,012 |
16,370 |
24,091 |
71,210 |
242,298 |
30,188 |
5,503 |
422,728 |
||||||||||||||||||||||||||||||
Other credit-related commitments |
87,609 |
1,675 |
3,481 |
2,736 |
2,805 |
808 |
701 |
248 |
85,671 |
185,734 |
||||||||||||||||||||||||||||||
Other commitments |
5 |
8 |
13 |
14 |
14 |
52 |
139 |
168 |
988 |
1,401 |
||||||||||||||||||||||||||||||
Total off-balance sheet items |
$ |
92,642 |
$ |
17,062 |
$ |
24,813 |
$ |
23,344 |
$ |
32,920 |
$ |
74,003 |
$ |
249,035 |
$ |
33,452 |
$ |
92,217 |
$ |
639,488 |
||||||||||||||||||||
| (1) | With the exception of debt securities within the Insurance segment, trading debt securities classified as FVTPL have been included in the less than 1 month category as there is no expectation to hold these assets to their contractual maturity. |
| (2) | Open reverse repo and repo contracts, which have no set maturity date and are typically short-term, have been included in the with no specific maturity category. |
| (3) | A major portion of relationship-based deposits are repayable on demand or at short notice on a contractual basis while, in practice, these customer balances form a core base for our operations and liquidity needs, as explained in the preceding Deposit and funding profile section. |
| As at October 31, 2025 | ||||||||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Less than 1 month |
1 to 3 months |
3 to 6 months |
6 to 9 months |
9 to 12 months |
1 year to 2 years |
2 years to 5 years |
5 years and greater |
With no specific maturity |
Total | ||||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||||||
Cash and deposits with banks |
$ | 84,814 | $ | 17 | $ | – | $ | – | $ | 6 | $ | – | $ | – | $ | – | $ | 2,551 | $ | 87,388 | ||||||||||||||||||||
Securities |
||||||||||||||||||||||||||||||||||||||||
Trading (1) |
100,479 | 905 | 1,362 | 1,395 | 849 | 220 | 455 | 14,329 | 99,073 | 219,067 | ||||||||||||||||||||||||||||||
Investment, net of applicable allowance |
4,740 | 8,258 | 17,570 | 12,021 | 20,806 | 82,377 | 85,610 | 109,883 | 1,456 | 342,721 | ||||||||||||||||||||||||||||||
Assets purchased under reverse repurchase agreements and securities borrowed (2) |
138,208 | 57,226 | 45,999 | 20,873 | 22,499 | 51 | – | – | 24,827 | 309,683 | ||||||||||||||||||||||||||||||
Loans, net of applicable allowance |
22,203 | 34,947 | 49,746 | 66,956 | 55,741 | 297,199 | 302,691 | 83,739 | 129,200 | 1,042,422 | ||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||||||
Derivatives |
13,116 | 26,962 | 15,562 | 10,433 | 7,553 | 19,937 | 36,149 | 47,494 | – | 177,206 | ||||||||||||||||||||||||||||||
Other financial assets |
52,621 | 5,568 | 2,636 | 769 | 766 | 452 | 148 | 4,582 | 5,327 | 72,869 | ||||||||||||||||||||||||||||||
Total financial assets |
416,181 | 133,883 | 132,875 | 112,447 | 108,220 | 400,236 | 425,053 | 260,027 | 262,434 | 2,251,356 | ||||||||||||||||||||||||||||||
Other non-financial assets |
4,137 | 2,055 | 2,568 | 364 | 1,436 | 2,661 | 4,479 | 6,413 | 49,537 | 73,650 | ||||||||||||||||||||||||||||||
Total assets |
$ | 420,318 | $ | 135,938 | $ | 135,443 | $ | 112,811 | $ | 109,656 | $ | 402,897 | $ | 429,532 | $ | 266,440 | $ | 311,971 | $ | 2,325,006 | ||||||||||||||||||||
Liabilities and equity |
||||||||||||||||||||||||||||||||||||||||
Deposits (3) |
||||||||||||||||||||||||||||||||||||||||
Unsecured borrowing |
$ | 106,190 | $ | 80,883 | $ | 105,974 | $ | 83,764 | $ | 71,428 | $ | 61,413 | $ | 91,338 | $ | 54,701 | $ | 750,271 | $ | 1,405,962 | ||||||||||||||||||||
Secured borrowing |
5,217 | 7,526 | 9,546 | 2,938 | 2,949 | 6,814 | 12,108 | 9,099 | – | 56,197 | ||||||||||||||||||||||||||||||
Covered bonds |
– | 3,259 | 3,214 | 5,088 | 6,416 | 19,323 | 11,929 | 4,228 | – | 53,457 | ||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||||||
Obligations related to securities sold short |
43,223 | 1,234 | 834 | 2,593 | 1,357 | 650 | – | – | – | 49,891 | ||||||||||||||||||||||||||||||
Obligations related to assets sold under repurchase agreements and securities loaned (2) |
166,329 | 71,225 | 16,610 | 6,446 | 4,214 | 1,672 | – | – | 23,020 | 289,516 | ||||||||||||||||||||||||||||||
Derivatives |
13,292 | 28,955 | 17,532 | 11,248 | 8,664 | 20,821 | 36,809 | 46,632 | – | 183,953 | ||||||||||||||||||||||||||||||
Other financial liabilities |
46,292 | 3,296 | 5,329 | 1,406 | 1,449 | 929 | 2,105 | 21,337 | 2,418 | 84,561 | ||||||||||||||||||||||||||||||
Subordinated debentures |
– | 2,091 | – | – | – | – | – | 11,870 | – | 13,961 | ||||||||||||||||||||||||||||||
Total financial liabilities |
380,543 | 198,469 | 159,039 | 113,483 | 96,477 | 111,622 | 154,289 | 147,867 | 775,709 | 2,137,498 | ||||||||||||||||||||||||||||||
Other non-financial liabilities |
1,426 | 6,513 | 435 | 239 | 223 | 2,261 | 1,860 | 23,506 | 11,894 | 48,357 | ||||||||||||||||||||||||||||||
Equity |
– | – | – | – | – | – | – | – | 139,151 | 139,151 | ||||||||||||||||||||||||||||||
Total liabilities and equity |
$ | 381,969 | $ | 204,982 | $ | 159,474 | $ | 113,722 | $ | 96,700 | $ | 113,883 | $ | 156,149 | $ | 171,373 | $ | 926,754 | $ | 2,325,006 | ||||||||||||||||||||
Off-balance sheet items |
||||||||||||||||||||||||||||||||||||||||
Financial guarantees |
$ | 1,125 | $ | 2,829 | $ | 4,578 | $ | 4,545 | $ | 4,543 | $ | 2,562 | $ | 6,055 | $ | 2,662 | $ | 29 | $ | 28,928 | ||||||||||||||||||||
Commitments to extend credit |
5,744 | 10,299 | 17,664 | 18,365 | 22,554 | 70,723 | 239,678 | 30,846 | 4,050 | 419,923 | ||||||||||||||||||||||||||||||
Other credit-related commitments |
82,651 | 1,751 | 2,287 | 3,360 | 2,673 | 880 | 715 | 125 | 86,828 | 181,270 | ||||||||||||||||||||||||||||||
Other commitments |
6 | 10 | 17 | 17 | 18 | 63 | 162 | 213 | 687 | 1,193 | ||||||||||||||||||||||||||||||
Total off-balance sheet items |
$ | 89,526 | $ | 14,889 | $ | 24,546 | $ | 26,287 | $ | 29,788 | $ | 74,228 | $ | 246,610 | $ | 33,846 | $ | 91,594 | $ | 631,314 | ||||||||||||||||||||
| (1) | With the exception of debt securities within the Insurance segment, trading debt securities classified as FVTPL have been included in the less than 1 month category as there is no expectation to hold these assets to their contractual maturity. |
| (2) | Open reverse repo and repo contracts, which have no set maturity date and are typically short-term, have been included in the with no specific maturity category. |
| (3) | A major portion of relationship-based deposits are repayable on demand or at short notice on a contractual basis while, in practice, these customer balances form a core base for our operations and liquidity needs, as explained in the preceding Deposit and funding profile section. |
Capital management |
Basel III capital, leverage and TLAC ratios |
OSFI regulatory target requirements for large banks under Basel III |
Domestic Stability Buffer (3) |
Minimum including Capital Buffers, D-SIB/G-SIB surcharge and Domestic Stability Buffer as at January 31, 2026 (4) |
RBC capital, leverage and TLAC ratios as at January 31, 2026 |
||||||||||||||||||||||||||||
Minimum |
Capital Buffers |
Minimum including Capital Buffers |
D-SIB/G-SIB surcharge (1) |
Minimum including Capital Buffers and D-SIB/G-SIB surcharge (1), (2) |
||||||||||||||||||||||||||||
| CET1 | 4.5% | 2.6% | 7.1% | 1.0% | 8.1% | 3.5% | 11.6% | 13.7% | ||||||||||||||||||||||||
| Tier 1 capital | 6.0% | 2.6% | 8.6% | 1.0% | 9.6% | 3.5% | 13.1% | 15.2% | ||||||||||||||||||||||||
| Total capital | 8.0% | 2.6% | 10.6% | 1.0% | 11.6% | 3.5% | 15.1% | 16.8% | ||||||||||||||||||||||||
| Leverage ratio | 3.0% | n.a. | 3.0% | 0.5% | 3.5% | n.a. | 3.5% | 4.4% | ||||||||||||||||||||||||
| TLAC ratio | 21.6% | n.a. | 21.6% | n.a. | 21.6% | 3.5% | 25.1% | 30.9% | ||||||||||||||||||||||||
| TLAC leverage ratio | 7.25% | n.a. | 7.25% | n.a. | 7.25% | n.a. | 7.25% | 9.0% | ||||||||||||||||||||||||
| (1) | A capital surcharge, equal to the higher of our D-SIB surcharge and the BCBS’s G-SIB surcharge, is applicable to risk-weighted capital. For leverage ratio, only 50% of our D-SIB surcharge for capital is the required surcharge. |
| (2) | The capital buffers include the capital conservation buffer of 2.5% and the countercyclical capital buffer (CCyB) as prescribed by OSFI. The CCyB, calculated in accordance with OSFI’s CAR guidelines, was 0.07% as at January 31, 2026 (October 31, 2025 – 0.06%; January 31, 2025 – 0.09%). |
| (3) | The DSB can range from 0% to 4% of total RWA and is currently set at 3.5%. |
| (4) | Minimum target requirements reflect CCyB requirements as at January 31, 2026 which are subject to change based on exposures held at the reporting date. |
| n.a. | not applicable |
| As at | ||||||||||||
(Millions of Canadian dollars, except percentage amounts) |
January 31 2026 |
October 31 2025 |
January 31 2025 |
|||||||||
Capital (1) |
||||||||||||
CET1 capital |
$ |
100,415 |
$ | 98,748 | $ | 93,321 | ||||||
Tier 1 capital |
111,549 |
110,393 | 103,718 | |||||||||
Total capital |
123,732 |
122,399 | 115,914 | |||||||||
RWA used in calculation of capital ratios (1) |
||||||||||||
Credit risk |
$ |
593,247 |
$ | 590,306 | $ | 579,866 | ||||||
Market risk |
40,498 |
41,506 | 36,530 | |||||||||
Operational risk |
100,948 |
98,413 | 92,545 | |||||||||
Total RWA |
$ |
734,693 |
$ | 730,225 | $ | 708,941 | ||||||
Capital ratios and Leverage ratio (1) |
||||||||||||
CET1 ratio |
13.7% |
13.5% | 13.2% | |||||||||
Tier 1 capital ratio |
15.2% |
15.1% | 14.6% | |||||||||
Total capital ratio |
16.8% |
16.8% | 16.4% | |||||||||
Leverage ratio |
4.4% |
4.4% | 4.4% | |||||||||
Leverage ratio exposure |
$ |
2,516,801 |
$ | 2,491,090 | $ | 2,367,402 | ||||||
TLAC available and ratios (2) |
||||||||||||
TLAC available |
$ |
227,152 |
$ | 230,385 | $ | 211,585 | ||||||
TLAC ratio |
30.9% |
31.5% | 29.8% | |||||||||
TLAC leverage ratio |
9.0% |
9.2% | 8.9% | |||||||||
| (1) | Capital, RWA and capital ratios are calculated using OSFI’s CAR guideline and the Leverage ratio is calculated using OSFI’s LR guideline. Both the CAR guideline and LR guideline are based on the Basel III framework. |
| (2) | TLAC available and TLAC ratios are calculated using OSFI’s TLAC guideline. The TLAC standard is applied at the resolution entity level which for us is deemed to be Royal Bank of Canada and its subsidiaries. A resolution entity and its subsidiaries are collectively called a resolution group. The TLAC ratio and TLAC leverage ratio are calculated using TLAC available as a percentage of total RWA and leverage exposure, respectively. |

| (1) | Represents rounded figures. |
| (2) | Represents net internal capital generation of $3.4 billion or 46 bps consisting of net income available to shareholders less common and preferred share dividends and distributions on other equity instruments. |
| (3) | Excludes the impact of items in Other. |
| (4) | Includes regulatory and model updates (5 bps), fair value OCI adjustments (5 bps), the impact of foreign exchange translation and other movements. |
For the three months ended January 31, 2026 |
||||||||||||
| (Millions of Canadian dollars, except number of shares) | Transaction date |
Number of shares |
Amount |
|||||||||
Tier 1 capital |
||||||||||||
Common shares activity |
||||||||||||
Issued in connection with share-based compensation plans (1) |
404 |
$ |
44 |
|||||||||
Purchased for cancellation (2) |
(4,225 |
) |
(63 |
) | ||||||||
Redemption of preferred shares Series BF (2), (3) |
November 24, 2025 |
(12,000 |
) |
(300 |
) | |||||||
Redemption of preferred shares Series BH (2), (3) |
December 8, 2025 |
(6,000 |
) |
(150 |
) | |||||||
Redemption of preferred shares Series BI (2), (3) |
December 8, 2025 |
(6,000 |
) |
(150 |
) | |||||||
Redemption of LRCN Series 2 (2), (3), (4) |
January 24, 2026 |
(1,250 |
) |
(1,250 |
) | |||||||
Issuance of LRCN Series 8 (2), (3), (4) |
January 30, 2026 |
1,000 |
1,361 |
|||||||||
Tier 2 capital |
||||||||||||
Maturity of January 27, 2026 subordinated debentures (2), (3) |
January 27, 2026 |
(1,500 |
) |
(2,035 |
) | |||||||
| (1) | Amounts include cash received for stock options exercised during the period and fair value adjustments to stock options. |
| (2) | For further details, refer to Note 9 of our Condensed Financial Statements. |
| (3) | Non-Viability Contingent Capital (NVCC) instruments. |
| (4) | For each limited recourse capital notes (LRCN) series, the number of shares represents the number of notes issued. |
As at January 31, 2026 |
||||||||||||
| (Millions of Canadian dollars, except number of shares and as otherwise noted) | Number of shares |
Amount |
Dividends declared per share |
|||||||||
Common shares issued |
1,396,814 |
$ |
20,844 |
$ |
1.64 |
|||||||
Treasury shares – common shares (2) |
(39 |
) |
(8 |
) |
||||||||
Common shares outstanding |
1,396,775 |
$ |
20,836 |
|||||||||
Stock options and awards |
||||||||||||
Outstanding |
7,845 |
|||||||||||
Exercisable |
4,134 |
|||||||||||
First preferred shares issued |
||||||||||||
Non-cumulative Series BO (3), (4) |
14,000 |
350 |
0.37 |
|||||||||
Non-cumulative Series BT (3), (4), (5) |
750 |
750 |
4.20% |
|||||||||
Non-cumulative Series BU (3), (4), (5) |
750 |
750 |
7.41% |
|||||||||
Non-cumulative Series BW (3), (4), (5) |
600 |
600 |
6.70% |
|||||||||
Other equity instruments issued |
||||||||||||
LRCN Series 3 (3), (4), (6), (7) |
1,000 |
1,000 |
3.65% |
|||||||||
LRCN Series 4 (3), (4), (6), (7) |
1,000 |
1,370 |
7.50% |
|||||||||
LRCN Series 5 (3), (4), (6), (7) |
1,000 |
1,396 |
6.35% |
|||||||||
LRCN Series 6 (3), (4), (6), (7) |
1,250 |
1,708 |
6.75% |
|||||||||
LRCN Series 7 (3), (4), (6), (7) |
1,350 |
1,869 |
6.50% |
|||||||||
LRCN Series 8 (3), (4), (6), (7) |
1,000 |
1,361 |
6.50% |
|||||||||
Preferred shares and other equity instruments issued |
22,700 |
11,154 |
||||||||||
Treasury instruments – preferred shares and other equity instruments (2) |
(284 |
) |
(23 |
) |
||||||||
Preferred shares and other equity instruments outstanding |
22,416 |
$ |
11,131 |
|||||||||
Dividends on common shares |
$ |
2,292 |
||||||||||
Dividends on preferred shares and distributions on other equity instruments (8) |
141 |
|||||||||||
| (1) | For further details about our capital management activity, refer to Note 9 of our Condensed Financial Statements. |
| (2) | Positive amounts represent a short position and negative amounts represent a long position. |
| (3) | Dividend rate will reset every five years. |
| (4) | NVCC instruments. |
| (5) | The dividends declared per share represent the per annum dividend rate applicable to the shares issued as at the reporting date. |
| (6) | For each LRCN series, the number of shares represent the number of notes issued and the dividends declared per share represent the annual interest rate percentage applicable to the notes issued as at the reporting date. |
| (7) | In connection with the issuance of LRCN Series 3, 4, 5, 6, 7 and 8, we issued a certain number of Non-Cumulative 5-Year Fixed Rate Reset First Preferred Shares, Series BS, BV, BX, BY, BZ and CA, respectively, to a consolidated trust to be held as trust assets. For further details, refer to Note 9 of our Condensed Financial Statements and Note 19 of our audited 2025 Annual Consolidated Financial Statements. |
| (8) | Excludes distributions to non-controlling interests. |
(Millions of Canadian dollars) |
October 31 2025 |
October 31 2024 |
||||||
Cross-jurisdictional activity (2) |
||||||||
Cross-jurisdictional claims |
$ |
1,304,223 |
$ | 1,023,919 | ||||
Cross-jurisdictional liabilities |
1,010,300 |
794,662 | ||||||
Size |
||||||||
Total exposures as defined for use in the Basel III leverage ratio (3) |
2,535,597 |
2,387,168 | ||||||
Interconnectedness (4) |
||||||||
Intra-financial system assets |
249,011 |
198,763 | ||||||
Intra-financial system liabilities |
170,957 |
160,819 | ||||||
Securities outstanding |
689,979 |
579,357 | ||||||
Substitutability/financial institution infrastructure (5) |
||||||||
Payment activity |
58,218,018 |
48,863,795 | ||||||
Assets under custody |
5,086,121 |
4,482,490 | ||||||
Underwritten transactions in debt and equity markets |
312,297 |
288,311 | ||||||
Trading volume |
||||||||
Fixed income |
10,790,746 |
9,494,080 | ||||||
Equities and other securities |
8,177,048 |
6,856,367 | ||||||
Complexity (6) |
||||||||
Notional amount of over-the-counter |
40,446,167 |
34,254,579 | ||||||
Trading and investment securities |
103,615 |
94,511 | ||||||
Level 3 assets |
5,380 |
5,404 | ||||||
| (1) | The G-SIBs indicators are prepared based on the methodology prescribed in BCBS updated guidelines published in July 2018 and are disclosed in accordance with OSFI’s Global Systemically Important Banks – Public Disclosure Requirements Advisory. The indicators are based on the regulatory scope of consolidation, which excludes RBC Insurance subsidiaries, unless otherwise specified by the assessment methodology. For our 2025 standalone G-SIB disclosure, please refer to our Regulatory Disclosures at rbc.com/investorrelations. |
| (2) | Represents a bank’s level of interaction outside its domestic jurisdiction. |
| (3) | Represents the total leverage exposures under the BCBS G-SIB methodology, which slightly differs from the OSFI-prescribed rules for leverage exposures. |
| (4) | Represents transactions with other financial institutions. |
| (5) | Represents the extent to which the bank’s services could be substituted by other institutions. |
| (6) | Includes the level of complexity and volume of a bank’s trading activities represented through derivatives, trading securities, investment securities and level 3 assets. |
Accounting and control matters |
Summary of accounting policies and estimates |
Controls and procedures |
Related party transactions |
Glossary |
| • | Adjusted effective income tax rate |
| • | Adjusted income before income taxes |
| • | Adjusted income taxes |
| • | Adjusted net income |
| • | Adjusted net income available to common shareholders |
| • | Adjusted non-interest expensenon-interest expense excluding the impact of specified items and amortization of acquisition-related intangibles. |
Enhanced Disclosure Task Force recommendations index |
Location of disclosure | ||||||||||
Type of Risk |
Recommendation |
Disclosure |
RTS page |
Annual Report page |
SFI page | |||||
General |
1 | Table of contents for EDTF risk disclosure |
47 | 136 | 1 | |||||
| 2 | Define risk terminology and measures |
65-69, 133-135 |
– | |||||||
| 3 | Top and emerging risks |
69-72 |
– | |||||||
| 4 | New regulatory ratios |
37-39 | 110-116 |
– | ||||||
Risk governance, risk management and business model |
5 | Risk management organization |
65-69 |
– | ||||||
| 6 | Risk culture |
65-69 |
– | |||||||
| 7 | Risk in the context of our business activities |
120 | – | |||||||
| 8 | Stress testing |
68, 83 | – | |||||||
Capital adequacy and risk-weighted assets (RWA) |
9 | Minimum Basel III capital ratios and Domestic systemically important bank surcharge |
38 | 110-116 |
– | |||||
| 10 | Composition of capital and reconciliation of the accounting balance sheet to the regulatory balance sheet |
– | * | |||||||
| 11 | Flow statement of the movements in regulatory capital |
– | 19 | |||||||
| 12 | Capital strategic planning |
110-116 |
– | |||||||
| 13 | RWA by business segments |
– | 20 | |||||||
| 14 | Analysis of capital requirement, and related measurement model information |
72-76 |
* | |||||||
| 15 | RWA credit risk and related risk measurements |
– | * | |||||||
| 16 | Movement of RWA by risk type |
– | 20 | |||||||
| 17 | Basel back-testing |
67, 72-74 |
31 | |||||||
Liquidity |
18 | Quantitative and qualitative analysis of our liquidity reserve |
29 | 90-91, 96-97 |
– | |||||
Funding |
19 | Encumbered and unencumbered assets by balance sheet category, and contractual obligations for rating downgrades |
30, 32 | 92, 95 | – | |||||
| 20 | Maturity analysis of consolidated total assets, liabilities and off-balance sheet commitments analyzed by remaining contractual maturity at the balance sheet date |
36-37 | 99-100 |
– | ||||||
| 21 | Sources of funding and funding strategy |
30-32 |
92-94 |
– | ||||||
Market risk |
22 | Relationship between the market risk measures for trading and non-trading portfolios and the balance sheet |
27-28 |
87-88 |
– | |||||
| 23 | Decomposition of market risk factors |
25-27 |
83-88 |
– | ||||||
| 24 | Market risk validation and back-testing |
83 | – | |||||||
| 25 | Primary risk management techniques beyond reported risk measures and parameters |
83-86 |
– | |||||||
Credit risk |
26 | Bank’s credit risk profile |
21-25 |
72-82, 180-187 |
21-31,* | |||||
Quantitative summary of aggregate credit risk exposures that reconciles to the balance sheet |
60-64 | 127-132 |
* | |||||||
| 27 | Policies for identifying impaired loans |
74-76, 122, 153-155 |
– | |||||||
| 28 | Reconciliation of the opening and closing balances of impaired loans and impairment allowances during the year |
– | 23, 28 | |||||||
| 29 | Quantification of gross notional exposure for over-the-counter |
77 | 32 | |||||||
| 30 | Credit risk mitigation, including collateral held for all sources of credit risk |
75-76 |
* | |||||||
Other |
31 | Other risk types |
102-110 |
– | ||||||
| 32 | Publicly known risk events |
107-108, 230-231 |
– | |||||||
| * | These disclosure requirements are satisfied or partially satisfied by disclosures provided in our Pillar 3 Report for the quarter ended January 31, 2026 and for the year ended October 31, 2025. |
| Interim Condensed Consolidated Financial Statements (unaudited) |
| Interim Condensed Consolidated Balance Sheets (unaudited) |
As at |
||||||||
(Millions of Canadian dollars) |
January 31 2026 |
October 31 2025 |
||||||
| Assets |
||||||||
| Cash and due from banks |
$ |
$ | ||||||
| Interest-bearing deposits with banks |
|
| ||||||
| Securities |
||||||||
| Trading |
||||||||
| Investment, net of applicable allowance (Note 4) |
||||||||
| Assets purchased under reverse repurchase agreements and securities borrowed |
|
| ||||||
| Loans (Note 5) |
||||||||
| Retail |
||||||||
| Wholesale |
||||||||
| Allowance for loan losses (Note 5) |
( |
) |
( |
) | ||||
| Other |
||||||||
| Derivatives |
||||||||
| Premises and equipment |
||||||||
| Goodwill |
||||||||
| Other intangibles |
||||||||
| Other assets |
||||||||
| Total assets |
$ |
$ | ||||||
| Liabilities and equity |
||||||||
| Deposits (Note 6) |
||||||||
| Personal |
$ |
$ | ||||||
| Business and government |
||||||||
| Bank |
||||||||
| Other |
||||||||
| Obligations related to securities sold short |
||||||||
| Obligations related to assets sold under repurchase agreements and securities loaned |
||||||||
| Derivatives |
||||||||
| Insurance contract liabilities |
||||||||
| Other liabilities |
||||||||
| Subordinated debentures (Note 9) |
||||||||
| Total liabilities |
||||||||
| Equity attributable to shareholders |
||||||||
| Preferred shares and other equity instruments (Note 9) |
||||||||
| Common shares (Note 9) |
||||||||
| Retained earnings |
||||||||
| Other components of equity |
||||||||
| Non-controlling interests |
||||||||
| Total equity |
||||||||
| Total liabilities and equity |
$ |
$ | ||||||
Interim Condensed Consolidated Statements of Income |
For the three months ended |
||||||||
(Millions of Canadian dollars, except per share amounts) |
January 31 2026 |
January 31 2025 |
||||||
Interest and dividend income (Note 3) |
||||||||
Loans |
$ |
$ | ||||||
Securities |
||||||||
Assets purchased under reverse repurchase agreements and securities borrowed |
||||||||
Deposits and other |
||||||||
Interest expense (Note 3) |
||||||||
Deposits and other |
||||||||
Other liabilities |
||||||||
Subordinated debentures |
||||||||
Net interest income |
||||||||
Non-interest income |
||||||||
Insurance service result (Note 7) |
||||||||
Insurance investment result (Note 7) |
||||||||
Trading revenue |
||||||||
Investment management and custodial fees |
||||||||
Mutual fund revenue |
||||||||
Securities brokerage commissions |
||||||||
Service charges |
||||||||
Underwriting and other advisory fees |
||||||||
Foreign exchange revenue, other than trading |
||||||||
Card service revenue |
||||||||
Credit fees |
||||||||
Net gains on investment securities |
||||||||
Income (loss) from joint ventures and associates |
||||||||
Other |
||||||||
Total revenue |
||||||||
Provision for credit losses (Notes 4 and 5) |
||||||||
Non-interest expense |
||||||||
Human resources (Note 8) |
||||||||
Equipment |
||||||||
Occupancy |
||||||||
Communications |
||||||||
Professional fees |
||||||||
Amortization of other intangibles |
||||||||
Other |
||||||||
Income before income taxes |
||||||||
Income taxes |
||||||||
Net income |
$ |
$ | ||||||
Net income attributable to: |
||||||||
Shareholders |
$ |
$ | ||||||
Non-controlling interests |
||||||||
$ |
$ | |||||||
Basic earnings per share (in dollars) (Note 10) |
$ |
$ | ||||||
Diluted earnings per share (in dollars) (Note 10) |
||||||||
Dividends per common share (in dollars) |
||||||||
Interim Condensed Consolidated Statements of Comprehensive Income |
For the three months ended |
||||||||
(Millions of Canadian dollars) |
January 31 2026 |
January 31 2025 |
||||||
Net income |
$ |
$ | ||||||
Other comprehensive income (loss), net of taxes |
||||||||
Items that will be reclassified subsequently to income: |
||||||||
Net change in unrealized gains (losses) on debt securities and loans at fair value through other comprehensive income |
||||||||
Net unrealized gains (losses) on debt securities and loans at fair value through other comprehensive income |
||||||||
Provision for credit losses recognized in income |
( |
) | ||||||
Reclassification of net losses (gains) on debt securities and loans at fair value through other comprehensive income to income |
( |
) |
( |
) | ||||
Foreign currency translation adjustments |
||||||||
Unrealized foreign currency translation gains (losses) |
( |
) |
||||||
Net foreign currency translation gains (losses) from hedging activities |
( |
) | ||||||
Reclassification of losses (gains) on foreign currency translation to income |
( |
) |
– |
|||||
( |
) |
|||||||
Net change in cash flow hedges |
||||||||
Net gains (losses) on derivatives designated as cash flow hedges |
( |
) |
||||||
Reclassification of losses (gains) on derivatives designated as cash flow hedges to income |
( |
) |
( |
) | ||||
( |
) |
|||||||
Items that will not be reclassified subsequently to income: |
||||||||
Remeasurement gains (losses) on employee benefit plans (Note 8) |
||||||||
Net gains (losses) from fair value changes due to credit risk on financial liabilities designated at fair value through profit or loss |
( |
) |
( |
) | ||||
Net gains (losses) on equity securities designated at fair value through other comprehensive income |
||||||||
( |
) |
( |
) | |||||
Total other comprehensive income (loss), net of taxes |
( |
) |
||||||
Total comprehensive income (loss) |
$ |
$ | ||||||
Total comprehensive income attributable to: |
||||||||
Shareholders |
$ |
$ | ||||||
Non-controlling interests |
( |
) |
||||||
$ |
$ | |||||||
For the three months ended |
||||||||
(Millions of Canadian dollars) |
January 31 2026 |
January 31 2025 |
||||||
Income taxes on other comprehensive income |
||||||||
Net unrealized gains (losses) on debt securities and loans at fair value through other comprehensive income |
$ |
$ | ||||||
Provision for credit losses recognized in income |
– |
– | ||||||
Reclassification of net losses (gains) on debt securities and loans at fair value through other comprehensive income to income |
( |
) |
( |
) | ||||
Unrealized foreign currency translation gains (losses) |
( |
) |
||||||
Net foreign currency translation gains (losses) from hedging activities |
( |
) | ||||||
Reclassification of losses (gains) on foreign currency translation to income |
– |
– | ||||||
Net gains (losses) on derivatives designated as cash flow hedges |
( |
) |
||||||
Reclassification of losses (gains) on derivatives designated as cash flow hedges to income |
( |
) |
( |
) | ||||
Remeasurement gains (losses) on employee benefit plans |
||||||||
Net gains (losses) from fair value changes due to credit risk on financial liabilities designated at fair value through profit or loss |
( |
) |
( |
) | ||||
Net gains (losses) on equity securities designated at fair value through other comprehensive income |
||||||||
Total income tax expenses (recoveries) |
$ |
$ | ( |
) | ||||
| Interim Condensed Consolidated Statements of Changes in Equity |
For the three months ended January 31, 2026 |
||||||||||||||||||||||||||||||||||||||||||||||||
Other components of equity |
||||||||||||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Preferred shares and other equity instruments |
Common shares |
Treasury – preferred shares and other equity instruments |
Treasury – common shares |
Retained earnings |
FVOCI securities and loans |
Foreign currency translation |
Cash flow hedges |
Total other components of equity |
Equity attributable to shareholders |
Non-controlling interests |
Total equity |
||||||||||||||||||||||||||||||||||||
| Balance at beginning of period |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||||
| Changes in equity |
||||||||||||||||||||||||||||||||||||||||||||||||
| Issues of share capital and other equity instruments |
– |
– |
( |
) |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||||||||||
| Common shares purchased for cancellation |
– |
( |
) |
– |
– |
( |
) |
– |
– |
– |
– |
( |
) |
– |
( |
) | ||||||||||||||||||||||||||||||||
| Redemption of preferred shares and other equity instruments |
( |
) |
– |
– |
– |
– |
– |
– |
– |
– |
( |
) |
– |
( |
) | |||||||||||||||||||||||||||||||||
| Sales of treasury shares and other equity instruments |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
| Purchases of treasury shares and other equity instruments |
– |
– |
( |
) |
( |
) |
– |
– |
– |
– |
– |
( |
) |
– |
( |
) | ||||||||||||||||||||||||||||||||
| Share-based compensation awards |
– |
– |
– |
– |
( |
) |
– |
– |
– |
– |
( |
) |
– |
( |
) | |||||||||||||||||||||||||||||||||
| Dividends on common shares |
– |
– |
– |
– |
( |
) |
– |
– |
– |
– |
( |
) |
– |
( |
) | |||||||||||||||||||||||||||||||||
| Dividends on preferred shares and distributions on other equity instruments |
– |
– |
– |
– |
( |
) |
– |
– |
– |
– |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
| Other |
– |
– |
– |
– |
( |
) |
– |
– |
– |
– |
( |
) |
– |
( |
) | |||||||||||||||||||||||||||||||||
| Net income |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
| Total other comprehensive income (loss), net of taxes |
– |
– |
– |
– |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| Balance at end of period |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||||
| For the three months ended January 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Other components of equity | ||||||||||||||||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Preferred shares and other equity instruments |
Common shares |
Treasury – preferred shares and other equity instruments |
Treasury – common shares |
Retained earnings |
FVOCI securities and loans |
Foreign currency translation |
Cash flow hedges |
Total other components of equity |
Equity attributable to shareholders |
Non-controlling interests |
Total equity |
||||||||||||||||||||||||||||||||||||
| Balance at beginning of period |
$ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Changes in equity |
||||||||||||||||||||||||||||||||||||||||||||||||
| Issues of share capital and other equity instruments |
– | – | ( |
) | – | – | – | – | – | |||||||||||||||||||||||||||||||||||||||
| Common shares purchased for cancellation |
– | ( |
) | – | – | ( |
) | – | – | – | – | ( |
) | – | ( |
) | ||||||||||||||||||||||||||||||||
| Redemption of preferred shares and other equity instruments |
– | – | – | – | – | – | – | – | – | – | – | – | ||||||||||||||||||||||||||||||||||||
| Sales of treasury shares and other equity instruments |
– | – | – | – | – | – | – | – | ||||||||||||||||||||||||||||||||||||||||
| Purchases of treasury shares and other equity instruments |
– | – | ( |
) | ( |
) | – | – | – | – | – | ( |
) | – | ( |
) | ||||||||||||||||||||||||||||||||
| Share-based compensation awards |
– | – | – | – | – | – | – | – | – | |||||||||||||||||||||||||||||||||||||||
| Dividends on common shares |
– | – | – | – | ( |
) | – | – | – | – | ( |
) | – | ( |
) | |||||||||||||||||||||||||||||||||
| Dividends on preferred shares and distributions on other equity instruments |
– | – | – | – | ( |
) | – | – | – | – | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Other |
– | – | – | – | ( |
) | – | – | – | – | ( |
) | – | ( |
) | |||||||||||||||||||||||||||||||||
| Net income |
– | – | – | – | – | – | – | – | ||||||||||||||||||||||||||||||||||||||||
| Total other comprehensive income (loss), net of taxes |
– | – | – | – | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| Balance at end of period |
$ | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| Interim Condensed Consolidated Statements of Cash Flows |
For the three months ended |
||||||||
(Millions of Canadian dollars) |
January 31 2026 |
January 31 2025 |
||||||
| Cash flows from operating activities |
||||||||
| Net income |
$ |
$ | ||||||
| Adjustments for non-cash items and others |
||||||||
| Provision for credit losses |
||||||||
| Depreciation |
||||||||
| Deferred income taxes |
||||||||
| Amortization and impairment of other intangibles |
||||||||
| (Income) loss from joint ventures and associates |
( |
) |
( |
) | ||||
| Losses (gains) on investment securities |
( |
) |
( |
) | ||||
| Adjustments for net changes in operating assets and liabilities |
||||||||
| Insurance contract liabilities |
||||||||
| Net change in accrued interest receivable and payable |
( |
) |
( |
) | ||||
| Current income taxes |
( |
) | ||||||
| Derivative assets |
( |
) | ||||||
| Derivative liabilities |
( |
) |
( |
) | ||||
| Trading securities |
( |
) |
( |
) | ||||
| Loans |
( |
) |
( |
) | ||||
| Assets purchased under reverse repurchase agreements and securities borrowed |
||||||||
| Obligations related to assets sold under repurchase agreements and securities loaned |
( |
) |
( |
) | ||||
| Obligations related to securities sold short |
( |
) |
||||||
| Deposits |
||||||||
| Brokers and dealers receivable and payable |
( |
) | ||||||
| Other |
( |
) | ||||||
| Net cash from (used in) operating activities |
||||||||
| Cash flows from investing activities |
||||||||
| Change in interest-bearing deposits with banks |
( |
) |
||||||
| Proceeds from sales and maturities of investment securities |
||||||||
| Purchases of investment securities |
( |
) |
( |
) | ||||
| Net acquisitions of premises and equipment and other intangibles |
( |
) |
( |
) | ||||
| Net cash from (used in) investing activities |
( |
) |
( |
) | ||||
| Cash flows from financing activities |
||||||||
| Issuance of subordinated debentures |
– |
|||||||
| Repayment of subordinated debentures |
( |
) |
( |
) | ||||
| Issue of common shares, net of issuance costs |
||||||||
| Common shares purchased for cancellation |
( |
) |
( |
) | ||||
| Issue of preferred shares and other equity instruments, net of issuance costs |
||||||||
| Redemption of preferred shares and other equity instruments |
( |
) |
– | |||||
| Sales of treasury shares and other equity instruments |
||||||||
| Purchases of treasury shares and other equity instruments |
( |
) |
( |
) | ||||
| Dividends paid on shares and distributions paid on other equity instruments |
( |
) |
( |
) | ||||
| Dividends/distributions paid to non-controlling interests |
( |
) |
– | |||||
| Change in short-term borrowings of subsidiaries |
– | |||||||
| Repayment of lease liabilities |
( |
) |
( |
) | ||||
| Net cash from (used in) financing activities |
( |
) |
( |
) | ||||
| Effect of exchange rate changes on cash and due from banks |
( |
) |
||||||
| Net change in cash and due from banks |
||||||||
| Cash and due from banks at beginning of period (1) |
||||||||
| Cash and due from banks at end of period (1) |
$ |
$ | |
|||||
| Cash flows from operating activities include: |
||||||||
| Amount of interest paid |
$ |
$ | ||||||
| Amount of interest received |
||||||||
| Amount of dividends received |
||||||||
| Amount of income taxes paid (refunded) |
( |
) |
||||||
| (1) | We are required to maintain balances due to regulatory requirements or contractual restrictions from central banks, other regulatory authorities and other counterparties. The total balances were $ October 31, 2024 – $ |
Note 1 General information |
Note 2 Summary of material accounting policies, estimates and judgments |
Note 3 Fair value of financial instruments |
As at January 31, 2026 |
||||||||||||||||||||||||||||||||||||
Carrying value and fair value |
Carrying value |
Fair value |
||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Financial instruments classified as FVTPL |
Financial instruments designated as FVTPL |
Financial instruments classified as FVOCI |
Financial instruments designated as FVOCI |
Financial instruments measured at amortized cost |
Financial instruments measured at amortized cost |
Total carrying amount |
Total fair value |
||||||||||||||||||||||||||||
Financial assets |
||||||||||||||||||||||||||||||||||||
Interest-bearing deposits with banks |
$ |
– |
$ |
$ |
– |
$ |
– |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Securities |
||||||||||||||||||||||||||||||||||||
Trading |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||
Investment, net of applicable allowance |
– |
– |
||||||||||||||||||||||||||||||||||
Assets purchased under reverse repurchase agreements and securities borrowed |
– |
– |
– |
|||||||||||||||||||||||||||||||||
Loans, net of applicable allowance |
||||||||||||||||||||||||||||||||||||
Retail |
– |
– |
||||||||||||||||||||||||||||||||||
Wholesale |
– |
– |
||||||||||||||||||||||||||||||||||
– |
– |
|||||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||
Derivatives |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||||||
Other assets (1) |
– |
– |
– |
|||||||||||||||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||||||||
Deposits |
||||||||||||||||||||||||||||||||||||
Personal |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||
Business and government (2) |
||||||||||||||||||||||||||||||||||||
Bank (3) |
– |
|||||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||
Obligations related to securities sold short |
– |
– |
– |
|||||||||||||||||||||||||||||||||
Obligations related to assets sold under repurchase agreements and securities loaned |
– |
|||||||||||||||||||||||||||||||||||
Derivatives |
– |
– |
– |
|||||||||||||||||||||||||||||||||
Other liabilities (4) |
– |
|||||||||||||||||||||||||||||||||||
Subordinated debentures |
– |
|||||||||||||||||||||||||||||||||||
Note 3 Fair value of financial instruments (continued) |
| As at October 31, 2025 | ||||||||||||||||||||||||||||||||||||
| Carrying value and fair value | Carrying value | Fair value | ||||||||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Financial instruments classified as FVTPL |
Financial instruments designated as FVTPL |
Financial instruments classified as FVOCI |
Financial instruments designated as FVOCI |
Financial instruments measured at amortized cost |
Financial instruments measured at amortized cost |
Total carrying amount |
Total fair value | ||||||||||||||||||||||||||||
Financial assets |
||||||||||||||||||||||||||||||||||||
Interest-bearing deposits with banks |
$ | – | $ | $ | – | $ | – | $ | $ | $ | $ | |||||||||||||||||||||||||
Securities |
||||||||||||||||||||||||||||||||||||
Trading |
– | – | – | – | ||||||||||||||||||||||||||||||||
Investment, net of applicable allowance |
– | – | ||||||||||||||||||||||||||||||||||
Assets purchased under reverse repurchase agreements and securities borrowed |
– | – | – | |||||||||||||||||||||||||||||||||
Loans, net of applicable allowance |
||||||||||||||||||||||||||||||||||||
Retail |
– | – | ||||||||||||||||||||||||||||||||||
Wholesale |
– | – | ||||||||||||||||||||||||||||||||||
| – | – | |||||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||
Derivatives |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Other assets (1) |
– | – | – | |||||||||||||||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||||||||
Deposits |
||||||||||||||||||||||||||||||||||||
Personal |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Business and government (2) |
||||||||||||||||||||||||||||||||||||
Bank (3) |
– | |||||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||
Obligations related to securities sold short |
– | – | – | |||||||||||||||||||||||||||||||||
Obligations related to assets sold under repurchase agreements and securities loaned |
– | |||||||||||||||||||||||||||||||||||
Derivatives |
– | – | – | |||||||||||||||||||||||||||||||||
Other liabilities (4) |
– | |||||||||||||||||||||||||||||||||||
Subordinated debentures |
– | |||||||||||||||||||||||||||||||||||
| (1) | Includes financial instruments recognized in Other assets. |
| (2) | Business and government deposits include deposits from regulated deposit-taking institutions other than banks. |
| (3) | Bank deposits refer to deposits from regulated banks and central banks. |
| (4) | Includes financial instruments recognized in Other liabilities. |
As at |
||||||||||||||||||||||||||||||||||||||||||
January 31, 2026 |
October 31, 2025 |
|||||||||||||||||||||||||||||||||||||||||
Fair value measurements using |
Netting adjustments |
Fair value measurements using |
Netting adjustments |
|
||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Level 1 |
Level 2 |
Level 3 |
Fair value |
Level 1 |
Level 2 |
Level 3 |
Fair value |
||||||||||||||||||||||||||||||||||
Financial assets |
||||||||||||||||||||||||||||||||||||||||||
Interest-bearing deposits with banks |
$ |
– |
$ |
$ |
– |
$ |
$ |
$ | – | $ | $ | – | $ | $ | ||||||||||||||||||||||||||||
Securities |
||||||||||||||||||||||||||||||||||||||||||
Trading |
||||||||||||||||||||||||||||||||||||||||||
Debt issued or guaranteed by: |
||||||||||||||||||||||||||||||||||||||||||
Canadian government |
||||||||||||||||||||||||||||||||||||||||||
Federal |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Provincial and municipal |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
U.S. federal, state, municipal and agencies (1) |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Other OECD government (2) |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Mortgage-backed securities |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Asset-backed securities |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Corporate debt and other debt |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Equities |
||||||||||||||||||||||||||||||||||||||||||
Investment |
||||||||||||||||||||||||||||||||||||||||||
Debt issued or guaranteed by: |
||||||||||||||||||||||||||||||||||||||||||
Canadian government |
||||||||||||||||||||||||||||||||||||||||||
Federal |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Provincial and municipal |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
U.S. federal, state, municipal and agencies (1) |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Other OECD government (2) |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Mortgage-backed securities |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Asset-backed securities |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Corporate debt and other debt |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Equities |
||||||||||||||||||||||||||||||||||||||||||
Assets purchased under reverse repurchase agreements and securities borrowed |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Loans |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||||||||
Derivatives |
||||||||||||||||||||||||||||||||||||||||||
Interest rate contracts |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Foreign exchange contracts |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Credit derivatives |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Other contracts |
||||||||||||||||||||||||||||||||||||||||||
Valuation adjustments |
– |
( |
) |
( |
) |
( |
) |
– | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||
Total gross derivatives |
||||||||||||||||||||||||||||||||||||||||||
Netting adjustments |
( |
( |
) |
( |
( |
) | ||||||||||||||||||||||||||||||||||||
Total derivatives |
||||||||||||||||||||||||||||||||||||||||||
Other assets |
||||||||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
( |
$ |
$ | |
$ | |
$ | |
$ | ( |
$ | |
|||||||||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||||||||||||||
Deposits |
||||||||||||||||||||||||||||||||||||||||||
Personal |
$ |
– |
$ |
$ |
$ |
$ |
$ | – | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Business and government |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Bank |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||||||||
Obligations related to securities sold short |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Obligations related to assets sold under repurchase agreements and securities loaned |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Derivatives |
||||||||||||||||||||||||||||||||||||||||||
Interest rate contracts |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Foreign exchange contracts |
– |
– | ||||||||||||||||||||||||||||||||||||||||
Credit derivatives |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Other contracts |
||||||||||||||||||||||||||||||||||||||||||
Valuation adjustments |
– |
( |
) |
( |
) |
( |
) |
– | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total gross derivatives |
||||||||||||||||||||||||||||||||||||||||||
Netting adjustments |
( |
( |
) |
( |
( |
) | ||||||||||||||||||||||||||||||||||||
Total derivatives |
||||||||||||||||||||||||||||||||||||||||||
Other liabilities |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
Subordinated debentures |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
( |
$ |
$ | $ | $ | $ | ( |
$ | |||||||||||||||||||||||||||||||
| (1) | United States (U.S.). |
| (2) | Organisation for Economic Co-operation and Development (OECD). |
Note 3 Fair value of financial instruments (continued) |
For the three months ended January 31, 2026 |
||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Fair value at beginning of period |
Gains (losses) included in earnings |
Gains (losses) included in OCI |
Purchases (issuances) |
Settlement (sales) and other |
Transfers into Level 3 |
Transfers out of Level 3 |
Fair value at end of period |
Gains (losses) included in earnings for positions still held |
|||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||
Securities |
||||||||||||||||||||||||||||||||||||
Trading |
||||||||||||||||||||||||||||||||||||
Corporate debt and other debt |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
$ |
( |
) | |||||||||||||||||
Equities |
( |
) |
( |
) |
( |
) |
– |
– |
||||||||||||||||||||||||||||
( |
) |
( |
) |
( |
) |
– |
– |
|||||||||||||||||||||||||||||
Investment |
||||||||||||||||||||||||||||||||||||
Mortgage-backed securities |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||
Corporate debt and other debt |
( |
) |
– |
( |
) |
– |
– |
|||||||||||||||||||||||||||||
Equities |
– |
( |
) |
– |
( |
) |
– |
– |
– |
|||||||||||||||||||||||||||
( |
) |
– |
( |
) |
– |
– |
||||||||||||||||||||||||||||||
Loans |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||
Net derivative balances (3) |
||||||||||||||||||||||||||||||||||||
Interest rate contracts |
( |
) |
( |
) |
– |
– |
( |
) |
– |
( |
) |
( |
) | |||||||||||||||||||||||
Foreign exchange contracts |
( |
) |
( |
) |
– |
– |
( |
) |
( |
) | ||||||||||||||||||||||||||
Credit derivatives |
( |
) |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||
Other contracts |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Valuation adjustments |
( |
) |
– |
– |
( |
) |
– |
– |
( |
) |
– |
|||||||||||||||||||||||||
Other assets |
– |
– |
– |
( |
) |
– |
– |
– |
||||||||||||||||||||||||||||
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
$ |
( |
) | ||||||||||||||||||
Liabilities |
||||||||||||||||||||||||||||||||||||
Deposits |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
– |
||||||||||||||||
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
– |
|||||||||||||||||
For the three months ended January 31, 2025 |
||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Fair value at beginning of period |
Gains (losses) included in earnings |
Gains (losses) included in OCI (1) |
Purchases (issuances) |
Settlement (sales) and other (2) |
Transfers into Level 3 |
Transfers out of Level 3 |
Fair value at end of period |
Gains (losses) included in earnings for positions still held |
|||||||||||||||||||||||||||
| Assets |
||||||||||||||||||||||||||||||||||||
| Securities |
||||||||||||||||||||||||||||||||||||
| Trading |
||||||||||||||||||||||||||||||||||||
| Corporate debt and other debt |
$ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | ||||||||||||||||||
| Equities |
( |
) | ( |
) | – | ( |
) | |||||||||||||||||||||||||||||
| ( |
) | ( |
) | – | ( |
) | ||||||||||||||||||||||||||||||
| Investment |
||||||||||||||||||||||||||||||||||||
| Mortgage-backed securities |
– | – | – | – | – | n.s. | ||||||||||||||||||||||||||||||
| Corporate debt and other debt |
– | – | ( |
) | – | – | n.s. | |||||||||||||||||||||||||||||
| Equities |
– | – | ( |
) | – | – | n.s. | |||||||||||||||||||||||||||||
| – | – | ( |
) | – | – | n.s. | ||||||||||||||||||||||||||||||
| Loans |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||
| Other |
||||||||||||||||||||||||||||||||||||
| Net derivative balances (3) |
||||||||||||||||||||||||||||||||||||
| Interest rate contracts |
( |
) | – | ( |
) | ( |
) | |||||||||||||||||||||||||||||
| Foreign exchange contracts |
( |
) | ( |
) | – | – | – | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
| Credit derivatives |
|
|
– | |
|
|
– | |
|
|
– | |
|
|
– | |
|
|
– | |
|
|
– | |
|
|
– | |
|
|
– | |
|
|
– | |
| Other contracts |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
| Valuation adjustments |
– | – | ( |
) | – | – | – | – | ||||||||||||||||||||||||||||
| Other assets |
– | – | – | – | – | – | – | |||||||||||||||||||||||||||||
| $ | $ | ( |
) | $ | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||||||||
| Liabilities |
||||||||||||||||||||||||||||||||||||
| Deposits |
$ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | |||||||||||||||||
| $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | ||||||||||||||||||
| (1) | These amounts include the foreign currency translation gains or losses arising on consolidation of foreign subsidiaries relating to the Level 3 instruments, where applicable. The unrealized gains on Investment securities recognized in OCI were $ |
| (2) | Other includes amortization of premiums or discounts recognized in net income. |
| (3) | Net derivatives as at January 31, 2026 included derivative assets of $ million (January 31, 2025 – $million (January 31, 2025 – |
| n.s. | not significant |
| Note 3 Fair value of financial instruments (continued) |
For the three months ended |
||||||||
(Millions of Canadian dollars) |
January 31 2026 |
January 31 2025 |
||||||
| Interest and dividend income (1), (2) |
||||||||
| Financial instruments measured at fair value through profit or loss |
$ |
$ | ||||||
| Financial instruments measured at fair value through other comprehensive income |
||||||||
| Financial instruments measured at amortized cost |
||||||||
| |
||||||||
| Interest expense (1) |
||||||||
| Financial instruments measured at fair value through profit or loss |
$ |
$ | ||||||
| Financial instruments measured at amortized cost |
||||||||
| Net interest income |
$ |
$ | ||||||
| (1) | Excludes interest and dividend income for the three months ended January 31, 2026 of $ million (January 31, 2025 – $ million) and interest expense for the three months ended January 31, 2026 of $ million ( January 31, 2025 – $million) presented in Insurance investment result in the Interim Condensed Consolidated Statements of Income. |
| (2) | Includes dividend income for the three months ended January 31, 2026 of $ million (January 31, 2025 – $million) presented in Interest and dividend income in the Interim Condensed Consolidated Statements of Income. |
| Note 4 Securities |
As at |
||||||||||||||||||||||||||||||||||
January 31, 2026 |
October 31, 2025 |
|||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Cost/ Amortized cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
Cost/ Amortized cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
||||||||||||||||||||||||||
| Debt issued or guaranteed by: |
||||||||||||||||||||||||||||||||||
| Canadian government |
||||||||||||||||||||||||||||||||||
| Federal |
$ |
$ |
$ |
( |
) |
$ |
$ | $ | $ | ( |
) | $ | ||||||||||||||||||||||
| Provincial and municipal |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| U.S. federal, state, municipal and agencies |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| Other OECD government |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| Mortgage-backed securities |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| Asset-backed securities |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| Corporate debt and other debt |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| Equities |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
$ |
$ |
$ |
( |
) |
$ |
$ | |
$ | |
$ | ( |
) | $ | |
||||||||||||||||||||
| (1) | Excludes $ million of held-to-collect securities as at January 31, 2026 that are carried at amortized cost, net of allowance for credit losses (October 31, 2025 – $ |
| (2) | Gross unrealized gains and losses includes $( million of allowance for credit losses on debt securities at FVOCI as at January 31, 2026 (October 31, 2025 – $( |
| • | Transfers between stages, which are presumed to occur before any corresponding remeasurement of the allowance. |
| • | Purchases, which reflect the allowance related to assets newly recognized during the period, including those assets that were derecognized following a modification of terms. |
| • | Sales and maturities, which reflect the allowance related to assets derecognized during the period without a credit loss being incurred, including those assets that were derecognized following a modification of terms. |
| • | Changes in risk, parameters and exposures, which comprise the impact of changes in model inputs or assumptions, including changes in forward-looking macroeconomic conditions; partial repayments; changes in the measurement following a transfer between stages; and unwinding of the time value discount due to the passage of time. |
For the three months ended |
||||||||||||||||||||||||||||||||||||||||||||
January 31, 2026 |
January 31, 2025 |
|||||||||||||||||||||||||||||||||||||||||||
Performing |
Impaired |
Performing |
Impaired |
|||||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 (2) |
Total |
||||||||||||||||||||||||||||||||||||
Balance at beginning of period |
$ |
$ |
– |
$ |
( |
) |
$ |
( |
) |
$ | $ | – | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||||||||
Transfers to stage 1 |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Transfers to stage 2 |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Transfers to stage 3 |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Purchases |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||||
Sales and maturities |
( |
) |
– |
– |
( |
) |
( |
) | – | – | ( |
) | ||||||||||||||||||||||||||||||||
Changes in risk, parameters and exposures |
( |
) |
– |
( |
) |
( |
) |
( |
) | – | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Exchange rate and other |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||||
Balance at end of period |
$ |
$ |
– |
$ |
( |
) |
$ |
( |
) |
$ | $ | – | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||
| (1) | Expected credit losses on debt securities at FVOCI are not separately recognized on the Interim Condensed Consolidated Balance Sheets as the related securities are recorded at fair value. The cumulative amount of credit losses recognized in income is presented in Other components of equity. |
| (2) | Reflects changes in the allowance for purchased credit-impaired securities. |
For the three months ended |
||||||||||||||||||||||||||||||||||||||||||||
January 31, 2026 |
January 31, 2025 |
|||||||||||||||||||||||||||||||||||||||||||
Performing |
Impaired |
Performing |
Impaired |
|||||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
||||||||||||||||||||||||||||||||||||
Balance at beginning of period |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||||||||
Transfers to stage 1 |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Transfers to stage 2 |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Transfers to stage 3 |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Purchases |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||||
Sales and maturities |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Changes in risk, parameters and exposures |
– |
( |
) |
– |
( |
) |
( |
) | – | – | ( |
) | ||||||||||||||||||||||||||||||||
Exchange rate and other |
( |
) |
– |
– |
– | – | – | – | ||||||||||||||||||||||||||||||||||||
Balance at end of period |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||||||||||||
| As at | ||||||||||||||||||||||||||||||||||||||||||||
January 31, 2026 |
October 31, 2025 |
|||||||||||||||||||||||||||||||||||||||||||
Performing |
Impaired |
Performing |
Impaired |
|||||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||||||||||||||
Investment securities |
||||||||||||||||||||||||||||||||||||||||||||
Securities at FVOCI |
||||||||||||||||||||||||||||||||||||||||||||
Investment grade |
$ |
$ |
– |
$ |
– |
$ |
$ | |
$ | – | $ | – | $ | |
||||||||||||||||||||||||||||||
Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||||||||||||||
Impaired |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||||||||
Items not subject to impairment (2) |
||||||||||||||||||||||||||||||||||||||||||||
$ |
$ | |||||||||||||||||||||||||||||||||||||||||||
Securities at amortized cost |
||||||||||||||||||||||||||||||||||||||||||||
Investment grade |
$ |
$ |
– |
$ |
– |
$ |
$ | $ | – | $ | – | $ | ||||||||||||||||||||||||||||||||
Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||||||||||||||
– |
– | |||||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses |
– |
– | ||||||||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
– |
$ |
$ | $ | |
$ | – | $ | ||||||||||||||||||||||||||||||||||
| (1) | Reflects $ |
| (2) | Investment securities at FVOCI not subject to impairment represent equity securities designated as FVOCI. |
Note 5 Loans and allowance for credit losses |
For the three months ended |
||||||||||||||||||||||||||||||||||||||||||
January 31, 2026 |
January 31, 2025 |
|||||||||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Balance at beginning of period |
Provision for credit losses |
Net write-offs |
Exchange rate and other |
Balance at end of period |
Balance at beginning of period |
Provision for credit losses |
Net write-offs |
Exchange rate and other |
Balance at end of period |
||||||||||||||||||||||||||||||||
Retail |
||||||||||||||||||||||||||||||||||||||||||
Residential mortgages |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||||||||||
Personal |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||
Credit cards |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||
Small business |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||
Wholesale |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
|||||||||||||||||||||||
Presented as: |
||||||||||||||||||||||||||||||||||||||||||
Allowance for loan losses |
$ |
$ |
$ | $ | ||||||||||||||||||||||||||||||||||||||
Other liabilities – Provisions |
||||||||||||||||||||||||||||||||||||||||||
Other components of equity |
||||||||||||||||||||||||||||||||||||||||||
| • | Model changes, as applicable, which generally comprise the impact of significant changes to the quantitative models used to estimate expected credit losses and any staging impacts that may arise. | |
| • | Transfers between stages, which are presumed to occur before any corresponding remeasurements of the allowance. |
| • | Originations, which reflect the allowance related to assets newly recognized during the period, including those assets that were derecognized following a modification of terms. |
| • | Maturities, which reflect the allowance related to assets derecognized during the period without a credit loss being incurred, including those assets that were derecognized following a modification of terms. |
| • | Changes in risk, parameters and exposures, which comprise the impact of changes in model inputs or assumptions, including changes in forward-looking macroeconomic conditions; partial repayments and additional draws on existing facilities; changes in the measurement following a transfer between stages; and unwinding of the time value discount due to the passage of time in Stage 1 and Stage 2. |
For the three months ended |
||||||||||||||||||||||||||||||||||||||
January 31, 2026 |
January 31, 2025 |
|||||||||||||||||||||||||||||||||||||
Performing |
Impaired |
Performing |
Impaired |
|||||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
||||||||||||||||||||||||||||||
Residential mortgages |
||||||||||||||||||||||||||||||||||||||
Balance at beginning of period |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||
Transfers to stage 1 |
( |
) |
( |
) |
– |
( |
) | – | – | |||||||||||||||||||||||||||||
Transfers to stage 2 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||||||||
Transfers to stage 3 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||||||||
Originations |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||||||||
Changes in risk, parameters and exposures |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||
Write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Exchange rate and other |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||||||||||||||||||||
Balance at end of period |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||||||
Personal |
||||||||||||||||||||||||||||||||||||||
Balance at beginning of period |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||
Transfers to stage 1 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||||||||
Transfers to stage 2 |
( |
) |
– |
– |
( |
) | ( |
) | – | |||||||||||||||||||||||||||||
Transfers to stage 3 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||||||||
Originations |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Maturities |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ( |
) | – | ( |
) | |||||||||||||||||||||||
Changes in risk, parameters and exposures |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||
Write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Exchange rate and other |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
Balance at end of period |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||||||
Credit cards |
||||||||||||||||||||||||||||||||||||||
Balance at beginning of period |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||
Transfers to stage 1 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||||||||
Transfers to stage 2 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||||||||
Transfers to stage 3 |
– |
( |
) |
– |
( |
) | ( |
) | – | |||||||||||||||||||||||||||||
Originations |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||||||||
Changes in risk, parameters and exposures |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||
Write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Exchange rate and other |
( |
) |
( |
) |
– |
( |
) |
– | – | |||||||||||||||||||||||||||||
Balance at end of period |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||||||
Small business |
||||||||||||||||||||||||||||||||||||||
Balance at beginning of period |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||
Transfers to stage 1 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||||||||
Transfers to stage 2 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||||||||
Transfers to stage 3 |
– |
( |
) |
– |
– | ( |
) | – | ||||||||||||||||||||||||||||||
Originations |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||||||||
Changes in risk, parameters and exposures |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||
Write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Exchange rate and other |
( |
) |
( |
) |
– | ( |
) | ( |
) | |||||||||||||||||||||||||||||
Balance at end of period |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||||||
Wholesale |
||||||||||||||||||||||||||||||||||||||
Balance at beginning of period |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||
Transfers to stage 1 |
( |
) |
– |
– |
( |
) | – | – | ||||||||||||||||||||||||||||||
Transfers to stage 2 |
( |
) |
– |
– |
( |
) | ( |
) | – | |||||||||||||||||||||||||||||
Transfers to stage 3 |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||||||||||||||
Originations |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Maturities |
( |
) |
( |
) |
– |
( |
) |
( |
) | ( |
) | – | ( |
) | ||||||||||||||||||||||||
Changes in risk, parameters and exposures |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||
Write-offs |
– |
– |
( |
) |
( |
) |
– | – | ( |
) | ( |
) | ||||||||||||||||||||||||||
Recoveries |
– |
– |
– | – | ||||||||||||||||||||||||||||||||||
Exchange rate and other |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Balance at end of period |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||||||||||||
Note 5 Loans and allowance for credit losses (continued) |
| • | Unemployment rates In our base forecast, we expect the Canadian unemployment rate to remain unchanged at in calendar Q1 2026 then decline over the short term, before returning to its long run equilibrium towards the latter end of the horizon. The U.S. unemployment rate is expected to peak at in calendar Q1 2026, then return to its long run equilibrium level in calendar Q4 2026. |
![]() |
![]() |
| • | Gross Domestic Product (GDP ) In our base forecast, we expect both Canadian and U.S. GDP to continuously grow in calendar Q1 2026 and thereafter. GDP in calendar Q4 2026 is expected to be above Q4 2025 levels in Canada and |
![]() |
![]() |
• |
Canadian housing price index |
As at |
||||||||||||||||||||||||||||||||||
January 31, 2026 |
October 31, 2025 |
|||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 |
Stage 2 |
Stage 3 (1) |
Total |
||||||||||||||||||||||||||
Retail |
||||||||||||||||||||||||||||||||||
Loans outstanding – Residential mortgages |
||||||||||||||||||||||||||||||||||
Low risk |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Medium risk |
– |
– | ||||||||||||||||||||||||||||||||
High risk |
– |
– | ||||||||||||||||||||||||||||||||
Not rated (2) |
– |
– | ||||||||||||||||||||||||||||||||
Impaired |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Items not subject to impairment (3) |
||||||||||||||||||||||||||||||||||
Total |
$ |
$ | ||||||||||||||||||||||||||||||||
Loans outstanding – Personal |
||||||||||||||||||||||||||||||||||
Low risk |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Medium risk |
– |
– | ||||||||||||||||||||||||||||||||
High risk |
– |
– | ||||||||||||||||||||||||||||||||
Not rated (2) |
– |
– | ||||||||||||||||||||||||||||||||
Impaired |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||
Loans outstanding – Credit cards |
||||||||||||||||||||||||||||||||||
Low risk |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Medium risk |
– |
– | ||||||||||||||||||||||||||||||||
High risk |
– |
– | ||||||||||||||||||||||||||||||||
Not rated (2) |
– |
– | ||||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Loans outstanding – Small business |
||||||||||||||||||||||||||||||||||
Low risk |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Medium risk |
– |
– | ||||||||||||||||||||||||||||||||
High risk |
– |
– | ||||||||||||||||||||||||||||||||
Not rated (2) |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Impaired |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||
Undrawn loan commitments – Retail |
||||||||||||||||||||||||||||||||||
Low risk |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Medium risk |
– |
– | ||||||||||||||||||||||||||||||||
High risk |
– |
– | ||||||||||||||||||||||||||||||||
Not rated (2) |
– |
– | ||||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Wholesale – Loans outstanding |
||||||||||||||||||||||||||||||||||
Investment grade |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||||
Not rated (2) |
– |
– | ||||||||||||||||||||||||||||||||
Impaired |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Items not subject to impairment (3) |
||||||||||||||||||||||||||||||||||
Total |
$ |
$ | ||||||||||||||||||||||||||||||||
Undrawn loan commitments – Wholesale |
||||||||||||||||||||||||||||||||||
Investment grade |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||||
Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||||
Not rated (2) |
– |
– | ||||||||||||||||||||||||||||||||
Total |
$ |
$ |
$ |
– |
$ |
$ | |
$ | |
$ | – | $ | |
|||||||||||||||||||||
| (1) | Includes $ |
| (2) | In certain cases where an internal risk rating is not assigned, we use other approved credit risk assessment or rating methodologies, policies and tools to manage our credit risk. |
| (3) | Items not subject to impairment are loans held at FVTPL. |
Note 5 Loans and allowance for credit losses (continued) |
As at |
||||||||||||||||||||||||||
January 31, 2026 |
October 31, 2025 |
|||||||||||||||||||||||||
(Millions of Canadian dollars) |
30 to 89 days |
90 days and greater |
Total |
30 to 89 days |
90 days and greater |
Total |
||||||||||||||||||||
Retail |
$ |
$ |
$ |
$ | $ | $ | ||||||||||||||||||||
Wholesale |
||||||||||||||||||||||||||
$ |
$ |
$ |
$ | |
$ | |
$ | |
||||||||||||||||||
| (1) | Excludes loans less than 30 days past due as they are not generally representative of the borrowers’ ability to meet their payment obligations. |
| (2) | Amounts presented may include loans past due as a result of administrative processes, such as mortgage loans on which payments are restrained pending payout due to sale or refinancing. Past due loans arising from administrative processes are not representative of the borrowers’ ability to meet their payment obligations. |
Note 6 Deposits |
As at |
||||||||||||||||||||||||||||||||||
January 31, 2026 |
October 31, 2025 |
|||||||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Demand |
Notice |
Term |
Total |
Demand (1) |
Notice (2) |
Term (3) |
Total |
||||||||||||||||||||||||||
Personal |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||
Business and government |
||||||||||||||||||||||||||||||||||
Bank |
– |
– | ||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ | $ | $ | $ | |||||||||||||||||||||||||||
Non-interest-bearing (4) |
||||||||||||||||||||||||||||||||||
Canada |
$ |
$ |
$ |
$ |
$ | $ | $ | $ | ||||||||||||||||||||||||||
United States |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Europe (5) |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Other International |
– |
– |
– | – | ||||||||||||||||||||||||||||||
Interest-bearing (4) |
||||||||||||||||||||||||||||||||||
Canada |
||||||||||||||||||||||||||||||||||
United States |
||||||||||||||||||||||||||||||||||
Europe (5) |
||||||||||||||||||||||||||||||||||
Other International |
||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
|||||||||||||||||||||||
| (1) | Demand deposits are deposits for which we do not have the right to require notice of withdrawal, which include both savings and chequing accounts. |
| (2) | Notice deposits are deposits for which we can legally require notice of withdrawal. These deposits are primarily savings accounts. |
| (3) | Term deposits are deposits payable on a fixed date, and include term deposits, guaranteed investment certificates and similar instruments. |
| (4) | The geographical splits of the deposits are based on the point of origin of the deposits and where the revenue is recognized. As at January 31, 2026, deposits denominated in U.S. dollars, British pounds, Euro and other foreign currencies were $ billion, $billion, billion and $billion, |
| (5) | Europe includes the United Kingdom and the Channel Islands. |
As at |
||||||||
(Millions of Canadian dollars) |
January 31 2026 |
October 31 2025 |
||||||
Within 1 year: |
||||||||
less than 3 months |
$ |
$ | ||||||
3 to 6 months |
||||||||
6 to 12 months |
||||||||
1 to 2 years |
||||||||
2 to 3 years |
||||||||
3 to 4 years |
||||||||
4 to 5 years |
||||||||
Over 5 years |
||||||||
$ |
$ | |
||||||
| (1) | The aggregate amount of term deposits in denominations of one hundred thousand dollars or more is $ billion (October 31, 2025 – $ |
Note 7 Insurance and reinsurance |
For the three months ended |
||||||||
(Millions of Canadian dollars) |
January 31 2026 |
January 31 2025 |
||||||
Insurance service result |
||||||||
Insurance revenue |
$ |
$ | ||||||
Insurance service expense |
( |
) |
( |
) | ||||
Net income (expense) from reinsurance contracts held |
( |
) |
||||||
$ |
$ | |||||||
Insurance investment result |
||||||||
Net investment income |
$ |
$ |
|
|||||
Insurance finance income (expense) |
( |
) |
( |
) | ||||
Reinsurance finance income (expense) |
||||||||
$ |
$ | |||||||
Insurance service and insurance investment results |
$ |
$ | ||||||
Note 8 Employee benefits – Pension and other post-employment benefits |
For the three months ended |
||||||||||||||||||
Pension plans |
Other post-employment benefit plans |
|||||||||||||||||
(Millions of Canadian dollars) |
January 31 2026 |
January 31 2025 |
January 31 2026 |
January 31 2025 |
||||||||||||||
Current service costs |
$ |
$ |
$ |
$ |
||||||||||||||
Net interest expense (income) |
( |
) |
( |
) |
||||||||||||||
Remeasurements of other long-term benefits |
– |
– |
( |
) |
||||||||||||||
Administrative expense |
– |
– |
||||||||||||||||
Defined benefit pension expense |
||||||||||||||||||
Defined contribution pension expense |
– |
– |
||||||||||||||||
$ |
$ |
|
$ |
$ |
||||||||||||||
For the three months ended |
||||||||||||||||||
Defined benefit pension plans |
Other post-employment benefit plans |
|||||||||||||||||
(Millions of Canadian dollars) |
January 31 2026 |
January 31 2025 |
January 31 2026 |
January 31 2025 |
||||||||||||||
Actuarial (gains) losses: |
||||||||||||||||||
Changes in financial assumptions (2) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
||||||||||
Experience adjustments |
( |
) |
– |
( |
) |
– |
||||||||||||
Return on plan assets (excluding interest based on discount rate) |
( |
) |
– |
– |
||||||||||||||
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||
| (1) | Market based assumptions, including Changes in financial assumptions and Return on plan assets, are reviewed on a quarterly basis. All other assumptions are updated during our annual review of plan assumptions. |
| (2) | Changes in financial assumptions in our defined benefit pension plans primarily relate to changes in discount rates. |
Note 9 Significant capital and funding transactions |
For the three months ended |
||||||||||||||||||
January 31, 2026 |
January 31, 2025 |
|||||||||||||||||
(Millions of Canadian dollars, except number of shares) |
Number of shares (thousands) |
Amount |
Number of shares (thousands) |
Amount |
||||||||||||||
Issued in connection with share-based compensation plans (2) |
$ |
$ | |
|||||||||||||||
Purchased for cancellation (3) |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||||
( |
) |
$ |
( |
) |
( |
) | $ | ( |
) | |||||||||
(1) |
The requirements of our dividend reinvestment plan (DRIP) are satisfied through either open market share purchases or shares issued from treasury. During the three months ended January 31, 2026 and January 31, 2025, the requirements of our DRIP were satisfied through open market share purchases. |
(2) |
Amounts include cash received for stock options exercised during the period and the fair value adjustment to stock options. |
(3) |
During the three months ended January 31, 2026, under the normal course issuer bid (NCIB) we purchased for cancellation common shares at a total fair value of $ |
| Note 10 Earnings per share |
For the three months ended |
||||||||
(Millions of Canadian dollars, except share and per share amounts) |
January 31 2026 |
January 31 2025 |
||||||
| Basic earnings per share |
||||||||
| Net income |
$ |
$ | ||||||
| Dividends on preferred shares and distributions on other equity instruments |
( |
) |
( |
) | ||||
| Net income attributable to non-controlling interests |
( |
) |
( |
) | ||||
| Net income available to common shareholders |
$ |
$ | ||||||
| Weighted average number of common shares (in thousands) |
||||||||
| Basic earnings per share (in dollars) |
$ |
$ | ||||||
| Diluted earnings per share |
||||||||
| Net income available to common shareholders |
$ |
$ | ||||||
| Weighted average number of common shares (in thousands) |
|
|||||||
| Stock options (1) |
||||||||
| Average number of diluted common shares (in thousands) |
||||||||
| Diluted earnings per share (in dollars) |
$ |
$ | ||||||
| (1) | The dilutive effect of stock options was calculated using the treasury stock method. When the exercise price of options outstanding is greater than the average market price of our common shares, the options are excluded from the calculation of diluted earnings per share. For the three months ended January 31, 2026, an average of with an average exercise price of $ were excluded from the calculation of diluted earnings per share. For the three months ended January 31, 2025, an average of |
| Note 11 Legal and regulatory matters |
| Note 12 Results by business segment |
For the three months ended January 31, 2026 |
||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Personal Banking |
Commercial Banking |
Wealth Management |
Insurance |
Capital Markets |
Corporate Support |
Total |
|||||||||||||||||||||
| Net interest income (2) |
$ |
$ |
$ |
$ |
– |
$ |
$ |
$ |
||||||||||||||||||||
| Non-interest income |
( |
) |
||||||||||||||||||||||||||
| Total revenue |
||||||||||||||||||||||||||||
| Provision for credit losses |
– |
( |
) |
|||||||||||||||||||||||||
| Non-interest expense |
||||||||||||||||||||||||||||
| Income (loss) before income taxes |
( |
) |
||||||||||||||||||||||||||
| Income taxes (recoveries) |
( |
) |
||||||||||||||||||||||||||
| Net income |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||
| Non-interest expense includes: |
||||||||||||||||||||||||||||
| Depreciation and amortization |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
| For the three months ended January 31, 2025 | ||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Personal Banking |
Commercial Banking |
Wealth Management |
Insurance | Capital Markets (1) |
Corporate Support (1) |
Total | |||||||||||||||||||||
| Net interest income (2) |
$ | $ | $ | $ | – | $ | $ | $ | ||||||||||||||||||||
| Non-interest income |
( |
) | ||||||||||||||||||||||||||
| Total revenue |
||||||||||||||||||||||||||||
| Provision for credit losses |
– | – | ||||||||||||||||||||||||||
| Non-interest expense |
||||||||||||||||||||||||||||
| Income (loss) before income taxes |
( |
) | ||||||||||||||||||||||||||
| Income taxes (recoveries) |
( |
) | ||||||||||||||||||||||||||
| Net income |
$ | $ | $ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||
| Non-interest expense includes: |
||||||||||||||||||||||||||||
| Depreciation and amortization |
$ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | |||||||||||||||||
| (1) | Taxable equivalent basis. |
| (2) | Interest revenue is reported net of interest expense as we rely primarily on net interest income as a performance measure. |
As at January 31, 2026 |
||||||||||||||||||||||||||||
(Millions of Canadian dollars) |
Personal Banking |
Commercial Banking |
Wealth Management |
Insurance |
Capital Markets |
Corporate Support |
Total |
|||||||||||||||||||||
| Total assets |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
| Total liabilities |
( |
) |
||||||||||||||||||||||||||
| As at October 31, 2025 | ||||||||||||||||||||||||||||
| (Millions of Canadian dollars) | Personal Banking |
Commercial Banking |
Wealth Management |
Insurance | Capital Markets |
Corporate Support |
Total | |||||||||||||||||||||
| Total assets |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
| Total liabilities |
( |
) | ||||||||||||||||||||||||||
Note 13 Capital management |
As at |
||||||||
(Millions of Canadian dollars, except percentage amounts) |
January 31 2026 |
October 31 2025 |
||||||
Capital (1) |
||||||||
CET1 capital |
$ |
$ | ||||||
Tier 1 capital |
||||||||
Total capital |
||||||||
Risk-weighted assets (RWA) used in calculation of capital ratios (1) |
||||||||
Credit risk |
$ |
$ | ||||||
Market risk |
||||||||
Operational risk |
||||||||
Total RWA |
$ |
$ | ||||||
Capital ratios and Leverage ratio (1) |
||||||||
CET1 ratio |
||||||||
Tier 1 capital ratio |
||||||||
Total capital ratio |
||||||||
Leverage ratio |
||||||||
Leverage ratio exposure |
$ |
$ | |
|||||
TLAC available and ratios (2) |
||||||||
TLAC available |
$ |
$ | ||||||
TLAC ratio |
||||||||
TLAC leverage ratio |
||||||||
| (1) | Capital, RWA and capital ratios are calculated using OSFI’s Capital Adequacy Requirements (CAR) guideline and the Leverage ratio is calculated using OSFI’s Leverage Requirements (LR) guideline. Both the CAR guideline and LR guideline are based on the Basel III framework. |
| (2) | TLAC available and TLAC ratios are calculated using OSFI’s TLAC guideline. The TLAC standard is applied at the resolution entity level which for us is deemed to be Royal Bank of Canada and its subsidiaries. A resolution entity and its subsidiaries are collectively called a resolution group. The TLAC ratio and TLAC leverage ratio are calculated using TLAC available as a percentage of total RWA and leverage exposure, respectively. |
Exhibit 99.3
Return on Equity and Assets Ratios
| Q1 2026 | For the Year-Ended October 2025 |
For the Year-Ended October 2024 |
For the Year-Ended October 2023(1) |
|||||||||||||
| Return on Assets |
0.89 | % | 0.85 | % | 0.77 | % | 0.73 | % | ||||||||
| Return on Equity |
17.6 | % | 16.3 | % | 14.4 | % | 14.3 | % | ||||||||
| Dividend Payout Ratio |
41 | % | 43 | % | 50 | % | 52 | % | ||||||||
| (1) | Amounts have been restated from those previously presented as part of the adoption of IFRS 17, effective November 1, 2023. |





